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General introduction 

Chapter 1 
1.1 Chromosomal aberrations in cancer 
It was not until 1960, with the finding of the Philadelphia chromosome in c1u'onic 
myelocytic leukemia (Nowell and Hungerford 1960), that the first specific chromosomal 
abnomlality was definitively associated with human cancer. This in spite of the fact that already 
more than 40 years earlier cancerous growth was associated with an abclTant genome (Bayed 
1914). The main reason for this delay was the lack of suitable tools for isolation and 
identification of human chromosomes. 
After the development of specific staining methods in the early seventies, initially 
mainly nOll-solid tUlllors were cytogenetically analysed because their meta phases were more 
easily obtained, Subsequently with the development of more recent cytogenetic teciUliques, 
chromosomal analysis of solid tumors became more feasible. A wide variety of chromosomal 
abenations are currently identified in human neoplasia (for revie\v; Mitelman et a1. 1997). 
These comprise numerical changes, resulting in gains or losses of whole chromosomes, 
stmcturaI changes as translocations, inversions, deletions, homogeneously stained regions 
(HSRs) and double minutes (DMs). An example of an abnonllai chromosomal pattell1 as found 
in a solid tumor is shown in Figure 1. 
2 3 4 5 
x 8 9 10 t1 12 
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Fig. 1: Kmyotype of a testicular semi1loma showing variolls chromosomal aherrations: 
IIl1merica! (chromosomes 1,2,6,7,8,1 0,1 2,14, 15,19,20,21,22,X alld I), s/!'IIc/llra! (chromosomes 
6,7,8,11 alld 12) alld two IIl1idell/ified chromosomes (markers, M1 alit! M2). 
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·While some abelTations can be inherited, the majority occurs de 1/ovo. They can either 
originate spontaneollsly (Bischoff et at. 1990) or under the influence of chemical or physical 
carcinogens (Li et a!. 1997) or vimses (Akagi et a!. 1989; Namba et a!. 1996), or a combination 
of them. When these abnollllalities are primary and causative, they can be specific for a certain 
type of cancer and may be useful for diagnostic and/or prognostic purpose (Karakousis et al. 
1987; Sandberg 1988; Trent et a!. 1989; Fletcher et a!. 1991). However, most are secondary, 
related to the progression of cancer, and therefore less specific (Johansson et a!. 1996). 
It has become clear that most solid cancers are clinically manifest after undergoing 
several genomic abelTations, involving multiple (parts of) chromosomes. Therefore, it usually 
takes decades for an incipient tumor to accumulate the aberrations required for malignant 
growth. The first cancel' of which the sequential genomic aberrations were elucidated was colon 
cancer (Vogelstein et a1. 1988). Its carcinogenesis appears to be a multistep process, in which at 
least five (epi-)genetic changes are necessary for complete malignant transformation ofnonnal 
colon epithelial cells. 
!Holecular changes in cancer 
\Vith the development of molecular techniques in the seventies, it became obvious that 
the chromosomal aberrations found in cancer, are indicators for smaller alterations at the DNA 
level. These alterations may influence various processes within a cell, e.g. DNA repair, 
apoptosis and cell cycle control (Pearson and Van der Luijt 1998; Jlyas et a!. 1999; Pihan and 
Doxsey 1999). Three main categories of genes are involved in carcinogenesis: proto-
oncogenes, tumor suppressor genes and DNA mismatch repair genes. Aberrations of these 
particular genes may influence tumor growth in different ways. Due to mutation, translocation 
or amplification proto-oncogenes can be activated (oncogenes) thereby stimulating tumor 
growth. A similar effect can be reached by inactivation of a tumor suppressor gene, either via 
physical loss, mutation or methylation. The DNA repair genes contribute in tumor development 
when they are mutated, which can lead to activation of proto-oncogenes and inactivation of 
tumor suppressor genes (Kinzler and Vogel stein 1997). In general, tumors with a defect in the 
repair system, characterised by microsatellite instability, are diploid (Fishel et a!. 1993). 
Thusfar, only few mutations have been found in mismatch repair genes especially in 
nonpolyposis colorectal carcinoma (Leach et al 1993; Peltomtiki et al. 1993). In contrast, 
numerous (proto-)onco- and tumor suppressor genes are involved in a wide range of human 
cancers (see for review hltp:ll\V\vw.biomedcomp.com and hUp:II\V\V\v.ncbLnlm.nih.gov/ 
ncicpap/CGAP). Some of these genes are frequently involved in different cancers. For instance, 
the tumor suppressor gene P53 is inactivated in approximately 50% of solid malignancies 
including breast, lung and colon cancer. Among the proto-oncogenes, the RAS genes (K-, H-, 
and N-RAS), coding for regulatOlY proteins in signal transduction, are 1110st frequently mutated 
in colon and pancreatic carcinomas and adenocarcinomas of the lung and oval)' (Anderson et 
a!. 1992). 
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In conclusion, activation (proto-oncogenes) and inactivation (tumor suppressor genes) of 
multipJe genes playa role in the development of cancer, and are often associated with a variety 
of chromosomal abnonnalities. Identification of these specific chromosomal anomalies is an 
important step in unravelling the molecular mechanisms of the pathogenesis of a particular type 
of cancer. Furthemlore, these findings may have applications in early detection, diagnosis and 
prognosis of cancer (Jones and Fletcher 1999). 
1.2 Methods for chromosomal analysis of cancer cells 
A major breakthrough in the analysis of chromosomal aberrations was the introduction 
of the banding techniques in 1970 (Caspersson et a1. 1970). It allowed the identification of all 
human chromosomes based on specific banding patterns and led to a fast development in the 
characterisation of specific chromosomal abnonllalities in cancer. Most karyotypic data have 
been obtained from hematological malignancies (Mitelman 1991), from which metaphases are 
more easily obtained than from solid tumors, Therefore, the search for altemative cytogenetic 
methods, that circumvent the need of cells in mitosis, continued, and was beneficiated with the 
development of ill situ hybridisation. Although this teclmique was already discovered in 1969 
(Pardue and Oall 1969), it only became widely applied in the eighties, with the introduction of 
fluorescence detection methods, i.e. fluorescence ill situ hybridisation (FISH) (pinkel et a1. 
1986), More recent developments of FISH resulted in comparative genomic hybridisation 
(COR) (Kalliolliemi et a1. 1992; Du Manoir et a1. 1993) and 24-colour hybridisation, also 
known as multi-colour FISH and SKY (Schrock e( a1. 1996; Speicher et al. 1996). These 
developments have expanded the knowledge of chromosomal aberrations in solid tumors (see 
for review http://\vww,ncbLnlm.nih.gov/CCAP/milelsum.cgil. An overview of the cytogenetic 
methods and their application in tumor biology is shown in Table 1. Because FISH and CGH 
were applied in the studies described in Chapters 2-7 of this thesis, these methods will be 
discussed in more detail in the next paragraphs. 
Fluorescence ill sU" hybridisatioll (FISH) 
The radioactive ill situ hybridisation approach, introduced by Gall and Pardue in 1969, 
was the basis for the development of several non-radioactive modifications, Because this 
teclmique is relatively fast and easy, FISH has become a widely used method for mapping, 
biomedical research and diagnostic applications (for review sec Le Beau 1993; Fox et al. 1995; 
Siebert and Weber-Matthiesen 1997; Wemer et a1. 1997; Luke and Shepelsky 1998). Whereas, 
conventional cytogenetics was limited by the low Humber and often poor quality of meta phases, 
FISH, which can also be applied on intelllhase nuclei, allowed identification of genetic 
alterations in many previously unsolved and di fficult cases. The teclmique is based on 
hybridisation ora single DNA strand (probe) to a single homologous stranded sequence (target), 
fixed on a slide. The probe can be labeled directly by incorporation of nucleotides conjugated 
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Metaphase 
Interphase 
(isolated nuclei! 
tissue sections) 
DNA 
Table 1: 
Overview of the applicability of the (molecular) cytogenetic methods used in this thesis 
for the identification of numerical and structural anomalies. 
METHODS SUITABLE FOR IDENTIFICATION OF: 
karyotyping numerical and (particular) structural anomalies based on chromosome-
specific banding patterns. 
FISH numerical and the majority of structural anomalies visualised with specific 
probes. Mainly for refining of the characterization of previously detected 
re-arrangements. 
SKY numerical alterations, markers and interchromosomal rearrangements 
involving large chromosomal fragments~ an overview of the genome 
FISH numerical anomalies and a minority of structural aberrations. Especially 
the detection of structural aberrations requires pre-lcrlowledge of the 
re-arrangements and the need of spanning and flanking probes. 
CGH gains and losses (of parts) of a 11 clrromosomes; an overview. 
RESOLUTION: 
>2Mb 
>5Kb 
>2Mb 
>5Kb 
2Mb* 
Abbreviations used: FISH = fluorescent in situ hybridisation; SKY = spectral karyotyping; CGH = comparative genomic hybridization . 
• The resolution for gains is dependent on the combination of size of the region involved and copy number. 
Chapler I 
to fluorochromes or indirectly by incorporation of nuc1eotides conjugated to haptens, such as 
biotin or digoxigenill, and detected with fluorochrome conjugated molecules. The specific 
hybrid is visualised by fluorescence microscopy using appropriate filters. The probes can be of 
various sizes and complexity, recognizing repetitive sequences such as centromeric and 
telomeric regions or single copy sequences. A collection of probes covering an area, such as a 
c1u'omosome or a part thereof, can be used as a "painting" probe (Yung 1996) (see Figure 2). 
Fig. 2: 
Schematic representation 
of differelll probes IIsed 
Jor ill sit/{ hybridisatiol1: 
A: centromeric; 
B: whole chromosome 
paint; 
C: unique sequence and 
D: telomeric. 
A 
(! I) 
(l ) 
B c D 
For visualisation of a hybridised probe, fluorescein isothiocyanaat (FITC) is the 
fluorochrome most commonly used. For two colour (double) FISH and more colours 
simultaneously, fluorochromes as Texas Red, lissamine, rhodamine or its derivatives, AMCA or 
cascade blue are applied (Tanke 1999). Beyond that, multiplicity of FISH is significantly 
increased by the use of comb inatori ally or ratio-labeled probes (Nederlofet al. 1990; Ried et al. 
1992). Simultaneous visualisation of all human chromosomes became possible by 
combinatorial labeling with five fluorochromes (Schrock et al. 1996; Speicher et al. 1996). 
Recently, combinatorial labeling was combined with ratio-labeling (Combined Binary Ratio 
labeling; COBRA) achieving a theoretical multiplicity of 48 with the same five fluorochromes 
(Tanke et al. 1999). 
FISH is a powerful tool in cancer research. A major application is the assessment of 
numerical aberrations in interfase nuclei of tumor cells with centromeric probes (Barranco et al. 
1998; Mendelin et al. 1999; Poetsch et al. 1999). Other examples are the precise mapping of 
deleted or amplified regions, (Bell et al. 1996; Elkahloun et al. 1996), identification of marker 
chromosomes (Bosehman et al. 1993; Shi et al. 1993; Brandt et al. 1994; Arkesteijn et al. 1999) 
and translocatiolls (Mancini et al. 1994; Janz et al. 1995; Shipley et al. 1996; \Veber-Matthiesen 
et al. 1996). 
Besides the use of FISH on metaphases and isolated nuclei, this teclUlique can also be 
used on frozen tissue sections and fonllalin-fixed, paraffin-embedded material, allowing 
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analysis of chromosomal anomalies in cells within their histological context (Schofield and 
Fletcher 1992; Werner et al. 1997). The value of this method can be enhanced by its 
combination with imlllunohistochemistty (Weber-Matthiesen et al. 1993; Nolte et al. 1995). 
The estimated lower detection limit of FISH lies between 1-5 kb of target DNA 
(Lawrence et al. 1988). However, targets of 10-40 kb are more suited for this technique. 
Several attempts have been made to improve the sensitivity either by amplification of the target, 
e.g. primed ill situ (PRINS) polymerase chain reaction (PCR) or amplification of the signal ill 
situ by, e.g. the CARD signal amplification method. The latter t~clmique seems the most 
promising and has resulted in a significant increase in the signal intensity for the detection of 
both repetitive sequences as well as single copy genes (Raap et at. 1995, for review; Speel et al. 
1999). The CARD amplification method is based on the deposition of a large number of 
haptenized tyramide molecules by peroxidase activity at the site of hybridisation. Visualisation 
of deposited tyramides can be perfonned either directly by the use of fluorochrome-labeled 
tyramides, or indirectly if biotin, digoxigenin or di- or trinitrophenyl conjugated to tyramide are 
used, and detected by fluoroclu'ome-Iabeled molecules (Speel et al. 1995). With this method for 
signal-amplification the intensity of the FISH signal could be improved in the range of two- to 
toO-fold. Furthennore, it improves the detection of weak signals of cosmids in tumor material 
(this thesis) and allows the detection of repetitive and single-copy DNA sequences (up to the 
level of 1-5 kb) in cell preparations. However, in spite of the higher signal intensities generated 
by this detection system, it remains to be proven if it allows the visualisation of small targets 
which cmmot bc detected by standard methods. 
Compa!'ative genomic hyb!'idisation (CGH) 
Although FISH is a powerful technique, in contrast with classical kmyotyping, it 
investigates a limited number of targets per experiment, and therefore the method requires 
previolls knowledge on the areas to be investigated. This infonnation is especially scarce for 
solid tumors. An altemative approach became available with the technique of CGH 
(Kallioniemi et al. 1992; Du Manoir et al. 1993). In a single experiment, CGH provides a global 
overview of relative chromosomal gains and losses compared to the average ploidy. Briefly, 
differentially labeled test (green) and reference DNA (red) are hybridised simultaneously to 
nonual metaphase chromosomes. The ratio between the nOl1ualised intensities of the 
fluorescence signals, reflects differences in the amount of tumor DNA compared with normal 
DNA per chromosomal region. Chromosomal regions with an increased greenlred fluorescence 
ratio represent DNA gains, while a reduced ratio is a consequence of loss. The average ratio is 
calculated for the entire length of each chromosome using a digital image analysis system, and 
plotted along ideograms of the corresponding chromosomes (see Figure 3). The potential of 
COH has been significantly increased with the use of tissue microdissection followed by peR 
amplification of DNA. This allows analysis of specific tissue areas or even individual cells 
(Speicher et al. 1993; Speicher et al. 1995; Wiltshire et al. 1995; Klein et al. 1999). 
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Tumor DNA Normal DNA 
green: me red: TRITe 
B i 
Fluorescence Ratio 
red 1.0 gre-<!n 
6 gain 
Di~trn Image Processing 
Ilybridulio~ 
fluoreHence Microscopy loss 
N()(m31 Human Metaphase 
Fig.3: Schematic overview of the CGH technique. Tumor alld reference DNA are labeled with a 
green and red fluorochrome, respectively, and hybridised to 1I0rmal metaphase spreads. Images 
of Ihe fluorescent signals are captured, and the green-Io-red signal ratios are digitally 
quantified for each chromosome homologue. (reprinted with permission from Hermsen ef al. 
/996). 
Another important breakthrough in the development and application of CGH is the use 
of archival (paraffin) material. In most studies test (tumor) DNA has been extracted from fresh 
or frozen samples and from cultured cell lines. Recently procedures were improved to isolate 
good quality DNA from paraffin-embedded material (Speicher et al. 1993; Isola et al. 1994). 
CGH with DNA extracted from paraffin~embedded matetial allows retrospective analysis of 
many tumors that are pathologically well characterised and of patients with known clinical 
outcome. The main difficulty with the use of paraffin~embedded material is to obtain DNA 
fragments which are suitable for CGH after labeling by nicktranslation. The optimal size of 
labeled DNA for CGH is 500-2000 bp, the same size that is often obtained of DNA extracted 
from paraffin-embedded material, or DOP (degenerated-oligo-primed)-PCR products. 
Nicktranslation will further reduce the fragment size by the use of DNase. To avoid this 
problem, a chemical labeling with plat in can be used (Aiel'S et al. 1999). These tecllllical 
developments have made CGH more easily applicable for the analysis of solid tumors both 
from frozen and paraffin embedded material (see for review 
http://www.nhgri.nih.govIDIRILCG/CGHlindex.html). 
Depending on the type of aberration, the ploidy of the tumor cells, intraHtumor 
heterogeneity and contamination with normal cells. of the specimens under investigation, CGH 
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allows identification of chromosomal gains and losses with a fair resolution. Amplifications are 
detectable at a higher resolution than deletions. Based on simulation models, an amplified 
region can be detected if the product of the size of the amplified region and the number of 
copies is at least 2 Mb (piper et al. 1995), In this way CGR can detect an amplified region as 
small as 100 kb as long as the copy number is at least 20 (Joos et al. 1993), The detection limit 
of a deletion is in the order of 3 Mb using special detection criteria (standard reference 
intervals) (Kirchhoff et al. 1999), Since the main limitation of CGH is the resolution of the 
hybridisation target (the chromosomes) (see Table 1) , CGR has recently been applied on DNA 
and cDNA clones from small regions on the genome, anayed on a slide, in so called micro-
arrays (Pinkel et al. 1998; Pollack et al. 1999), This modification highly improves the resolution 
of the approach and can be considered as a bridge behveen cytogenetics and molecular genetics. 
1.3 Testicular germ cell tumors; origin and development 
Human geml cell tumors are a heterogeneous group of tumors of which the (primordial) 
genn cell is the cell of origin. They occur mainly in the gonads, but also in specific 
extragolladal sites. This distribution is explained by the migration route of the primordial genn 
cells, originating in the yolk sac endodellll of the 4th week embryo and migrating along the 
dorsal mesentery to the genital ridge. In the male, genn cell tumors may develop either in the 
testis or in midline sites of the body such as the sacrococcygeal region, retroperitoneUlll, 
mediastinum and brain (Mostofi 1973; Scully 1979), In adolescents and adults (including 
elderly) the most frequent site of is the testis. In neonates and infants the majority is found in 
the sacral region, predominantly affecting females. The testicular genu cell tUlllors can, based 
on their histology, age of the patient at clinical diagnosis and biological behaviour, be classified 
into three groups; 
Testicular genu cell tumors of neonates and infants (GeTI): teratomas and yolk sac 
tumors; 
Testicular geml cell tUnlors of adolescents and young adults (TOCT): seminomas and 
nonseminomas; 
Testicular genu cell tumors of the elderly man (SS): spenuatocytic seminomas. 
In the next paragraphs the main characteristics of these groups and the current view on their 
relationship(s) will be reviewed, 
Testicular germ cell tUIllors of neonates and infants (GeTI) 
GCT! are found in young children with an incidence of 0,12 per 100,000 (Looijenga 
1999, for review). They occur mostly in extragonadal sites (67%), especially in the sacral region 
18 
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(45%), and only occasionally in the testis (6%). Histologically, the GCT! are composed of 
teratoma or yolk sac tumor. The teratomas are benign and can be cured by orchidectomy alone, 
The yolk sac tumors, occuning more often than the teratomas (4: 1) (Hanns and Janig 1986), are 
malignant and may require additional chemotherapy. 
In contrast to its presence in the adjacent parenchyma of TGCT (see below), carcinoma 
ill sitll (CIS), the common precursor of TGCT (Skakkebrek et al. 1987), has not been 
convincingly demonstrated adjacent to GCTL Sacrococcygeal genu cell tumors are usually 
large, benign teratomas presenting at or shortly after biI1h, Patients older than 6 months of age 
have a greater risk of developing a malignant yolk sac tumor either within a pre-existing 
teratoma or at the site of a previously incompletely resected teratoma (Perlman et a1. 1994). 
Flow cytometry studies have shown that teratomas are in general diploid (Hoffner et a1. 
1994; Silver et al. 1994; Stock et al. 1995) while yolk sac tumors may be aneuploid, mainly 
near-tetraploid (Oosterhuis et a!. 1989; Konulloss et a!. 1990; Perlman et al. 1994; Jenderny et 
a!. 1995). This ploidy difference was confil111ed by cytogenetics: both FISH and karyotypic 
analyses showed no chromosomal aberrations in the teratomas and several aberrations in the 
yolk sac tumors. \Vllether this absence of chromosomal aberrations in the teratomas is due to 
loss 0 f tumor cells upon handling is unknown thUSh1f. In the yolk sac tumors, kmyotyping 
revealed anomalies of the short ann of chromosome 1, in particular loss of band p36, the long 
arm of chromosome 6 and abnormalities of 3p (Kaplan et at. 1979; Oosterhuis et a1. 1988; 
Oosterhuis et a!. 1993; HOmler et al. 1994; Perlman et a!. 1994; Bussey et a!. 1999). FISH 
confinned the chromosome 1 aberrations but demonstrated also copy number changes for 
chromosomes 8,10,12,17 and X in the yolk sac tumors (Hu 1992; Stock et al. 1994; Jendemy 
et al. 1995; Perlman et al. 1996). No FISH data on chromosome 3 and 6 are available. 
Testicular germ cell tumors of adolescents and adults (TGCT) 
Epidemiology 
Although TGCT are one of the rarer types of malignancies, accounting for only 1 ~3 % of 
all neoplasms in men, it is the most coml11on cancer in young adult males (15 - 45 yrs) 
(Swerdlow 1993). The worldwide incidence has more than doubled over the past 40 years (Bosl 
and Moizer 1997). Several epidemiological studies show geographical and racial differences in 
the occurrence of these tumors. In European populations the incidence is about 5/100.000 while 
the incidence is lower in African and Asian populations (Parkin and Muir 1992) with exception 
of the New Zealand Maori, in whom the incidence is one of the highest in the world 
(8.3/100.000). There is also a wide variation within geographical regions: for instance, in 1980, 
Denmark showed a ten fold higher incidence than Lithuania (Adami et al. t 994). There is no 
explanation for these racial and geographic differences thus far. Interesting is the finding that 
cryptorchidism, which is a major risk factor (4-5x) (Pottem et al. 1985; Giwercman et al. 1987) 
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for the development ofTGCT, is three times lower in black than in white males (Henderson et 
al. 1988), Other factors can be the onset of puberty, which occurs late in Maori boys, and 
genetic predisposition (Wilkinson et al. 1992). Suggestions that environmental factors are of 
etiological importance came from a study in Denmark. It showed that men bom during the 
second world war have a lower risk for TGCT than those in birth cohorts preceding and 
following the \var (Moller 1989). Recent publications suggest that the increasing presence of 
estrogenic compounds in the enviroilluent plays a role in the increasing incidence of TGCT 
(Sharpe and Skakkebaek 1993; Toppari et al. 1996). 
Histology, clinical behaviour and models of progression 
Clinically and morphologically, TGCT can be divided into two different entities: 
seminoma (SE) and nonseminoma (NS). SE becomes clinically manifest at a mean age of 35 
years, while NS usually presents approximately one decade earlier. SE is composed of the 
neoplastic counterparts of early genu cells, probably primordial genn cells. NS may be 
composed of embryonic tissues (embryonal carcinoma, immature and mature teratoma) and/or 
extra~embryonic tissues (yolk sac tumor and choriocarcinoma). Of the TGCT, 40 % and 50 % 
present as NS and SE, respectively. The remaining TGCT, composed of both a SE and a NS 
component, are classified as combined tumor (CT) according to the British classification (pugh 
1976) and as NS according to the WHO classification (Mostofi et al. 1998). 
In general, SE is less aggressive than NS, although the aggressiveness of the latter 
depends on the histologic SUbtype. The overall cure rate of patients with TGCT is high, but still 
about 10 % orthe patients die of their disease. Aggressive treatment may lower this percentage. 
Thus h1r there are no reliable factors predicting outcome of therapy on an individual basis 
(Bokemeyer and Schmoll 1995). 
SE and NS have a common precursor, known as CIS (Skakkeb",k et al. 1987), 
composed of intratubuJar tumor cells resembling SE cells. Extrapolation, based on follow up 
studies of men diagnosed for CIS without an invasive TGCT, showed that CIS will always 
progress into an invasive TGCT (Burke and Mostofi 1988; Dieckmann and Loy 1993; 
Giwercman et aL 1993). The initial expansion of the CIS cells can be seen either as intratubular 
or micro~invasive seminoma. 
Basically two models exist for the development of CIS into an invasive TGCT. One 
ass limes that all histological variants of TGCT originate independently (Mostofi 1984; 
Sesterhenn 1985) while the other supposes SE to be an intennediate stage between CIS and the 
various nonseminomatolls lineages (Oliver 1987; Oosterhuis et al. 1989). Cytogenetic studies 
favor the latter model with the finding of common stmctural chromosomal abelTations in both 
the SE and NS component ofa CT (Haddad et al. 1988; Van Eehten-Arends et al. 1995a). This 
model was recently adjusted with the hypothesis that in every stage during the development of 
TGCT, reprogramming of CIS or seminoma cells to pluripotent embryonal carcinoma cells, the 
stem cells of nonseminomas, can take place (Oosterhuis et al. 1997). It is suggested that the 
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chance of reprogramming of CIS and SE to a NS decreases with age, explaining the observation 
that the nonseminomas are clinically manifest at an earlier age than the seminomas (Oosterhuis 
et a!. 1989). 
Chromosomal constitution 
Flow cytomctric studies showed that rocr arc aneuploid tumors with SE being 
hypel1riploid and NS hypotriploid (Oosterhuis et a!. 1989; Fossa et a!. 1991; EI-Naggar et a!. 
1992). In contrast to the model proposed by Nowell (Nowell 1976; Nowell 1986) in which 
polyploidization is related to tumor progression, in TGCT polyploidization is most likely one of 
the first events, followed by net loss of chromosomal material. The propensity for 
polyploidization in TGCT Illay be related to the (plimordial) genu cell derivation of these 
tUlllors. These cells may be particularly prone to polyploidization because they combine high 
mitotic activity and bridge fOl1uation. Interestingly, a defective mechanism of bridge fOllnation 
has been implicated in the pathogenesis ofTGCT (Gondos 1993). 
Polyploidization and subsequent net loss of chromosomes in TGCT results in a specific 
pattem of copy numbers of chromosomes as found by karyotyping (De Jong et a!. 1990; 
Castedo et a!. 1989; Van Echten-Arends et a!. 1995b). These studies showed, compared to a 
triploid DNA index, overrepresentation ofclumllosomes 7, 8,12 and X and undelTepresentation 
of chromosomes 11, 13, 18 and Y, both in SE and NS. Other frequently found cluomosomal 
abnonllalities are loss of cluomosome 4, 5 and 9, gain of chromosome 21 and at a lower 
frequency « 20%) deletions or derivatives of Ip21-26, 6qI4-25, 7qll-q36 and 12q12-24 
(Murty and Chaganti 1998). These are, however, not consistently found and occur also in other 
tumors, suggesting a tumor progression related event. Despite common aben"ations found in SE 
and NS, a significantly higher copy number of chromosomes 7, 15, 19 and 22, and a 
significantly lower number of cluomosome 17 was found in SE compared with NS (Van 
Echten-Arends et a!. 1995b). 
Besides the fact that TOCT are virtually always nearHtriploid, the only other consistent 
genetic anomaly is overrepresentation of the short ann of chromosome 12, mostly as an 
isochromosome of 12p [i(12p)] (see Figure 4). This isochromosome was first described in 1982 
(Atkin and Baker 1982) and is found in about 80% ofTGCT (De Jong et a!. 1990; Sandberg et 
a!. 1996). The uniparental origin of both chromosomal al1us of i(12p) (Sinke et a!. 1993) 
supports the idea that i(12p) originates from misdivision of the centromere rather than from a 
non-sister chromatid exchange as supposed by others (Mukherjee et a!. 1991). Even though 12p 
aberrations are always present in TOCT, polyploidization precedes i( 12p) fonnation. This was 
shown by the finding of retention of heterozygosity of the long ann ofcluomosome 12 in i(12p) 
positive TGCT (Geurts van Kessel et a!. 1989). 
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Fig.4: Representatives of schematic and actual G-banding of a normal chromosome 12 (AJ and 
(II/ isochromosome l2p ri(l2p)] (B). 
The idea that oven·epresentation of the short ann of clu-omosome 12 is of importance in the 
development of TGCT was confinned by FISH (Samaniego et al. 1990; Suijkerbuijk et al. 
1993). It was shown that also the i( 12p) negative TGCT show gain of 12p. Moreover, 
amplification of a restricted region of the short ann of chromosome 12 was found in a 
metastasis of a SE (Suijkerbuijk et al. 1994). 
(Proto-)ollcogelles alld suppressor genes 
Although infonnalion becomes available about the cytogenetic changes in the 
development of TGCT, molecular research in Tocr is still in its initial stage. To obtain more 
information about the possible role of tumor suppressor genes, loss of heterozygosity was 
addressed in several studies. Although contradictOlY results were obtained, some results were in 
accordance with cytogenetic data, e.g. deletions of regions involving Ip (Mathew et al. 1994), 
5q (Murty et al. 1994a; Peng et aJ. 1995; Peng el al. 1999) and 12q (Murty et aJ. 1992). 
In addition, some hal spots for deletions have bcen found, including DCC (I 8q21) and 
RB 1 (I 3q 14) (Mmty et aJ. 1994b). However, most tumor suppressor genes and (proto-
)oncogenes show no or only a low percentage of abenations in TOCr: e.g. A1YC (c-MYC; 
8q24, N-MYC; 2p24), c-KlT(4ql 1-12) (Tian et aJ. 1999) and P53 (17pI3) (Lathe et al. 1995), 
K-RAS (12pl 2) (Dmitrovsky et al. 1990) and NMEl (I 7q22) (Schmidt et aJ. 1997). 
At the RNA level, increased expression has been found of the proto-oncogenes c-KlT 
(Raj pert-De Meyts and Skakkeb",k 1994; Strohmeyer et aJ. 1995), N-MYC, c-MDS (Shuin et 
aJ. 1994), cyclin D2 and K- or N-RAS (Houldsworth et aJ. 1997). A decrease or loss of 
expression was found for RB, DCC (Murty et aJ. 1994b), INT-2 (Yoshida et aJ. 1988; 
Shimogaki et al. 1993) and c-ERB-l and 2 (Shuin et aJ. 1994). 
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Since no microsatellite instability has been found thusfar with one exception (Murty et 
al. 1994c), there is no indication that defects of repair genes participate iH the development of 
TGCT (Lothe et al. 1995), 
Familial rGCr 
Epidemiological and linkage analyses suggest that one third of all TGCT -patients may 
be genetically predisposed (Nicholson and Harland 1995), Several investigators have tried to 
identify the chromosomal regions harboring the susceptibility gene(s), Linkage analysis of 50 
families with 221 markers, (Leahy et al. 1995) identified regions on chromosomes I, 4 (2 
regions), 5, 14 and 18 as candidates. Re~analysis of this series and combining the results with 
those of an extended study by the Intemational Testicular Cancer Linkage Consortium, provides 
suggestive evidence for linkage to parts of chromosomes 3, 5, 12 and 18 (Rapley et al. 1998), 
Unfortunately, the results do not provide strong evidence for the location of a predisposing 
gene, for which genetic heterogeneity (different genes causing the same disease endpoint) might 
be an cxplanation, A recent study indicated linkage to Xq27 in case of bilateral TGCT and 
TGCT related to cryptorchidism (Rapley et aI., 2000), 
Germ cell tumors of the elderly man (88) 
The third type of geml cell tumor which can be distinguished in the testis is 
spennatocytic seminoma (SS), predominantly found in elderly men, usually over 50 years of 
age, They never arise in extra~testicular sites, and mostly nm a benign course (Talennan 1980; 
Burke and Mostofi 1993), Phenotypically, SS is characterised by cellular heterogeneity with 
large, intellnediate and small cells, Morphologically they can mimic SE (Talennan 1980), In 
contrast to the SE, SS are supposedly derived from more differentiated cells: the spennatogonia 
B (Masson 1946; Rosai et al. 1969; Romanenko and Persidskii 1983), CIS cannot be found in 
the adjacent parenchyma of these tumors, although intratubular SS, supposedly the pre~invasive 
precursor of this neoplasm, is often present (Muller et al. 1987), 
Although in general a separate pathogenesis for SS is accepted, there are still some 
doubts, Based on the finding of c-KlT positivity in 40% of SS, it was most recently suggested 
that at least some of the SS originate more directly from primordial gen11 cells (Kraggerud et aL 
1999). Immunohistochemical detection of PLAP indicated clear differences between the 
different histologies, SS were negative (Dekker et al. 1992; Burke and Mostofi 1993) while CIS 
and SE were positive (Munivcl et al. 1987). Flow cytomehy showed a heterogeneolls pattcl11 for 
SS including both diploid and aneuploid stem lines (Takahashi 1993, Looijenga et al. 1994), 
Because of their rarity (0,2 per 100,000) (Burke and Mostofi 1993) little is known about their 
chromosomal constitution. 
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1.4 Aims of this thesis 
This thesis aims at a further understanding of the molecular genetics of genu cell tumors 
of the testis. In particular, the three entities (GCT!, TGCT and SS) are investigated regarding 
their chromosomal constitution using karyotyping, CGH and FISH. The results will be used to 
identify chromosomal abnollllalities involved in the development of these types of cancer, as a 
first step in the identification of the involved genes. In addition, the results will be used to 
discuss the possible pathogenetic relationship between these tumor types. 
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Abstract 
Chromosomal infonnation on germ cell tumors of the infantile testis, i.e, teratomas and 
yolk sac tumors, is limited and controversial. We studied two teratomas and four yolk sac tumors 
using comparative gcnomic- and ill situ hybridisation (CGH and FISH). No chromosomal 
anomalies \vere found in the teratomas by any of the methods, not even after CGH on 
microdissected tumor cells. All yolk sac tumors showed aneuploidy, loss of pUlis of 4q and 6q, 
and gain of parts of20q, Underrepresentation of parts of Sq, and Dverrepresentation of parts of3p, 
9q, 12p, 17, 19q, and 22 were detected in most cases. In addition, one recurrent yolk sac tumor 
after a sacral teratoma was studied, showing a highly similar pattem of imbalances. While COR 
demonstrated loss of 1 p36 in one testicular yolk sac tumor, FISH revealed loss of this region in all 
yolk sac tumors, High level amplification of the 12q13-q14 region was found in one yolk sac 
tumor, :MDM2, of which the encoding gene maps to tIus chromosomal region, was found in all 
cases using immunohistochemistry, while no P53 could be detected. Accordingly, no mutations 
within exons 5-8 ofthe P53 gene were obselved, 
These data prove absence of gross chromosomal abenations in teratomas of the infantile 
testis, and show a characteristic pattern of gains and losses in the yolk sac tumors. Besides 
confinnation of previously found anomalies, the recurrent losses of Ip21-31, 4q23-33 and gains of 
9q34 and 12p12-13 are novel. While genetic inactivation of P53 seems unimportant in the 
pathogenesis of these tumors, biochemical inactivation by :MDM2 might be involved. These data 
slipp0l1 the existence of three entities of genll cell tumors of the human testis, Le. teratomas and 
yolk sac tumors of infants, seminomas and nonseminomas of adolescents and young adults, and 
spem1atocytic seminomas of elderly, each with their own specific pathogenesis. 
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Introduction 
Human geml cell tumors comptise a heterogeneous group of neoplasms. which can be 
found at different anatomical localizations (gonads and several extragonadal sites), and present 
clinically at different ages (Oosterhuis ct ai., 1997; Looijenga and Oosterhuis 1999, for review). 
Within the testis, three entities can be distinguished. The most conml0n types are those of 
adolescents and young adults: the seminomas and nonsemillomas (Mostofi et aI., 1987). They 
originate from carcinoma ill sitll (CIS) (Skakkeb!ek 1972), which can be frequently found in 
preserved parenchyma adjacent to an invasive tumor. Both seminomas and nonseminomas are 
characterized by consistent gain of the complete short ann of chromosome 12 (Sandberg ct al., 
1996, for review). In addition, these tumors express wild type P53 extensively (Schenkman et 
ai., 1995; Guillou et aI., 1996). Less common are spennatocytic seminomas, mostly found in 
elderly men (Burke and Mostofi 1993). We demonstraled recently using karyotyping and 
comparative genomic hybridisation (CGH) that these tumors are characterised by gain of 
chromosome 9 (Rosenberg et al., 1998). The third group of testicular geml cell tumors comprise 
those found at young age, histologically divided into teratoma and yolk sac tumor, although other 
histological elements have sporadically been repo11ed. 
Infonnation about the chromosomal constitution of genu cell tumors of infants, 
including those of the testis, is limited, mainly due to their rareness, and sometimes 
inconsistent. Flow cytometry demonstrated in general that teratomas are diploid, whereas yolk 
sac tumors can either be diploid, tetraploid or aneuploid (Kommoss et aI., 1990; Silver et a1., 
1994). This difference was confimled by karyotyping, showing no aberrations in teratomas, 
while anomalies of the short arm of chromosome 1, in particular loss of band p36, the long ann 
of chromosome 6, and abnormalities of 31' were observed in yolk sac tumors (Kaplan et aI., 
1979; Ooslerhuis et ai., 1988; Oosterhuis et ai., 1993; HOm,er el aI., 1994; Perlman et ai., 1994; 
Stock et ai., 1995; Stock et aI., 1996; Bussey et aI., 1999). III situ hybridisation sUPP0l1ed 
absence of numerical abnonnalities in teratomas, but demonstrated in addition to chromosome 1 
ahen'ations, also copy number changes for chromosomes 8, 10, 12, 17, and X in the yolk sac 
tUl110rs (Hu et ai., 1992; Stock et ai., 1994; Jendemy et aI., 1995; Perlman et ai., 1996). The 
cytogenetic studies so far include only a few infonnative cases, possibly explained by loss of 
tumor cells during sample-preparation. Even the largest study on pediatric genu cell tumors 
(Bussey et aI, 1999) reported only one testicular yolk sac tumor, present in a patient under Ihe 
age of 10 years, with an abnonnal karyotype. Furthenl1ore, conflicting data with respect to 12p 
(Perlman et ai., 1994; Stock et ai., 1995; Jendemy el ai., 1995) and the presence of CIS (Slamp 
and Jacobsen 1993; Jorgensen et ai., 1995; Hawkins et ai., 1997) have been found. These 
uncertainties fluel the discussion about the pathogenetic relationship between germ cell tumors 
of the infantile testis and seminomas and nonseminomas. 
We performed fluorescent ill situ hybridisation (FISH) and CGH on a series of two 
teratomas and four yolk sac tumors of the infantile testis. Both teratomas were also karyotyped. 
In addition, a recnrrent yolk sac tumor of a sacral teratoma was studied. CGH can be perfonned 
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on fresh, frozen and fOffilalin-fixed (archival) material, and allows a screen of chromosomal 
imbalances throughout the whole genome within a single experiment (Kallioniemi et al., 1992). 
This method was previously found to be highly infonnative in our hands, even when applied on 
a relative small number of cases (Rosenberg et al., 1998). In case of absence of imbalances, 
CGH was also done with DNA from microdissected tumor cells. The role of P53 and MDM2 
was investigated by immunohistochemistry and mutation analysis of exons 5-8 of p53, 
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Material and methods 
Samples 
The samples included in this study were collected in close collaboration with urologists 
and pathologists in the south-westem part of the Netherlands and the University Hospital in 
Groningen. Directly after surgical removal, representative parts of the tumor and adjacent Honnal 
tissue (when available) were snap fi'Ozen and other pieces were fixed ovemight in 10% buffered 
fonnalin and subsequently embedded in paraffin. Of one case (no. 4) only paraffin-embedded 
material was available. The hlmors were diagnosed according to the World Health Organisation 
classification for testicular tumors (Mostofi 1980). Two cases were pure mature teratomas, while 
four \vere pure yolk sac tumors. In addition, we shldied one recurrent yolk sac hlmor of a sacral 
teratoma which we reported previously (Oosterhuis et aI., 1993). 
Metaphase preparations 
Representative parts of the tumor were enzymatically digested (collagenase, Sigma). and 
cultured in T75 flasks (Costar) for several days under standard conditions. i.e. 3T'C in a 
humidified atmosphere of 5% CO, in DMEMlHFI2 with 10% heat-inactivated FCS (BRL-
GIBCO), as repOlted before (Castedo et ai, 1989). Mitotic cells were harvested after 2-4 hours of 
colcemid treatment, swollen in hypotonic solution, and fixed in methanol:acetic acid (3: 1). For 
conventional G~band katyotyping, air~dried preparations were digested with pancreatin (Sigma). 
The chromosome constitution was described according to the IntemationaI System for Human 
Cytogenetic Nomenclature 1995 (Mitelman 1995). 
For CGH, metaphase spreads were prepared using standard procedures from in vitro 
phytohemagglutinin-stimulated peripheral blood lymphocyte cultures of a healthy male. 
Comparative Genomic Hybridisation 
High molecular weight DNA was isolated fi'om the snap fi'ozen tissue samples (test DNA) 
and fi·om peripheral blood of a Bannai male (reference DNA) using standard procedures (Maniatis 
et aI., 1982). DNA of the paraffin-embedded yolk sac tumor was isolated as described before 
(Alers et aI., 1997). In case no aberrations were identified on the initial DNA sample (both 
teratomas), DNA of purified tumor cells was acquired from frozen tissue as follows. Tissue 
sections of 20 micron thickness of the samples were cut and air dried. In addition, a 
hematoxylin and eosin staining was done of a parallel tissue section of 4 micron thickness for 
additional histological controL The cells of interest were identi fled using an invet1ed 
microscope (AxiovCl1 10, Carl Zeiss) and microdissected with a self~made glass capillary piece. 
The section after microdissection was also stained for histological check. The tissue pat1s were 
directly p~t into a reaction vessel, and dissolved in TNE (10 mM Tris, 400 mM NaCI, 2 mM 
EDTA pH 8,2). Proteinase K (10 mg/ml) and SDS (10%) was added, and incubation was done 
ovemight at 37C. Subsequently, DNA was extracted with phenoVchlorofonnl isoamylalcohoI 
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(25:24:1) (Merck) and precipitation was perfomled with glycogen (10 mgtml) (Boehringer) as 
catTier. Pellets were dissolved in TE (Tris 10 mM, EDTA 0,1 mM, pH 8,0). Eight to 25 ng of 
DNA from each microdissected teratoma sample and from a Hennai male were amplified by 
standard DOP-PCR (Telenius et a!., 1992). The quality of this approach was checked with 
control DNA amplified with the same procedure derived from nonnaimaies (XY) and females 
(XX). In total seven independent experiments were pcrfonned, and all showed a balanced 
profile for the autosomes. The sex chromosomes showed the expected imbalances in genderH 
mismatched hybridisations. In addition, CGH \vas performed on an osteosarcoma of a patient 
with Rothmund-Thomson sYlldrom, both 011 genomic DNA without, as well as aftcr DOP-PCR, 
From the 20 imbalances found in the genomic DNA, 18 were observed aftcr amplification (two 
false negatives). No aberrations were detected only in the sample after amplification (no false 
postives). This method was reproducibly applicable on 8 ng DNA, equivalent to about 900 
nuclei with a diploid DNA content (not shown). Of the samples studied, DNA equivalent of at 
least 1500 nuclei was used for the amplification. This approach was successfully used to 
investigate the chromosomal imbalances of various developmental stages of both seminoma and 
nonseminoma, including CIS (Looijenga et ai, 2000). 
The CGH procedure and analysis was perfonned as described before (Rosenberg et a!., 
1998). Both the control male DNA and the tumor DNA were directly labelled by nick-translation 
with lissamine and FITC respectively. The data were analysed using Quips XL software from 
Vysis (Downers Grove, IL). Nom18lisation was carried out using the average of the green to red 
fluorescent intensities for the entire metaphase. Five metaphases were shtdied for each case. 
Losses of DNA sequences were defined as clrrol1losomal regions where the average green~to~red 
ratio and its 95% CI are below 0.9 while gains are above 1.1. These naITO\V thresholds of 0.9 and 
1.1 are suitable for the direct labelling procedure, as used in this study (see above), as discussed by 
us before (Rosenberg et a!., 1998). The results obtained, with and without DOP-amplification, 
resulted in narrow 95% confidence intervals (not shown and Looijenga et al., 2000). The 
heterochromatic blocks of chromosome 1,9,16 and Y, and the immediate telomeric regions were 
excluded from the analysis because these regions present variable results in experiments with 
nonnal control DNAs. 
III situ hybl'idisatioll 
FISH was perfonlled with a chromosome 13 probe (Y AC 908C2, mapped to 13q34) 
(Kingsley et aI., 1997) kindly provided by B. Eussen (Depaliment of Clinical Genetics, Erasmus 
University Rotterdam). Since chromosome 13 did not show imbalances in any of the tumors by 
CGH, combination of the FISH and CGH data made discrimination between diploid and 
polyploidy possible. This approach has been found to be informative in previous studies on a cell 
line (Rosenberg et at., 1998) and invasive seminomas and nonseminomas (Rosenberg et al. in 
press). 
Chromosome I band p36 is a critical region for CGH. Therefore possible loss of the I p36 
39 
Germ cell tllmors of the infantile testis 
region was studied in addition to CGH in more detail by means of a double FISH approach using a 
probe specific for the centromeric region of chromosome 1 (Cook and Hindley 1979), as well as a 
probe specific for the Ip36 region (cosmid: DIS32, pBG2.8, kindly provided by Prof. dr.A. de 
Paepe, Centre of Medical Genetics, University of Gent, Belgium). Representative fomlalin-fixed 
paraffin-embedded tissue section of 5 micron thickness were used. The procedure used is a 
slightly modified method described previously (Hopman et aI., 1992). Briefly, the sections were 
deparaffinized by xylene and methanol, pretreated in 1M NaSCN at 80'C and pepsin (8000U/ml) 
at 37'C respectively followed by rinsing in distilled water and PBS and dehydrated. Probes were 
labelled by nick-translation, according to standard procedures, either with dioxigenin-ll-dUTP 
(Boehringer MatUlheim, Germany) or biotin-16-dUTP, and applied in 10-15 ul hybridisation 
mixture on the tissue slides (13q probe: 20 ngiul, Ip36: 2 ngiul and chromosome I centromere 2 
ngiu!). The probes were denaturated together with the target by placing the slide for 10 min. on the 
bottom of a 80'C oven. After hybridisation ovemight at 37'C, the slides were washed stringently 
and the hybrids were detected by FITC-conjugated sheep-anti-digoxigenin (Boehringer 
Marmheim, Gennany) and CY3-conjugated avidine (Jackson Immuno Research laboratories, Inc. 
Westgrove, PA, USA) as described by us before (Mostel1 et aI., 1998). Results were studied with a 
Zeiss Axioskop fluorescence microscope (Carl Zeiss lena, Jena, Genllany) with a Pinkel filter in 
combination with a triple band-pass filter to visualise FITe, CY3 and DAP! simultanously. This 
set of probes was verified to be usefull on a series of 110nnal tissues, showing a 1: 1 ratio (not 
shown), as well as on host cells within the same histological section of which the tumor ceHs were 
investigated. The tumor component was only scored when a 1: 1 ratio was found in the controls. In 
total 30 nuclei of each component were investigated, of which possible differences were 
investigated using Student' t test analysis. 
P53 mutation analysis 
Since the majority (78%) of the missense mutations in the p53 gene are found in exons 
5-8, the tumors were screened for mutations in this region using PCR amplification and 
subsequent single strand confonnation polymorphism analysis (SSCP) as described previously 
(Schuyel' et aI., 1998). Briefly, the specific exon regions were amplified using commercially 
available primers (Clontech, Palo Alto, CA, USA) and analysed by SSCP. PCR products 
showing an altered electrophoretic mobility were re-amplified and sequenced by double 
stranded sequencing. 
ImlllUIl ohistochemistry 
Immunohistochemistry was perfollned on representative fOlTIlalin-fixed, paraffin 
embedded tissue section of 3 micron thickness of both teratomas and all yolk sac tumors. The 
P53 specific antibodies (DO-7, DAKO AlS, Derunark) were used in a final concentration of80 
ugiml and the MDM2 specific antibodies (clone SMPI4, NeoMarkers, Union City, USA) in a 
final concentration of 40 ug/ml. The sections were pretreated with a modified heat induced 
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antigen retrieval method (Shi et aI., 1991) using 10 mmolll citrate buffer pH 6.0. The detection 
was done with the avidin-biotin-peroxidase complex (DAKO NS Denmark) according to the 
manufacturer's instructions using 3,3' -diaminobenzidine as ciuomogen. Sections were lightly 
counterstained with hematoxyline. In all experiments, both positive (samples with known 
presence of P53 and MDM2) and negative controls (samples without the presence of P53 and 
MDM2, and without the first antibody) were included. Photographs were made using an 
Olympus BX 50 microscope, equiped with a Olympus DP 10 camera and the Olympus DP-Sof\ 
analysis system version 3.0 for Windows (Genllany). 
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Results 
The age of the patients at clinical presentation was 10 months for both teratomas, and 16, 
18, 21, and 24 months for the yolk sac tumors. Both teratomas presented at stage I, and were 
treated with surgelY only. The patients were disease free 80 and 84 months after initial diagnosis. 
All testicular yolk sac tumors presented also at stage l. After surgical removal of the affected 
testis, the elevated alpha~fetoprotein level decreased according to halfwlife. Within several months, 
however, a gradually elevated alpha~fetoprotein level was observed in two patients (cases no. 4 
and 5), and multiple metastases in lung, abdomen, and lymph nodes adjacent to the left kidney and 
the para~ao11ic region were identified. Chemotherapeutic treatment resulted in complete remission 
both by marker analysis and scanning techniques, although follow-up is less than 1.5 years. The 
other two patients (no. I and 2) are still disease ft'ee 6 and 12 years after initial diagnosis. 
Testicular parenchyma could be observed in all cases, in which immature genn cells, but no CIS, 
were found (not shown). In addition, one recurrent yolk sac tumor ofa sacral teratoma (case no. 3) 
was investigated. The teratoma was diagnosed at bh1h, whereas the yolk sac tumor presented 19 
months later with multiple metastases in lymph nodes in pelvic and spinal cord region. After 
chemotherapy, a residual mature teratoma was found after surgical intervention. Twelve years 
after initial diagnosis, the patient is still disease free. 
Classical katyotyping after short tenn in vUro culturing showed 46,XY for both testicular 
teratomas. The sacral teratoma was previously found to be diploid, aneuploidy was observed in 
the recurrent yolk sac tumor (Oosterhuis et a1., 1993). None of the testicular yolk sac tumors were 
kalyotyped successfully. No chromosomal aberrations were detected with COR in the teratomas 
using DNA isolated from the total sample. Therefore the tumor cells were specifically purified 
from frozen tissue sections using microdissection (see Figure I), of which DNA was isolated and 
used again for CGH (see MATERIAL AND METHODS section). 
Fig. 1." Representative example of a frozen tissue section of a teratoma of the inflmtile testis, 
before (left panel) and after (righlplIne/) microdissection. 
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Fig. 2A: Summal)' of the chromosomal imbalances detected by CGH in/our yolk sac tumors of 
the infantile testis (110. 1, 2, 4, and 5) and aile recurrent yolk sac tumor of II sacral teratoma 
(110. 3), DNA of all cases, except case 110.4, was isolated from SlIap frozen tissue. DNA of case 
110. 4 was obtained from Jormalhz-fixed, paraffin-embedded tissue, CGH was pel/armed 011 
DNA isolated directly from the samples, withollt amplification. Lines 011 the left ami right side 
of the ideograms indicate Ilflder- and overrepresentation of chromosome material. The thick 
lines indicated the regions of high level amplification. The Ilumbers 011 top of each lille refer to 
the case analysed. B: average profiles of case 110. 1 (see also Figure 2A). Gains of part of 3p, 
9q, 17, 19q, 20q. alld 22, alld losses of parts of 4 alld 6, as well as the amplificatioll of a 
discrete region all the long arm of chromosome 12 and 17 can be seen. 
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Even using DNA isolated from these emiched tumor cells no chromosomal imbalances were 
observed (not shown). As indicated previously (Rosenberg et ai., 1998 and Rosenberg et aI, 2000) 
FISH with a specific probe against a chromosome showing a balanced pattenl in CGR is 
infonllative to obtain more infonllation about the ploidy of the cells under investigation. FISH 
using a chromosome I3-specific probe revealed only tumor cells with two or less signals per 
interphase nucleus (mean 1.8/SD 0.46 and 1.9/0.58, respectively, not shown), supporting diploidy. 
Because of the high percentage oftumor cells in the yolk sac tumors (more than 80%, see Figure 4 
right panel for a representative example), no microdissection of the tumor cells and subsequent 
DNA amplification prior to CGH has been perfonned for these samples. All cases showed 
chromosomal imbalances, sununarized in Figure 2A, of which corresponding profiles are shown 
in Figure 2B. Except for chromosome 13, all chromosomes showed imbalances at least in one of 
the samples. In particular, loss of parts of 4q and 6q, and gain of palis of 20q were observed in all 
cases, and gain of parts of3p, 9q, 12p (see below), 17, 19 and 22, and loss of parts of8q was 
obsetved in the.majority of them. The yolk sac tumors which developed distant metastases (cases 
no. 4 and 5) showed specifically loss of parts of chromosome 5 and gain of parts of 14q and 
chromosome 21. Although the recurrent yolk sac tumor after a sacral teratoma (case no. 3) showed 
a highly similar pattem of imbalances as found for the primary testicular yolk sac tumors (see 
Figure 2A), loss of a part of 18q and gain of a pati of 4p was specifically observed in this tumor. 
Using FISH with the chromosome 13 specific probe, alJ yolk sac tumors (except case no. 2, of 
which no appropriate material was available anymore) demonstrated tumor cells with three or 
1Il0re signals (between 12 and 30%) for chromosome 13, supporting aneuploidy (not shown). 
CGH showed loss of the Ip21-p31 region in two testicular yolk sac tumors and the 
recurrent case of a sacral teratoma, while loss of Ip36 was found in only one of the testis. 
Double FISH using a probe for the centromeric region of chromosome 1 in combination with 
a lp36-specific probe showed significant loss of the lp36 region in all yolk sac tumors, but 
not the teratomas (see Table 1 and Figure 3). This particular set of probes showed a 1:1 ratio 
in all controls included (not shown). 
Fig. 3: Representative example of the 
double fluorescent in situ hybridisatioll 
with a probe specific for the 
centromeric region of chromosome 1 
(red siglla/), alld aile for the 1p36 
regioll (green signal) on a formalin-
fixed, paraffill-embedded yolk sac 
tumor of the infantile testis (case 110.4). 
Note the reduced Jlumber of signals of 
the lp36 region (green) compared to 
the celltrolllere (red) (see also Table 1). 
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Table l. 
Results of the double fluorescent in situ hybridisatioll with a probe specific for the centromeric 
region of chromosome J and Jp36. The samples incl/ldes formalin-fixed, parafjill-embedded tissue 
o/two teratomas, three yolk sac tumors of the infantile testis (case 110. 2 ,vas not studied). and one 
recurrent yolk sac tumor after a sacral teratoma (case 110. 3), (Afean, standard deviatioll (between 
brackets). ami corresponding p-values of Student's t analysis are indicated) 
Histology: Case: Centromere: Ip36: p-value 
Teratoma: 
A 1.7 (0.60) 1.9 (0.57) NS' 
B 1.8 (0.44) 1.8 (0.38) NS 
Yolk sac tUllIor: 
1 2.0 (0.64) 1.5 (0.82) <0.001' 
3 1.5 (0.57) 0.9(0.31) <0.001' 
4 3.8 (0.90) 2.0 (0.29) <0.001' 
S 3.1 (0.82) 2.1 (0.71) <0.001' 
!INS = not significantly different; 'significantly different 
One testicular yolk sac tumor (case no. I ) showed high level amplification of the 12q 13-
ql4 region, and although at a lower level, of region 17q12-q21 (see Figure 2B). 
Immunohistochemistry showed that all teratomas and yolk sac tumors are positive for MDM2 (see 
Figure 4), of which the corresponding gene maps to 12q 13-q 14. No p53 protein could be obselved 
(see Figure 4), and no mutation within exons 5-8 of this gene were found (not shown). 
45 
Gerlll eelltulllors a/the ill/alllile testis 
TERATOMA 
." 
,. 
YOLK SAC TUMOR 
I 
W 
m 
Fig. 4: Representative examples of the immunohistochemical detectioll of the P53 protein 
(middle panel) and MDM2 protein (lo'wer panel) all a tissue section of a JormaUl1:fixed, 
paraffin-embedded teratoma (left panel) and yolk sac tllmor (right panel) a/the ill/all/tIe testis. 
No P53 cOllld be detected. while all tllmor cells showed the presellce 0/ MDM2. The 
corresponding hematoxylin and eosin (H&E) stained slide is represented ill the upper panel of 
the illllstratioll. (magnification 100 X) 
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Discussion 
The pathogenetic relationship behveen the rare testicular genn cell tumors of infants and 
the more frequent testicular genu cell tumors of adolescents and young adults, i.e., seminomas 
and nonseminomas, is a matter of debate. This is partly because of misdiagnosis of testicular 
genu cell tumors of adolescents and young adults of especially young patients as those of the 
infantile testis. In our study, the oldest patient was 24 months of age at clinical diagnosis, 
thereby excluding this possibility, Indeed, the histologies found in this series were only 
teratoma and yolk sac tumor, as suggested before to occur in this particular subgroup 
(Oosterhuis et ai., 1997). In addition, none of the cases showed CIS in the adjacent parenchyma, 
being the precursor cells of seminomas and nonseminomas (Skakkebrek 1972), 
Infollnation about the chromosomal constitution of genn cell tumors of the infantile 
testis is limited, and on some points contradictory, Both flow cytomehy and karyotyping 
suggested that teratomas of the infantile testis are diploid without gross chromosomal 
aberrations (Kaplan et aI., 1979; Silver et aI., 1994; Stock et aI., 1995). To exclude 
misintelpretatiol1 due to loss of tumor cells during sample preparation, we perfollned CGH and 
FISH, No chromosomal abenations were observed, not even using DNA for CGH derived from 
microdissected tumor cells. These results prove for the first time that teratomas of the infantile 
testis are diploid without gross numerical chromosomal anomalies, In contrast, chromosomal 
abelTations were observed in the yolk sac tumors, In particular, loss of parts of 4q (23-33) and 
6q (16-22), and gain ofpat1s of20q was found in all cases, and loss of parts of lp (21-31) and 
8q (23), and gain of parts of 3p (22-24), 9q (34), 12p (12-13), 17q (22-25), 19q (13), and 22 
(13) was present in at least three (the minimal overlapping regions are indicated between 
brackets), These data provide a clear overview of chromosomal imbalances most often found in 
yolk sac tumors of the infantile testis, Several of these abelTations are in accordance to earlier 
findings, In paliicular, loss of 6q and 3p abelTations have been consistently found in the few 
katyotyped cases (Oosterhuis et aI., 1988; Oosterhuis et aI., 1993; Perlman et aI., 1994; Bussey 
et ai., 1999). In addition, imbalances of (parts of) chromosome 8, 17, 19, 20 and 22, have been 
reported occasionally (Oosterhuis et ai., 1988; Jendemy et aI., 1995). Loss of the 1 p36 region, 
consistently found in infantile yolk sac tumors, including those of the testis (Perlman et ai., 
1994; Stock et aI., 1995; Jendemy et aI., 1995; Perlman et ai., 1996; Bussey et ai., 1999), is 
supported by our FISH data, However, the recun'ell! aberrations anomalies found on 
chromosomes lp (21-31) and 4q (losses) and 9q and 12p (12-13) (gains) are novel. Notew0l1hy, 
development of distant metastases might be related to loss of paris of chromosome 5, and gain 
of parts of 14q and 21, which serves further investigation. 
The recurrent yolk sac tumor of a sacral teratoma included in this study showed a highly 
similar pattem of imbalances compared to those of the infantile testis, in accordance to two 
cases studied by karyotyping (perlman et aI., 1994). This suggests that the chromosomal make 
up of this tumor is more associated with histology than with anatomical site. We recently 
perfonned CGH on a pure yolk sac tumor component of a mixed nonseminoma of the adult 
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testis (Looijenga et ai, 2000). Although in general this yolk sac component showed a different 
pattem of chromosomal losses and gains compared to the results found in this study, loss of 6q 
was an exception. This anomaly was specifically found in the yolk sac tumor component of the 
nonseminoma of the adult testis, as well as in all yolk sac tumors included in this study, which 
suggests that it is related to yolk sac histology. 
Three of the yolk sac tumors of the infantile testis showed Qverrepresentation of the 
12p12-13 region specifically, which might explain the inconsistency found in literature 
(perlman et aI., 1994; Jendemy et aI., 1995; Stock et aI., 1995). Gain of the complete short arm 
of chromosome 12 is the most reCUlTent, and characteristic, chromosomal aberrations in 
testicular geml cell tumors of adolescents and young adults (Sandberg et al., 1996, for review). 
II) addition, high level amplification of the 12pI1.2-12.1 region can be found additionally 
(Mostert et aI., 1998). Moreover, both seminomas and nonseminomas are consistently 
aneuploid (Oosterhuis et aI., 1989; Van Echten-Arends et aI., 1995; Mostert et aI., 1996; 
Rosenberg et aI., 1999), with a characteristic pattem of numerical aberrations: gain of parts of 
chromosomes 7, 8, 12 (ShOli ann), and X, and loss of (parts of) 4, 5, II, 13, 18, and Y. We also 
showed that gain of chromosome 9 is specifically found in spennatocytic seminomas (Rosenberg 
et aI., 1998). These pattems are clearly different from that found in the yolk sac tumors (and 
teratomas) of the infantile testis as reported here. 
The available data so far favour independent pathogenetic pathways for geml cell tumors 
of the infantile testis and those of the adult testis, i.e., seminomas, nonseminomas and 
spennatocytic seminomas. This is also sUPP011ed by the absence of P53 both in teratomas and 
yolk sac tumors, whereas it has been consistently found in seminomas and nonseminomas 
(Schenkrnan et aI., 1995; Guillon et aI., 1996). Becanse of this finding, and absence of mutations 
within exons 5w 8 of this gene, genetic inactivation of p53 in infantile testicular genu cell tumors 
is unlikely, although presence of the MDM2 protein might inactivate P53 by proteolytic 
breakdown (Prives 1998, for review). Amplification of the 12q13-qI4 region, as found in one of 
the yolk sac tumors studied, and the immunohistochemical data, are compatible with such an 
involvement of MDM2. 
In conclusion, the three entities of testicular geml cell tumors, i.e., teratomas and yolk 
sac tumors of infants, seminomas and nonserninomas of adolescents and young adults, and 
spennatocytic seminomas have separate pathogenetic pathways, associated with characteIistic 
chromosomal anomalies. Application of FISH with probes for the chromosomal regions 
specifically lost or gained in the different groups of testicular geml cell tumors might be 
applicable in a diagnostic setting. 
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No data on the chromosomal constitution of spermatocytic seminomas are available thus far because of their rarity. Ploidy 
analysis performed on paraffin.embedded cases showed varying results from (near.) diploid to aneuploid. We applied 
comparative genomic hybridization 011 four snap·frozen primary spermatocytic seminomas of three different patients. 
Conventional cytogenetic analysis was successful in one, and "interphase cytogenetics" with centromeric region·specific probes 
was applied to another. The results from comparative genomic hybridization showed almost exclusively numerical chromo-
somal aberrations, in agreement with the data from karyotyping. Despite the limited number of cases studied, a nonrandom 
pattern of chromosome imbalances was detected: chromosome 9 was gained in aH spermatocytic seminomas. This suggests that 
that this aberration plays a role in the development of this cancer.lnterphase cytogenetics shows that the copy number of most 
chromosomes ranges from two to four, with an average of near trisomic. This constitutes the first report on the chromosomal 
constitution of spermatocytic seminomas. Genes Chromosomes Cancer 23:286-29/, 1998. ~ 1998 Wi!ey.Uss.lnc.. 
INTRODUCTION 
Spermatocytic seminomas are rare testicular cu-
mors of germ cell origin that occur preferentially in 
elderly men (Burke and Mostofl, 1993; Cummings 
et al., 1994). In general, they are benign (Talerman, 
1980; Talerman et aI., 1984; Burke and 1iostofl, 
1993), and bilateral presentation has been reponed 
(Talerman, 1980; Burke and Mostofl, 1993). Due to 
the low incidence of spermatocytic seminomas, 
cytogenetic analyses have not been reported on 
these tumors to date. The only chromosomal data 
available are the modal chromosome numbers of 
twO cases that were described in 1973 (Atkin, 1973) 
which showed 52 and 82 chromosomes. However, 
ploidy analyses by means of flow cytometry and 
image analysis showed varying and sometimes 
conflicting results (Talerman et a\., 1984; Dekker et 
aL, 1992; Takahashi, 1993; Looijenga et ai., 1994). 
\Ve applied comparative genomic hybridization 
(CGH; Kallioniemi et al., 1992) on four snap-frozen 
primary spermatoc)'tic seminomas from three differ-
ent patients, One of the spermatoc)'tic seminomas 
was analyzed successfully also by using cytogenetic 
analysis without in viuo culture, and tbat case 
constitutes the first in the literature. Because no 
ploidy information can be associated with CGH 
results without complementary studies, in addition, 
we investigated one of the spermatocytic semino-
mas by using fluorescence in situ hybridization 
(FISH) with centromerie-speciflc probes. 
MATERIALS AND METHODS 
Samples 
Testicular samples were collected in collabora-
tion with Departments of Urology and Pathology at 
institutions in tbe Southwestern pare of the Nether-
lands. After incision, representative samples were 
snap frozen, formalin fixed, and, subsequently, 
paraffin embedded. Paramn-embedded tissue sec-
tions were stained with hematoxylin and eosin and 
PAS for glycogen content, and tbey were stained 
immunohistochemically for placental-like alkaline 
phosphatase, a-fetoprotein, human chorionic go-
nadotropin, cytokeratins 8 and 18, and vimentin. 
The tumors were classified according to the World 
Health Organization classifICation for testicular tu-
mors (~lostofi and Price, 1973). In addition, an 
enzyme-histochemical detection of alkaline phos-
SUpporlcJ hi: Dun.h CJnca Sol'i~IY; ContrJct grJJ\t nllrnhc~. 
KWF_llDIlK ')+--'''1(,: 'I h~ 1""1 (;wJU.HC S~hn"l ;I.\"k<,uldr ;l.kJ" 
(ine: I'Jtl"'ph) ,jolu)';)' "I' (,n",!h Jnd Diffcrcnli.oti"n (>1'(;0). 
'CorrnpOlltknl'C In: LC'(n,krt I1.J. L""ijcng~, Llh"rJtof)' for 
Expcrirntllt.11 l'Jth"·Om,,lo'h,)·, D.lnid <len H,,~d C:.lnCcr (:~ntcr. 
(;rn~ne HilkJijk .101, .1(t7.'i E,\ [{ot(<:{,l.lm, 'Ilic' N~thL'!I-'nd, 
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phatase reactivity was applied, as reponed previ-
ously CMosselman et aI., 1996), 
CGH 
High-molecular-weight DNA was isolated from 
histologically checked samples (test DNA) and 
from peripheral blood of a normal male (reference 
DNA) by using standard procedures (8ambrook et 
aL, 1989). The CGH procedule was based on the 
protocol described by Kallioniemi et al. (1994) wieh 
a few modifications. Briefly, test DNA was direct 
labeled with lissamine-dUTP (NEN Life Science 
Products, Brussels, Belgium), and control nlale 
DNA was labeled wieh digoxigenin-dUTP (Boeh-
ringer Mannheim, 1hnnheim, Germany), Two hun-
dred ng of each labeled DNA and 10 pg of Cot-l 
DNA were hybridized to normal male meta phases. 
Test DNA was detected with one layer ofantidigoxi-
genin-fluorescein isothiocyanate (FITC; Boeh-
ringer i\Iannheim), and slides were counterstained 
with 4,6-diamidino-2-phenylindole (DAP!), in an 
anti fade solution (VectaShield; Vector Laboratories, 
Burlingame, CAl. Digital images were collected by 
using an epifluorescence microscope (Di\.J; Leica, 
Wetziar, Germany) equipped with a triple band-
pass beam splitter and emission filters (P-I filter 
set; Chroma Technology, Brattleboro, VT) and 
analyzed by using QUIPS XL software from Vysis 
(Downers Grove, IL). Losses of DNA sequences 
were defined as chromosomal regions where the 
average green-to-red ratio and its 95% confidence 
interval were below 0.8, whereas gains were above 
1.2. These threshold \'alues were based on measure-
ments from a series of five controls. 
Cytogenetic AnalysiS 
Representative parts of three out of the four fresh 
spermatocytic seminomas were processed to pro-
duce metaphase spreads direccly after surgical re-
moval, as described previously (for review, see Van 
Echten et aI., 1995b). The chromosomal constitu-
tions were described according to the recommenda-
tions of the ISCN (1995). 
FISH 
Centromere-specific probes were used to ascer-
tain the chromosome copy number and evaluate 
the CGH results in the tumor designated spermato-
cycic seminoma 2 (SS2). The probes used were 
PUCL77 (chromosome 1; Cooke and Hindley, 
1979), pcd2H8 (chromosome 12; Looijenga et al., 
1990), D1521 (chromosome 15; Higgins et ai., 
1985), pl8.4 (chromosome 18; DeviJee et aL, 1986), 
pBamX (X chromosome; Willard et ai., 1983), and a 
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probe for the Y chromosome (Wolfe et aI., 1985). 
Probes were labeled by using nick translation either 
directly, with fluorochromes (lissamine-dUTP or 
FITC-dUTPj NEN Life Science Products), or 
indirectly, with biotin-dUTP (Sigma, St. Louis, 
i\fO) and were then detected with one layer of 
streptavidin-FITC (Vector Laboratories). Hybridiza-
tions were performed by using combinations of two 
probes in different colors, Le" chromosomes 1 and 
15, chromosomes 12 and 15, chromosomes 18 and 
1.5, and the X and Y chromosomes. Target slide 
preparation from frozen material, in situ hybridiza-
tion, and posthybridization washes were performed 
as described previously (Fechner e{ ai., 1994; Rosen-
berg et ai., 1994). 
RESULTS 
At the time of diagnosis, the patients were 46, 48, 
48, and 83 years of age for SSI-SS4, respectively. 
SS2 and SS3 were from a bilateral case, and both 
tumors were clinically manifest within 6 months. 
None of the patients had cryptorchidism. The 
diagnosis of spermatocytic seminoma, which was 
made initially on a frozen hematoxylin and eosin-
stained tissue sections, was supported by the nega~ 
tive results of enzymatic alkaline-phosphatase reac-
tivity, In each case, the diagnosis was confirmed 
also by morphological and immunohistochemical 
analysis of paraffin-embedded sections. Three dif-
ferent cell types could be identified in each case: 
small, intermediate, and large cells, of which the 
intermediate cells were most abundant. No expres-
sion of a~fetoprotejn, human chorionic gonadotro-
pin, vimentin, or glycogen was detected, whereas 
some pl"J.cental~like alkaline phosphatase-express-
ing cells were found in all four cases, and cytokera-
tin-positive cells were found in two cases (SS2 and 
SS4; not shown). Testicular parenchyma was pre-
sent adjacent to all tumors and lacked carcinoma in 
situ, which is the precursor of testicular seminomas 
and nonseminomas (Skakkeba::k, 1972), This was 
determined by morphological criteria, immunohis-
tochemical analysis for expression of placenta-like 
alkaline phosphatase, and enzymatic staining for 
alkaline-phosphatase reactivity, However, intratubu-
lar spermatocytic seminoma, which is supposed to 
be the precursor lesion of this cancer (Scully, 1961; 
Talerman, 1980), was found in two cases (SSl and 
8S2; not shown), No differences in immunohisto-
chemical staining patterns were observed between 
the paraffin~embedded and snap-frozen samples, as 
described previously (Matoska et aI., 1988), 
CGH was performed by using DNA from repre-
sentative snap-frozen tissue sections from each case 
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Figure 1. Results of COmplr;l.Uye genomic h~bridjlation of spermatocyric seminoma 2 (552) showing a 
representative example of a d'git.ll image 01 a normal meuplu.se spread (46.X'i) hybridized with DNA 
Iselned from the tumor (detected in green) and referellce DNA (46.XY] (detected in red). 
that had been checked histologically for the pres-
ence of at least 80% tumor cells. A representative 
pseudocolor CGH image from one of the tumors, 
S52, is shown in Figure 1. The chromosomal 
imbalances detected are summarized for each tu-
mor in Figure 2. Excluding the Y chromosome, 23 
imbalances were found in total. All included full 
chromosome gains or losses, with one exception: 
overrepresentation of lq in SS4. Some imbalances 
were detected only once, i.e., gain of chromosomes 
5,6, and 21 and loss of chromosomes 7.19, and X. 
Others were found in at least two cases, in particu-
lar, gain of chromosomes I(q), 9, 18, and 20 and loss 
of chromosomes 13, 15, and 22, of which the 
aberrations of chromosomes 13, 15, and 18 were 
present only in the bilatcral cases. In total, the 
bilateral cases showed seven gains of (t1\'e differ-
ent) chromosomes and also seven losses of (five 
different) chromosomes. Eight of the 14 imbalances 
(57%) were detected in both cases. Gain of chromo-
some 9 was present in an spermatocytic seminomas 
s' i1 ; • , i i ~I " r 
• 5 ~ F ~ ~ § , ~: i~ 
" 
'! ~ "~ ~ , fl ~ ~ 
'I a' 
" 
'3 
i. 
'a § 
" 
Fi,gure 2- Summary of chromosomal imbalances deteaed by compara. 
tive genomic hybridization in the four spermatocytic seminomas studied. 
lines on tne left and right sides 01 the ideograms indlCate under. and 
over.repreSentation of chromosome material, respectively. The num-
bers on tOP of each l1ne refer to the case analyzed. Note that SS2 and 
SS) are b;lateral 
tested, whereas gain of chromosomes I and 20 and 
loss of chromosome 22 werc found in at least two 
independent cases. Other than involvement of 
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figure 3. RepreSentative karyotype of spermatocytic seminoma ($$1). for composite karyotype 
description. see Results. 
chromosome 9, seven of the 13 chromosomes 
showed imbalances in twO or more cases, and all 
presented either gain or loss. 
In an attempt to produce metaphase spreads that 
were suitable for cytogenetic analysis, three of the 
four spcrmatocytic seminomas (cases SSI, SS2, and 
SS3) were processed directly after orchidectomy. 
Despite the high mitotic indices, as demonstrated 
by histological examination (not shown), the at-
tempt was successful only for SSI, in which 22 
metaphase spreads could be analyzed completely. A 
representati,'e karyotype is shown in Figure 3. In 
agreement with the CGH results (see above), 
mainly numerical aberrations were detected. The 
chromosome number ranged from 74--83, which 
corresponds to a borderline ploidy between tri-
ploid and tetraploid, The composite karyotype 
was 74-83<3n>, }"'Y,add(X)(pll)[4], + Y, + I, add 
(4)(pI5.1)[8], + 5, +6, +add(6)(q21)[8], -7, +9, +9, + 10, 
inv(10)(q22q24)X2, del(12)(pI1.2pI2)[5], +14, +17, 
+ 19, +20, -22,+mar [cp22j, i\·Iore than four copies 
of chromosomes 5, 6, 9, 17, and 20 were found, and 
fewer than 2.5 copies of chromosomes 7, 10, and X 
were found: By using CGH, these copies were to be 
over-represented and under-represented, respec-
tively, with the exception of chromosomes 10, 17, 
and X. The undetected loss of the X chromosome is 
explained by the use of male DNA as a reference. 
The Structural (nonbalanced) aberrations that were 
identified by cytogenetic analysis probably were 
not detected by CGH because of the fact that only a 
minority of the metaphases studied contained these 
aberrations. Although 22 meta phases were studied, 
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the structural aberrations were found in eight or 
fewer, 
Bicolor FISH with centromeric, region-specific 
probes was performed on isolated nuclei from 
frozen material from case SS2 (one of the bilateral 
cases). Because CGH indicated that only complete 
chromosomes showed imbalances in this particular 
tumor, centromere-specific probes were suitable to 
determine the copy numbers of chromosomes, The 
centromeres investigated included chromosomes 
that showed no imbalances in CGH (chromosomes 
I and 12), one that showed under-representation 
(chromosome 15), and one that showed over-
representation (chromosome 18) along with se-
quences for the centromercs of chromosomes X 
(which also showed no imbalanccs with CGH) and 
Y (which showed amplification with CGH both by 
profile and by visual evaluation), l\,tOSt nuclei 
showed tWO to four signals for the centromere of 
chromosomes 1 and 12, Howevcr, almost no nuclei 
were found that contained three copies of chromo-
some 12. The majority of nuclei contained one or 
two signals for chromosome 15 and four or fj,'e 
signals for chromosome 18. r.,'iost nuclei showed one 
or two copies of the X chromosome and two to four 
copies of the Y chromosome. These results are in 
overall agreement with the CGH data found (sec 
above). The bicolor FISH approach illustrated that 
different subpopulations of tumor cells can be 
distinguished within this spermatocytic seminoma 
(not shown). All nuclei containing one X chromo-
some also comained one Y chromosome, and most 
of the nuclei containing two copies of the X 
chromosome also showed tWO copies of the Y 
chromosome. Howc\'cr, the majority of nuclei with 
three copies of the X chromosome contained tWO 
copies of the Y chromosome, which was also found 
for nuclei that contained four copics of the X 
chromosome. Only nuclei with either one or tWO 
copies of chromosome 15 werc identified, whereas 
the copy numbers of chromosomes 1, 12, and 18 
varied between two and four, two and seven, and 
onc and five, respectively. 
DISCUSSION 
The lack in the literature of cytogenetic data on 
spermatocytic seminomas is likely to be due to the 
rarity of these tumors. In a period of about 6 
consecutive years, we collected a cowl of 357 fresh 
testicular germ cell tumors from adolescent and 
adult patients, i.e., seminomas and nonseminomas, 
in the Southwestern part of the i\etherlands. In the 
same period, the four fresh spermatocytic semina· 
mas described here were collected. 
The morphological and {immuno)histoehemical 
data from the spermatocytic seminomas included in 
this study were in agreement with earlier findings 
(Talerman, 1980; 1Iatoska et al., 1988; Dekker et 
al., 1992; Burke and r.iostofi, 1993; Cummings et 
al., 1994; Eble, 1994). However, a number of 
relevant observations were made on the chromo-
somal constitution of the spermatocytic seminomas 
by using CGH supported by cytogenetic analysis in 
one case and supported by FISH in another case. 
The majority of chromosomal aberrations detected 
were gains and losses of full chromosomes, indicat-
ing missegrcgation of chromosomes as the main 
mechanism for producing chromosomal aberrations 
in spermatoc)'tic seminomas. The fact that struc-
tural chromosomal aberrations are rare in spermato-
cytic seminomas might be related to their benign 
behavior (Talerman, 1980; Talerman et aI., 1984; 
Burke and l\loscofi, 1993). Therefore, it may be 
interesting to study the chromosomal constitution 
of the sarcomatous elements that are sometimes 
found in spermacocytic seminomas, predicting a 
poor clinical outcome (11atoska et al., 1988; Burke 
and 110stofi, 1993; Eble, 199~). Other than the 
pattern of almost exclusively numerical aberrations, 
gain of chromosome 9 was found in all four sper-
matocytic seminomas, which, therefore, seems to 
be important in the development of this cancer. It is 
of interest that this particular chromosome is usu-
ally under-represented in testicular seminomas and 
nonseminomas (i>.Iostert et al., 1996; for review, see 
Van Eehten et al., 1995a). These tumors also 
originate trom germ cells but from ,to earlier stage 
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of maturation, most likely primordial germ cells 
(Skakkebrek, 1972; Jorgensen et al., 1995). Among 
the other imbalances found in the spermatocytic 
seminomas tested, no chromosome that was found 
to be under-represented in one sample was found 
to be over-represented in another, and vice versa. 
This indicates that gains and losses of chromo-
somes in spermacocytic seminomas are nonrandom. 
These findings, together with the fact that gain of 
12p scquences is characteristic for testicular semino-
mas and nonseminomas (Van Echten et aI., 1995a; 
Korn et al., 1996; 110sterc et al., 1996) but are nOt 
found in spermatocytic seminomas (this report), 
add the cytogenetic differences between these tWO 
types of germ cell-derh'ed tumors of the adult testis 
to the differences already established at other 
levels. 
1Iorphologically, spermatocytic seminomas are 
composed of three types of cells: small, intermedi-
ate, and large (Burke and ).[ostofi, 1993; Cummings 
et a\., 1994-; Looijenga et al., 199~; this study; for 
review, see Eblc, 1994). Although cytogenetic analy-
sis did not demonstrate any heterogeneity, most 
likely due to selection of a subpopulation of cells in 
mitosis at the time of handling, the results obtained 
by using bicolor FISH indeed showed the presence 
of cell popUlations with different chromosomal 
constitutions, despite the fact that CGH revealed 
no imbalances for chromosomes L 12, X, and Y. 
These chromosomes constitute a good parameter 
with which to estimate the ploidy of the tumor 
cens. Although distributions of these chromosomes 
differ among each other, the chromosomes that 
were found to be "balanced" by CGH presented a 
disuiburion between two and four copies, with an 
average of ncar trisomic. The distribution of the sex 
chromosomes suggests that at least diploid (XY), 
tetraploid (XXi!'), and a more heterogeneous popu-
lation of hypertetraploid (XX)..ll' and XA'X)..l'Y) 
cells are present. Because almost all cells contained 
onc or two copies of chromosome IS, we conclude 
that loss of chromosome 15 is an early event in the 
pathogenesis of this spermatoeytic seminoma, i.e .. 
before generation of the hyperdiploid cells. In 
contrast, a more heterogeneous copy number distri-
bution was found for chromosomes 1, 12, and 18, 
indicating that more complex mechanisms of gains 
and losses in addition to simple polyploidization of 
the cells affect these chromosomes. Although these 
data support the morphological and ploidy analysis 
by showing the presence of different populations of 
cells in spermarocytic seminomas, no conclusions 
can be drawn regarding the relationship between 
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AllSTRACT; nV~rr~pf(~sunlation of the shorl (Ifill of chromosouw 12 i.~ !/f:!(/up.ntly detected in lWlI1rlTl 
/cStiCU/Of gil/III (',.,11 tumors of adolescents alld l1Iiul/" (TGeT). This ol'effeprf'!;;tw/a/ion mostly ff'8ulis 
from the formatioIl of (1/1 i.mdtromosomu: j(12p). 1l'1u!ilWf tJH~ ()\'f~rrcp[CscntQtion con~'i,~{ent1J' im'oh'cs 
the (:(Jl1lplute 12p ann iI/eluding the cenirouwm is still unc!efJ(, \\'e sludied firc TGCT·dl;!ri\'l:~d cell lines 
(NT2, 2/(/2Ep, 11l2.1, NCCIT, am/ 82), cowhining com'cntiollaj chmmosolllu handing, j7'/(Jresr:f~nw ill 
silu hyhridization {FlSlfj, and compam/iI'H gtmfllnir: hybridization (CGH) 10 jm'l~stigQte the .~uil(/hjJily of 
('aell of il,eSt! /edll1if{ues to de/ect aberrations involving chromosonllJ 12. Karyotyping sholl't!d (Jne or 
mare i( 12p}s in NT2, 2102/:'p, H12.1, and 52. HOIl'el'el', F/,<,'H with a centmmel'e.sper:ijic probe (po12HlJ), 
II 12[1 "paint" and a 12pl1.2-p12.1 region·specijic pmbe ye(J,~1 Ilftijicial chromosome (rAe) #5 and CGH 
couh/ not ullljirm the presonce of 11/1 if12/1) in 52. "ldditio/tul mnr/olllly distributed 12p sequenccs wore 
detected II)' FISH in Jl12,l, NCCIY, and S2, In most of these C(J.~P.~, (a part of) the centromere was 
included. ,,1lI ()\'(-'rrep/f!.,'en/f~d 12p regions, ex(.'ept for those ill 52, showed hyhridization willi }';4C#5. 
CGI-I sholl'ed increm;ed 1:f1J1Y numbers of the comp/ele 12p arIll in the cell liw".~ H'ilh onc or more if 12J1).~ 
hut WI o\'(~rrcprcsulltati()n Ims noted in the cull linps Idlbll/1/ it 12p}. In nwtopllU.~e spwads, the ceniw. 
llit'lic him:/.: of tbe i(12p}s differt!d in ::>i1.e as compamd with tlio::>p oj normal chromo.,omp::> 12. This was 
rardy noted in interphase nuclei."l df-!r:rea.~e in size of the I:entromeric block ill 2102Hp (llld 1112.1 
caused 0 II'ell/.: FISH .~ignal, lI'hicl! Ims dljJkuit to detcct, especially in interphase /lw:!pi. 'f'hu [(Itio 
l}etll'l~l~n pu12lf8. 111/11 YAC#!J·deril'cd signals refleded the pmsence Of {Jbsence of one or mOfe i{12[l}s. 
Our rt!sults indicate tll(1/ dflllllle nSf{ with a cel/tmmere· and a 12p·specific pmht! can be used to deled 
12p ot'erwpres(~ntation (includillg i(12[l)} in TGCT iJoth in mf~taphaso spwads Ilnd interphase nuclei. 
eGl! confimlt!rI Ilw re/atim OI'ermpleselltatirlIl of 12p st!lluew:es liS de/ected b.l' FISH (lnd shol\'od tllat 
in these cell lilies tIlt! r:olllpkte 12p 1\'(18 im'o/ved. 
INTRODUCTION 
Human testicillar germ cell tumors of udolescents and 
,HIli It::; (TGeT) 1:;1\1 clinically and histologic;llly be grouped 
FIOll! Ill!! L'IboraIOl), fur r;"1Wrilllt!nlal Pallio'()lIm!ogy Dr. 
Dllllif" dH/! /fund Olnrl'[ CHnla, /JlliI'I,'n;i/y Hospilalllollt'rdulII 
IM,\/, C. ,\1 .• JI. \·d I~, /. II~ 0" L, H, f. L.).1/nIl1'ldum; Depanmeal 
of .\f"dim/ CI'ne/irs /J/lit·I'/ . ;ily HI/'pitn! Cralling(,ll (f. I' E.), 
(;ronillgen; /lI1f/ n.'/mnmenl of J/UlIlII1! G'·Untirs. Uni\'er,;ity /In,· 
pi/ul Nijllu<gen, 1lJ. (). I\~, /1. G. I' K,), NijllWg('II, Tlw Netlif'rlands. 
Add,,',,_~ wprinl reqUl'.'I . ; 10: AI. ,\1, C. ,\Ioslf'ft, /"'J/w[(llory for 
[{-"(lnrimenlul ('"llio.Onc%gy, v/,. [J'lIIid Ii"ll Hoed Conrer Om-
IeI', G[<li'nI-1 HilledijJ:. ,1()/, .1075 EA flo/lf'l'dam, TIll! N~lhPflonds. 
[11'1''';1'/,"" luly ,c;. 1.995; 0'-':('/,11',( l1ug1lst1.'>, 1!lfl.r,. 
into two entities; thH .~t~l!Iinomas (SE) and non seminoma· 
lOllS TGeT (NS) (1, l). All TGLT originate from a \;ommon 
precursor, carcinoma in situ {CIS) 13). Despite a hypertrip· 
loid DNA COil lent for CIS and SE and u hypotriploid DNA 
content for NS [4-5], they show a striking similarity in 
chromosome constitution 171. supporting il common patho~ 
gellp.tic origin. ThH on]~' f\~Cllrrent Chl'OHlOSOIIHl abnormal· 
it~' dtl\(~cted both in SE awl NS by com'en\io)!a] knryotyping 
is an isochromosome of the ::>hnrt arm of chro!llo$uIIW 12 
li(12pll. pn~s(lnl in c~70% of all TGer [oj. The presencH nf 
an i(12p) is suflkitmtly specific to classify a cancer of the 
male gonad as H TGe!' [9, 10J. In addition, tho number of 
copies of i(12p)s h<ls lwen suggested to 1m a prognostic 
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parameter [11, lzl. Cytogenotically, TGLl' without i(IZp) 
show significantly more breakpoints in the lZp13 band as 
compared with those with i{12p) Ill, (3). 
Recently, fluorescence in situ hybridization (FlSII), 
which c;m be applied on metapllflse spreilds as well as on 
interphase nuclei ("interphase cytogenetics"), was intro-
duced [14-17). This technique confirmed the genllinu 
nature of the i(12p) in TCeT (18, HIJ and showed that all 
i(12p)·negative TGCT tested so far contained additional 
12p sequences [13, 20J, implying that rolative overrepre-
sentati(ln of lZp sequences is crucial for the de\'clopment 
of a dinically manifest TCCT. FISH on int{lrplwso nuclei 
with a centr!lllwre·spccific probe for cbrolllOsollW 12 has 
been used to identify TGLl' [11, ZIJ, based on a r.onsistent 
siztl difference betwefln thn hybridizing centromeric region 
of the isochromosome and the normal chromosome 12 
hOlllologlles. The reliauility of this method depends on the 
consistent inVol\'ement of centromeric seqllences in the 
formation of i{l2p). TGCT without sLw diffewnccs of 
the centromeric regions of the chromosomes 12 and their 
derivatives, including the "i{l2p)'negath'e" TGCT, will not 
be recognized by this appro<lch. 
We used the combinatioil (If chromosome banding and 
FISH on metaphase spreads to study {Iverrepresentation of 
centromeric and 12p sequences in five TGGJ' cell lines. 
The results were compa.rod with the findings on interphaso 
nuclei. In addition, we used the cOlllparative genomic 
hybridization (CGH) technique [22, 23J to study the pres-
ence of 12p ovell'epresentation in these cell lines. 
MATERIALS AND I'.H~I'HOJ)S 
Cell Lines 
We analyzed five established TGGT·derh'ed cell lines, 
three derived from NS (i.e., NT2 [241. ZlOZEp [25J. and 
H12.1, a gift from H.-J. Schmoll, Hunnover, Germany) and 
two cell lines reported to show SE-like characteristics (i.e., 
NCC!T [261 11 gift from I. Damjanov, TX, U.S.A.) and S2 fa 
gift from A. von Keitz, Marburg. Germany}. The cel! lines 
were cultured by conventional methods (37 CC, 5']{, COz) in 
culture flasks (Costar, Carnbridgo, Engl<lnd) and p<lssaged 
overy 2-4 days by trypsinization, depending of the gro\\1h 
fate of e<lch individual cell Hne. 
Slide Preparation for Con\'cnlional chromosome 
Handing and FISH 
Coli susponsions for gerwfiltion of metaphase spre<lds of 
the five cell lines we!e prepared ac(:ordiTlg In standard 
procedures. The mitotic cells were har\'e~ted after 2-4 h of 
Cotcemid (Lif(l Technologies, NY, U.S.A.) treatment, swol-
len in hypotonic KCI solution, and fixed v.'ith methanol: 
acetic acid fixative. 
For conwmtional karyotyping, air-dried prep<lrations 
were banded with pancreatin (Sigma, SI. Louis, MO, U.S.A.) 
as rflJlortcd previously 1271. Tho chromosome constitution 
is described uccording to tho Intefll<ltional System for 
Human CytogBrwtic N()r11t~ndatllre 1211], except that it is 
calculated on the basis of a triploid iustead of a diploid 
DNA contp.nt because of the consistent peritriploid DNA 
cont(mt ofTGCT 14,71. 
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Tlw slides used for the combination of GTG·banding 
and FISH wore prepared as reported previously 129], wHh 
some Illodific<ltions. Air-dried slides were incubated over-
night at tilfC. During the first minutes, thft tempefilture 
was continuously raised from room temperature to the 
fin<ll temperature. Subsequently, the slides were washed 
in Z X SSC for I.S h. After a single w<lsh in 0.B5% NaCI, 
tho slides were digested for 1-5s at roomt()!Tlperiltllre with 
0.25% trypsin (Difco, Brunschwig, Amsterdam, The Neth-
erlands) in the same buffer. Aftor two washes in 0.115% 
N<le!, they wew stained for :1 min with Giemsa, according 
to the manufadurur's recommendations (Unmschwig Che· 
mie, Amsterdam, The Netherlands). Tlw slides were washed 
twice and air dried. Melaphases of interest were photo· 
gfilphed with <In Axiophot microscope (Zeiss, Weesp, The 
Nethurlands) and then destained in 70% ethanol for 15 
min at room temperature and directly used for FISH. 
Generation and Laheling of the Probes for FISH 
To obtain a suitable i2p "p<lint" for FISH, i(l2p)s from the 
cell line NT2 were flow sorted, amplified, and biotin labeled 
by degenCfated oligonucleotide primed (DOP)·polymerase 
chain reaction (PCH) as previously tlescribed [301. In <lddi-
\iou, a yeast artificial chromosome (YAC)IIS (;1 gift from Dr. 
R Gemmill, Denver, CO, U.S.A.), mapped 10 chromosome 
region 12p11.2-p12.1 (23) was usod. This YAC, "'300 kilo-
bases (kb) long, was purified by pulse-fiold gel electro· 
phowsis and amplified hy DOP-PCI{ (3B cycles) as 
descrilmd pwviously [31). Subsequently, the DNA was 
labeled with biotin·14·dUTP (GIBCD-BRL, Gaithersburg, 
l ... fD, U.S.A.) ill a sfll:!JIld round of amplification (30 cycles) 
undor the same couditions, oxcept that the drrp concen-
tration waS reduced to halL Th~ centromeric region of 
chromosome 12 was visualized with probe pa12HII 1:12, 
33], which was labeled by a standard nick-translatiOIl kit 
(Boehringer, Mannheim, Germany) with biotin-11·dUTP 
(CmCD·BRL) for the single and with digoxigenin-l1·dUTP 
(Iloehringer) for the double FISH experiments. 
FISH 
The labeled proiJns were dissolved separately in 10 J.l-I 
hybridization mixture (hybmix), zxSSC containing 50% 
formamid (Merck, Darmstadt, Germany), 10% dextr<ln sul-
fate (Phurmacia, Uppsala, Sweden), and S IIlg/ml herring 
sperm as e.1rrier DNA in 2XSSC (final pH 7.0), The probe 
concentrations in the hybmix WCfe Z ng/J.l-I for pa12II8 
and 20 ng/fl.1 for both the 12p paint nnd YACII5. FISH was 
performed as described, previously [14J, with :wuw minor 
modifications. After denaturation (70°C for 5 min in hyh-
mix), the 12p paint and purified YAC#5 were preannealed 
with a 25·fold excess of COT-l DNA (Life Technologies). 
For the double FISH, tlle heat-denaturated (100~C for :1 
min) p(d2HB was added to the hybmix after preannealing 
of YAC#5. The denatur'lted probe mix was added to dena-
lurated slides (4 min in 70% formamid at 72eG, 2XSSC, 
pH 7.0) and hybridized for 16 h (overnight). 
The hybrids wero visualized with 1II0}lsfl-anti-digoxige-
nin, tetnllnethylrhodamine isoUIiocyanate (TRITC) conju-
gatt~d rabbil-anti,U\oIlS{J and TRITC-conjugated goat-anti· 
rabbit (all Sigma) or alternating layers of FITC-(:onjugated 
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avhlin and biotinylated goal-noli-avidin antibodies (Vector 
Laboratories, Burlingame, CA, U.S.A.), Finally, the slides 
were mounted in Hntifade (p-phenylenediamine dihydro-
chloride, 90% glycerol. pH 8.0), supplemented with 4,6-
diarnino-Z-phonyllndole (DAPl. Sigma) (final concontra-
tioll 1 Ilg/ml) for cOllnlorstaining of tho chromosomes. 
Results were studied with a Zeiss Axi!lpitol flpifluores-
cence microscope, equipped with appropriate filters for 
tho visualization of FITC, TRITe, and oJ\pr fluorescence, 
Representativo photographs were made conventionally or 
with a Photornotrics high-pcrformuoco CII250/A cooled 
CeD-camera (Photometries, TUcson, AZ, U.S.A.). Tho final 
figut'es wore generated with a Macintosh Quadra 950 COITl-
puter using the 80S-image FISH software package (Dncor, 
Gaithersburg, r-.m, U.S.A,), 
marizcd as tho mean number of spots/metaphase (MNSM) 
or interphase nucleus (MNSI), llnd 811 was calculated. The 
differences in sizes of the fluorescent' centromeric block of 
the nomml and chromosome 12 derivatives, including 
i{l2p), were also scored, Statistic analysis was porformed 
\-.'ith the unpaired Student's t test. 
CGH 
Screening and Interpretation 
The karyotypos wore intorpreted hy an oxperienced (:yto-
genetic technician unaware of the FISH results, FISH 
results were scored separately by two individuals, For 
each experiment, 25 meta phases and 100 interphase nuclei 
were counted, Signal distributions per sample were sum-
CGH was perfoflllP.ci on cOll\'entionally prepared slides for 
karyotyping as described pre\'iously [22, 23, 34, 35J. The 
meta phases as well as control DNA for the hybridization 
were obtained from a normal male individual. For each 
hybrldizatlon, 400 ng tumor DNA was labeled with digox-
igenin ;md a similar amount of control DNA was ]alleled 
with biotin. COT-J DNA BO j-Lg (Life Technologies) was 
added to reduce background signal due to repetitive 
sequences. After incubation for 2--4 days under 11 cO\'Ofslip 
in 11 moist chamber, the slides were washed by procedures 
described for FISH. The hybrids wow visualized witb 
FITC-conjugated sheep-antidigoxignnin (Boehringer) (tumor 
specific signalJ, <lnd JlBntamethine cyanine dye isothlocy-
anate (CY3) conjugated avidin (Jackons, Immuno Research, 
'[';Iblc 1 Modal composite karyotypes of the testicular germ cell tUlllor derived celllilles studied' 
cdl Hne Chromosomal constitution 
NT2 56-6 l.add(X](q24),aer{X]I(X:l){rI13;q 11), + der(X)I{X: 1](pll:p22],- Y, de!{1 )(p:16), 
i( I )(p 10) ,add(2)( (34), -4, - 5, --6 ,add(O }(q2 5) ,aOl (7)1(7: 17)('122 :<]21), - fI,adct(9) (q21 ), 
"- IO,~dd( 1O)(p 11,1), -11,dpr(11)l(11;15)(q II:qI5), +!(12)(plO)x2, -13,add( 13)(q21), 
-14, - \!i, - 1 7, - 18, - HI,Add(20)(p 13}. - 21, -22, -22, +fi-8mar(cp9] 
21U2Ep 51-50,XX, - Y,dup(1 )(q 111121), - 2, - 3,del(3)(qll),-4, -5, -6,dic(7;9]{q II ,2:p13}, -ii, 
add(B)(pll),-9, -9, -!O,del(ll}{q 13q21)X2,rlel(12]{q22j, + ,ler(12)1(3: 12)(rlll ;'t 11}. 
+ t( 12]{p 10). -13, -13, -14,Bdd(14j(p 11.1),-15,add(tG)(q24), - 1 7, - HI, -I \1. -21, 
-·22," 22, + 5-lOmRr!cp 10] 
1112,1 Clone A: 52-55,XX, - Y,der(1)l(1;7)(p32:pI5),-2,add(2)(p25),-3,add(3)(q29).-4, -5, 
-tl,del((i)(qlll),add(7)(rt21), -- G, - 9, - IO.add( IO)(p15},der( II)add( I 1){q13)del(1 I) 
(p15).+i( 12){plO)x2,-13,der(J 3)1{ 13:1 3)(]l12;q 12). - H.add(14){p II], _. IS, -15, -11l, 
-17,der{ 17)l( II ;171{q11 :pI2), -Hl,add(lB)(pll.l), -19,-19, -2o,der(20)1(1I:20) 
(f) 13;'113), -- 21, - 22,. 4-7mar(cp4! 
Clone R: 57-5!l,XX, + der(X)t{X: 10){q25:q21),-Y,der( 1)1(1:7)(p32:p 15),dup( 1) 
(q llq21), -2,add(2)(p25). -4, ". 5,de1(6){q 16), +add(7)(q21). -B,add{B)(p II), -9,-9, 
-10,-11, -12,i(12)(plO). +i(12)(p10], -13, ··13, _. 14, .. 14,·' 15,add(t6)(q241. -17, 
-iB,-iB,-19,-20, -22,+5-7mar[cp2) 
Clone C: 53-57 ,x,'X, +der(X}I{X: 1O){q25:q211. - \',dup(lj{'111'l2 I), - 2,'·2,-3, -- 5,· I), 
arld(B)(plll.-9, -9,-10, -11,del(12)(q22), +1(12)(p1O):.:2, -13, -13, -14, -15, -1Il, 
-19, -21, -22, + 2---4rnarfcI'2] 
NCCIT 53~57,add(Xl(p22, 1),add(X)(p22.1), - Y.add(I)(p21),del(1j{p21),+dcl( 1 )(q24), 
+dol(l} (q31),add(3)(f) 1 I), -4,d el(4)(p 15.2p 15,31,-6,add(6)(pll.2),del(G)(p23), -7, 
add(7)(p15j,del(7)(ql1,2),-B,dol(8)(p22), -9. _. 9, -10, - 10,adrl(11 )(p II ,2),der(12) 
1(9;12)(qI2;q 12),-13,-14,add(14j(p11). -15,der(15}t(15:1;15)(pll, I :1;'111), -II), -17, 
-18.dor(l9)1(7:19){q l1.2;p13.1). -20, -21 ,-22,-22,+der(?)I(?:I)(?:p 13).+dor('!) 
1(?:10)(?;q 11.2), +4-umar[cplol 
S2 54-57,X,dur(X)t(X;B)(pll ;pl1), - Y, - I, -I ,add(2){p25):.:2.add(2)(p 16),-3, -3,add(3) 
(q II), -4,-4,der(4)1(4:12)(p13;ql1), -5, -5, - 5.actd(O)('111 ),dllI{6)(q2?),-G,del(B) 
(p21), -9, -10,-10, -IO,der( 11)t(5;?:11)(q 13:?;pl1 ),arl(12)1{8: 12J(q 13;'l24):.:2,i{12) 
(p10). -13, -14,Rdd(t4]{p I 1),- 15,add{t5)(pl1).der( 15)t(5: 15J(q 13:p12).-!G, -17, 
-lB, -lB,dor(Hl)I(1:1 g)(p12:p13.2), ·-20,add(20)(q 13,3).+add(21j(p 12),-22,-22, 
+der(?)1(1; 1)(?;q21), +der(?)t(?:3)(?:pl1), +B-12mar[cp7) 
'De,cliption~ ar~ f",~d on ,1 triploid n~A CDnlen!. 
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West Grove, U.S.A.) (c.ontrolsignal). The results were eval-
uated with a Zeiss Axiophot epifluorescencc microscope, 
equipped with a Photometries high-performance CH250/A 
cooled charge-coupled de\'ice (CCD)-camera (Photomet-
ries) connected to a Macintosh Quadra 950 computer 
using the comparative genomic hybridization applications 
provided ill the HDS-image FISH software package 
(Oncm). I'rom each cenline, at least 10 metaphase spreads 
with similar imbalances on both cill'omatids of both chro-
U\oSOll1e 12 homologues were interpreted. The individual 
chromosomes were identified by computer images obtained 
from the DAPI-banded nwtaphasn chromosomes. Digital 
analysis allowed representation of the results as flumes-
CllilC(l intensity profile for each fluorochrolTlO nlong the 
ciuornosunw. The avcrilge greenlred ratio was calculated; 
peaks in the gfl~en prome were interpreted as overrepre-
sentation. Photographs were made directly hom the com-
puter screen. 
RESULTS 
Conventional c:hrotnosome banding was performed on fiVtl 
TGCT-derived cell)iJlf)s. Thfl results are shown in Table I 
ns modal composite karyotypes. Three different clones 
wem detected in 1112.1. In the context of this study, we 
focus only on chromosome 12 and related abeuations. 
NT2, 2102Ep, HI2.1, and NCClT showed at least two nor-
mal chromosomes 12. All j(12p) WHS identified in NT2 (2), 
2102Ep (1), 1£12.1 (2) and S2 (1). No i(12p) WilS noted in 
NCCIT, but this ccliline showed a der(12)t(\J;12)(qI2:(!12). 
S2 contains two der(12)t(B;12)(q13;q24) and olle der(4) 
t(4;12)(pI3;q 11), and 2102Ep showed (t der(12)t(3; 12)(q 1l; 
gIl) and a del(12)(q22). The )aller iUHlfTlaly was also 
present in HI2.!. Con\'entional chromosnllW analysis 
indicated that threc copies of the short ann of chromo-
some 12 wef1--J pflJsont in NCCIT, 4 were present in S2, 0 
and 7 were present in HI2.1, fi were present in 2102Ep, 
and 7 were present in NT2. The expected copy numbers of 
I:entrollwric regions arc therefore, 3, 3, 5, 5, and 5, mSr)(~C­
tive)y. 
For the simultaneolls detf~ctioll of centromeric and 12p 
sequences, double FISH wit)l I)uI2HIl and YAC#5 was per-
formcd. In this approach, pu12Hfl was labeled with digox-
igenin (detected with TRlTC) and the YAC with biotin 
(detected with FITe). In addition, pal2HB labeled with 
biotin was used in single FISH. The mean numbers of sig-
nals per metaphase spread alld interphase nuclells (and 
corresponding SD) of single and doublr. FISH Hre shown in 
'[hble 2. The fISiI patterns are shown in Fig. 1 Hnd ft~pre­
sentative examples arc shown in rig. 2. The results 
obtained from NT2 Hlld NCCIT confirmed the findings of 
karyotyping. In con\!ast, FISH .~h()\\'ed that the cytogeneti~ 
cally defined i(l2p) in S2 contailwd llO chromosome 12-
derived sequences and was therefore incorrectly identified 
as such (Fig. IA). In addition, FISH showed that der(4) 
t(4;12)(pl:l;qtl) mllst be reclassified as der(12)t(4;12}(gI2; 
pl1.2)(Fig.lB). 
Despite lack of hybridization of YA(;IIS with one of the 
chromosome 12 derh'atiYes in S2, the 12p paint recog-
lIizt~d a slllal) region jllst proximal to the centromere (Pig. 
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'fahle 2 Summary of tlw single and double FISH results 
using the centromcrc-sllccific probe pn12HIl Hnd 
YAC#5 for the 12pll.2-p12.1 sllbband on 
metaphase~ ilnd interphase nuclei of fjve TGCT-
derived I:elllilws 
Single FISIl iJo11hle FISH R~tio YACI 
Celllino p(c12lill p"-1211!l YAC p,,12Hfl 
NTZ 
MNSM 5.0 (n.:1) 4.7 (n.fl fi.7 (0.4) 1.4 
MNSJ 5.0 (I.U) 4.2 (1l.7) li.l(Il,fI) 1.5 
21U2Ep 
MNSM :l.!l (n.7) 4.0 (0.7) 5.0In.o) 1.> 
tlINSJ 3.3 (0.5) 2.11 (n.A) .,.:1 (I. 1) 1.9 
1112.1 
I\INSM 4.5 (n.li) 4.1 (0.5) 5.2 (lUi) \,:1 
MNS! :l.!l (ll.B) :1.4 (1.0) U(1.0) 1.3 
l\!CC!T 
MNStll UI (0.5) 2.11 (n.7) 2.U (n.u) l.n 
MNSJ 3.:1 (n.7) V (0.7) 2.11 (0.0) l.n 
52 
MNSM 3.0 (0.2) 2.!1 (O.:l) 2.n (n.o) 11.7 
MNS[ .1.2 (0.7) 2.3 (0.7) 1.0 (0.:1) IUl 
Ah/'rnialion;: nSII, flu. 'I,·, •• "',' in ,II" h} hridiz~\i"n; ?>lNS.\l and MNSJ. 
rnr·.1n nUmb,'r Olf spOlLs P"I m"\Jl'h.l<~ .111.1 1"'1 i"\."l'h.\", ,,, .. t<>I"; Y AC 
)'~~'I arUfi. ht, j,r"",,,,')"'''' 
The c~n\,,,mHi" 1'1010" \\'." t.,I",j"rl wilh bioI in lor til" ,i~gt" ~[jJ ",Oh 
dlgo"igenin fo[ th" douL!" nsJ[. Th" ~lNS~l "lid MNst ." \,,·tt ." rorn'-
'11011.1;[11,( Sf) (in h,--;"~"l') "'" InrJicatrd. Tb" f~lio h~I"""n th~ 11"",10.·[..; ,,[ 
YAC- and p(j12HIl·d~fi\·~d 'iwnt, [nr".leh, "It lin" i., shoWTl 
lH). In addition, in this cell line cryptic 12p S(~qlwn~es 
were detected in derU)tU;3)('!;p II) and in the cytogeneti-
cally identified add( lH)(p 11.1) in If 12.1. Analysis showed 
that this latter region also contained a small p(d2I1S-
hybridizing fragment (Fig. 1(;), as well ns a ft~gion n~cog· 
nbo;ed by YACII5 (data not shown). III contrast, lIO YACII5 
hybridization WHS detected in the aforementioned 12p-
derived region in S2 (data not shown). The 12p sequences 
other than those pl'eSllllt in normal copi~~s of chromosome 
12 and i(12pJs were distlibuted randOlllly thf(lugh~lUt thn 
genUIne, i.e., as~ociated with (parts 00 chromosomes :1, 4, 
B, 9, Ill, and 1!-l. 
No size diffeJence~ hflt\\'(~{)n tllfJ flllOf(~Scent c{)ntromeric 
regions of the norlllal ChWll\OS0l1WS 12 illld its d!~ri\'ati\'es 
were detected in NCCIT and S~. In (;ontl'ast, Oll llletaphastl 
spreads, both i{I2p}s in NT2 contained an enlarged centro-
meric region {Fig. JI)), whereas the i(I2p)s in 2102Ep and 
1£12.1 contained a Slllal!nr hybridiziog f(!gion. Thcse size 
differences could only be idenUDed on <fi';:, of tlw inter-
phase nuclei whether biotinylated or digoxigenin-labeled 
pa12HB WilS used, as illustrated by Fig. IE, which shows 
nucleus of NT2 hybridized simultaneollsly with pnI2IIB 
and YACIt5. The appearance of tito diffnn~l1t signills imli· 
cates the presence of three nOlJllill ch[lllnOSOlJle.~ 12 and 
two i{I2p)s. The pld2lfB-hybIidizing wgion in add(IB) 
(plt.l) of H 12.1 already mentioned and the region present 
in dcr(12)t{:l:12)(ql1;ql1) of 2102Ep wern reduC(!d in size 
as compared with their normal homologue (not shown). 
Despite multiple attempts, the !at\!Jf centromeric h-lgioll 
umld be detected by FISH in only 30% of the metaphase 
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Figure 1 Fluo[p$cence in situ hyhridiz~li(jn (FISH) r<,>ults in 
Chrolll<JSnrnn 12 Hnd dl'ril'dtivl's (arrow) with tho {.entftlmrric 
proLe po.1211!l (indir.llrd II)' a [I[nd.:) (lnd )'Past artificial chromo-
somp. (YAC)~5 (circles). 
spreads. Ber.atlsfJ of the involveillent of IhH centromere of 
chromosome 12 in this iransiocatiOll, it must be reclassi-
fied as dcr(12)t(3;12)(qll:q to). 
In metaphase spreads of 2102Ep, NCClT, ,md S2, :-;imilar 
IIllmb(~rs of centromeric regions \\'(~w d,:lec\t:d with the bloti-
nylated and dignxigfmin-lallHled po.t2HIl probe (Table 2). 
Lower c.opy lHlluilers wflre observed in NT2 and !I12.l 
when the latter was compared with the former {p < 0.05 
and 0.02, respectively}. On interphase nuclei, this decn'a~H 
in copy numbers was significant in all cell lines (p < 
0.001). In general, a lower number of centromeric- and 
12jl-SIWcific signals \\·;lS ohsen'.!d on interphase nuclei as 
r.ompared with metaphase spreads. This was mainly true 
of the centromeric region in the cell lines showing H 
reduced size of the fluorescent signal of tho chrotnosollW 
IZ derivatives (ZIOZEp and H lZ.I). 
Single hybridization with Wd2HII showed chromo-
SOlllfl 12-centrollwrk regions of more than two in aU cell 
lines tested. Distinction between a normal chromosome 
1Z, an i(lZp), or another chromosome 1Z derivativo could 
not be made with this approuch on intnrphHsIl nll!:lni. Thn 
simultaneous applkation of P(1 IzHn and YAl.#5 indicated 
Chapter 4 
a lelative 12p overrepresenlation as compared with the 
centromeric regions in all three i(J2p)-mntaining cell 
lines (Nn, 2102Ep, and 1I1Z.1), i.o., ratio of YACil5 to 
pI< 12HII (If p 1.:1. Tlw ceillin('s witl! no i(12p) (NCl.l"!' and 
S2) had a ratio of E; 1.0. 
To study the \'alue ofCCH for thn detection of lZp O\'cr-
representation in TGGT in comparison to com'entional 
c)10genetic and fiSH analysis, CGIl was used on thn five 
cell lines included in this survey. The analysis wns hased 
on a triploid DNA content of the tumor t:ells, without con-
t,lmination of the sample with host cells. No 12p ovenep-
rtlsenlation WIIS detected in the cell lines NCCIT and S2. 
This finding is in agreement with the combined results 
obtained by cytogenetic and FISH analyses, showing TlO 
more than three copies of the short nrm of t~hrOlw)somp. 12 
in these rdllines. The inability to dllter\ the underrepre-
s,mtation of 12p sequences in S2, most probably due to the 
sm!sitivily of this Illethod, is noteworthy. The other three 
cell lines (NT2, 2I02Ep, 1112.1) showed overrepresenta-
lion of the complete short arm of chromosome 1Z uV r.GH 
(shown for NT2 in fig. if), in accordance with the ~(~slllt.\ 
of cytogenetic analysis combined with FISH, showing six 
or more copies of IZp pllr Iluc!mls. 
DISCUSSION 
After the first report of the presence of an i(lZp) in TCr.T 
in Iflfl2 [3GI, multiple studies of this isochromosomH were 
published. dealing with the possible clinical implications 
1:)71 ,IS wHlI as diffHrent detection lllethods. The latter 
includH conventional kalyotyping, molecular and FI1)H 
strategies. Cytogenetically, i(12p) can be detected in most 
TGGT [7, 38, 3[1], supported by molecular Ilata [:Hl, 40[. 
The fi1)11 approach [II] is based on the use of a cen-
tromew sped fie pro\w for dlfolllosmne \2. This probe has 
bl~lm ftllwrted to deted a consistent size difference between 
the hybddizing region of a normal chromosome 1Z and an 
i(12p). Because of n discrepancy in the literature regarding 
this phenomenon [18-20, Z3, 411. <1S well ,IS tltH occur~ 
rence ofTGCT without [(IZp) 1\:-1, 20, 4ZI. we studied the 
possibility of idnntifying 12p overrepresentation in gen· 
!Jr;ll, all(l of i{12p) in particular, on metaphase spreads Hnt! 
interphase nuclei with a double fiSH appro<lch. In ,1\ldi-
tion, CGII was applied to investigate whether tlHl entirl' 
12p arm was overropresented. 1l(~Ca\lSI1 nll\ IiUHS, in con-
tr.:lst to tumor silmples, enabl" II detailed description of the 
cilrollloSOlHP. constitution and comparison of the data 
ohlained from metaphase spreads and interphase nudlJi, 
five TGCT~derived cell lines were included in this stud\,: 
three NS (NT2, Z102Ep, .md HI2.I) and two cell lill~S 
reported to be 1)E-like (NCCIT lllul S2). Ours is the first 
study in which the reproducibility and sensitivity of dif-
fm'lIlt !Jlp.thnds in detecting chromosome 12 abcrrations in 
TCr.Ts was tested in detail. 
Conventional karyotyping in combination with FISH 
showed the pwsence of i(IZp) in <ill tlH\~e NS cell lines but 
not in the two with a ,sE-likH phenotypp., which is of inter-
.~st l)j~came j(12p) is lIlore frequently detected in NS as 
compared with SE; 83 \'€rsus [jG'){, in the largest sories of 
primary TGGT (102) nnalyzed su far [8]. The abe[[,mt si:le 
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'.'igurc 2 (A) Vlm!,[o flllOnJIUlI\I,,, ill situ hyhridization (FISH) of a mctljphase spread of 1'>2 with tho C<lntf<Jm~re­
Spt'cific prohe p,,12111l {t"tr,lm(lthyl·r"rI'lmine isotJliocyarlate THITC; led signnl) ~nd 12p Jlilint (rITC, yellow sig-
n.d). and DAr! as counkbtaining of tho, hromosollll1s; No 12p· or ((iIltIOm(Jf,,·(l!)ri\"l~d se{lul:nr;!'~ are present on 
th" '.)'to);"II"U< dlly i,j'Hltifkd i(121') (~rro\\'), whert<as 12]1 and centHJIl101re sequenu)~ are hidden in tIl" Gytog,eneti. 
of the fluoresoml cimtrolllfnic region of the i(12p) as com-
pared with the normal chromosomes 12 detected in 
metaphaSD spreads of tho cell lines was not obscn'cd COIl-
sistently on interphase nudei hybridized in the ~il"Hl 
(lxpflrimull!. Tiwwfuf(l, FISH with only a centronwric 
regioll-specific probe is not suffir.itmt to screen for the 
presence of one or more i(l2p)s in interphase nuclei. This 
conclusion is strengthened by the fact that in two cell 
lines (2102Ep and 1112.1) 11 reduced size of tho hybridizing 
centromeric regions was <11$0 ob~cr\'cd in d(~ri\,ilth'(~s of 
(;hroJJlOS(jllW 12 nthll[ than i(12p). Therdore, the finding 
of i{12p) in pediatric germ r.ell tUlilors, as recently 
repllrlHri [1:11. mllst be velified. The douule FISH approach 
lIsed in this study might be informative. 
As compared with conventional karyotyping, mIdi-
tional chromosomo 12·derived ~f~qllOnces were detect\~d 
with FII::iH in H12.1 ilnd 1:>2. All f~fllllil\Ps e:nntained a rela-
ti\'(1 (l\'nrn~presmltatioll elf thtl e:mltHHnHrie: regielll and short 
arm SOCl\lfl1lCOS of cht"OlUosome 12 as cOlllpared with their 
mndal cluomnsome r.onsititution (hypotriploid). CGII 
showed overreprosentation of 12p sequences only in tho 
cell lines with marc than one extra copy of the complote 
short arm of chromosome 12 [those with <1t least one 
i{12p)]' The ratio of the 12p-duri\'(~d signals to tilUSH 
reflecting the mntromeric regions indicah~s the prflsenCH 
(>t.ul or i1hs!H\!:1l (~1.0) of Olltl or Illore HI2p}s. This ratio 
might 1m llseful to study tUllIors for the presence of the 
i(12p), using interphase cytogenetics. This is currently 
under ilH'esligation. To visualize the presence or absence 
of i(I2p) on interphase nuclei, a 12p·spec:ific prolm map-
ping closer tn tho ClHltrOlnnrn !IHln YACII5 would be lIHHIl 
informative. Dnuble FISH proved a suitable method for the 
rintHc\i01l of 12p o\'flrrepresentation in general and of i(I2p) 
in particular on mfltaphaso spreads and interphasn nnclei 
of TGCT-derh'ed ceB lines. Currentl\', we <1H1 detemlining 
the critical region of O\'errepresentation of tlw short ann of 
chromosome 12 in 1'GeT using a combination of cytog,~. 
netic and rll::iH analysis. lkc;luse CGH confirmed thp. cyto-
genetic finding~ on duot1\osomt:l 12 of the cell lines 
included in this study, and lwcause of the recent report of 
tlw detection of amplillcatioll of a restricted region of the 
shorl arm of chromosome 12 in a metastasis of a SE !2:1). 
as well as in primary TGCTs 143). we will also use this 
tp.chnique in the analysis of the 12p aberrations in primary 
TGCT. This combined approach will finally [I~s\llt in the 
identification of tho chromosome region from which the 
candidate gene or genes causing developme1lt of this can-
cer can bo isolated. 
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Chapter) 
Comparative Genomic Hybridization of Germ Cell 
Tumors of the Adult Testis: Confirmation of Karyotypic 
Findings and Identification of a 12p-Amplicon 
M. M. C. Mostert, M. van de Pol, D. Olde Weghuis, 
R. F. Suijkerbuijk, A. Geurts van Kessel, J. van Echten, 
J. W. Oosterhuis, and 1. H. J. Looijenga 
ABSTRACT: Comparatke genomic hybridization (CGH) was carried out on 15 primm}' testicular germ 
cell tumors (TGCT) of adolescents and adults and 111'0 metastatic residual tumors after chemotherapeu-
tic treatment. The results were compared with kOI}'ot)'pic data obtained form the same tumor specimens 
after direct han'8sting of metaphases or short-term in ~ritro culture. Both techniques ret'ealed that the 
most consistent abnormality in primary TeeT is gain of 12p-sequences. Although in most cases m'er-
representation 0/ the complete short arm was obsen'ed, CGH rel'eaied a specific amplification of 
12pl1 .1-p12.1 region in tn-a independent primaI}' tumors. In addition, loss of (parts of) chromosome 13 
(always inl'Oking q31·qter), and gain af(parts of) chromosome 7 (mostly im'oJt.ing qll), (parts of) chro-
mosome 8, and the X chromosome were detected in more than 25% of the tumors by this lalter tech-
nique, Loss of 6q15-q21 in both residual tumors analyzed may suggest a role for this anomaly in 
acquired resistance to chemotherapeutic treatment. 
Ot'eraIl, the CCH analyses confirmed gains and losses of certain chromosomal regions in TCCT as 
obsen'ed by kaI}'otyping, and thus support their role in the development of these neoplasms. The ampli-
fication of a restricted region of 12p in primaI}' TCCT confirms and extends our previous obsen'ations 
and, as such, represents an important step fonrard in the identification of gene(s) on 12p relevant for 
the pathogenesis of these tumors. 
I.\.TTRODUCTION 
:"he most common cancer in the caucasian young adult 
llIale population is the germ cell tumor of the testis 
(TGCT) [1, for review]. Because its incidence is still 
ill creasing, and effective treatment in its preim·asive stage 
is possible [2]. understanding of the mechanisms involved 
ill the etiology of this neoplasm may have important 
implications for the development of early detection strate-
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gies. In spite of its technical limitations in the study of 
solid tumors in general, karyotyping has been highly infor-
mative in the detection of chromosomal aberrations in 
TGCT [3-5J. In accordance with results of total DNA con-
tent analysis IB, 71. TGCT are found to be aneuploid, 
around the triploid range. Besides consistent over- and 
underrepresentations of some (parts 00 chromosomes, the 
only recurrent structural abnormality is the isochromo-
some 12p [i(12p)J 15], first reported in TGCT by Atkin and 
Baker in 1983 [BJ. This anomaly is found less frequently in 
seminomas (SE), composed of malignant counterparts of 
early germ cells, than in nonseminomatous TGCT (NS), 
which are caricatllres of early embryonal development 
composed of embryonal (embryonal carcinoma (Ee) and 
teratoma (TEl) and/or extraembryonal (yolk sac (YS) and 
choriocarcinoma (CH)) components [9, 10). Fluorescence 
in situ hybridization (FISH) using region-specific probes 
showed that also i{12p)-negative TGCT invariably exhibit 
overrepresentations of 12p-sequences (11, 121. Because 
conventional cytogenetic information is derived from 
mitotic cells, such data may be biased due to selection of 
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subpopulations of ceUs by the mothods of direc.t harYest-
ing or short-term in vitro culture. This has recently lleen 
sURliested for :m with respect to tho presence of i(t2p) 
[13]. Also the presencu of markers of which, by definition, 
the chromosomal origin can not be determined, may ham-
per the identification of certain chromosomal regions 
important for the development of this cancer. 
Comparative genomic hybridization (CGH) allows the 
detection of DNA copy number changes in relatively Sllltlll 
amounts of tumor DNA [14J. BeCiHlso no metaphase spreads 
are required CGH can be applied regardless of mitotic ac-
tivity, thereby exduding in vh'o or in vitro solection. In 
addition, CGH offers tho possibility of revealing regions of 
amplification or deletion that arc not identifiable via kary-
otyping. 
We analyzed a sories of Hi primary TGCT (including 
both SE and NS) and two metastatic residual tumors aftHr 
chemotherapelltil: treatment using both karyotyping aud 
CGll. The metaphaslJ spreads were isolated viti direct har-
vesting of the SE and nfter short-term in vitro culture of 
the NS. Similarities aud differences in the ciUoHlosomal con-
stitution of the various tumor samplos as detected hy both 
techniques arc evaluated. 
MATERIALS AND METHODS 
Patient samples 
Fifteen TGCTs eollected from collabordting hospitals in 
the Western part of tho Netherlands were Ilsed in this 
study. The tumors weru classified according to tho World 
Health Organization (WHO) recommendations [!:Ii, as de-
scribed {61. and identified as six SE, seven NS, a!Hl two 
comhined tumors (crj 115]. TJ1I1tumors were smgieal\y re-
moved before the patient was tr"a\!;d with chemotherapy 
and/or irradiation. In addition, two lTletastatic residual tu-
mors, one maWre TE (2101) and one EC (.'Jfi9S), were stud-
ied_ Representative p<lrts of tumor compol1ent(s) were 
snap frozen in liquid nitrogen ([or DNA isolation) and 
fixed in 4% buffered formalin for paraftln embedding (for 
hi~to[ogical ciassificati(m). 
Slide Preparation and Karyofyping 
Metaphase spreads of SE and NS wele prHpl1{\~d uccording 
to standard procedures. Briefly, the mitotic cells of the SE 
were, after mechanieal dbsociation of the tumor, directly 
harvested in the presencl:l of Colcemid (Life Tec.hnologies, 
New York, USA). The cells were subsequently swnl\El/\ in 
hypotonic Kcl solution and fixed with methanol-actltic 
neid (:l:l). The NS were enzymatically digested using col-
lagenase and cultured in vitro for a few days, after whieh 
they were treated as reported hefonJ 116, 171. 
For karyotyping, air-dried prtlpamtions were banded 
using pancre;lIin (Sigma, SI. Louis, [JSA) 1IS reported [181_ 
Tho chroU\()son!ai constitutions were descrilwd according 
to the recolilmendations of the ISCN 1981 [lU), and calcu-
lated on the basis of a triploid DNA content, to stress tho 
over- and underrepresentations of (parts 00 chroillosonws 
relali\'e to the triploid situation. Although the NS W\Jru 
randomly selected, five i(t2p)·negative SE were chusell for 
this survey (see Tnble I). Such tumors may be instwllwn-
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tal in tho dalineation of the critical region of overreprosen-
tation of the short ann of chromosome 12, as was suggested 
recently through the analysis of a metnstasis of a SE [12]. 
Compar.-tlh'e Genomic Hybridization and Interpretation 
For CGH, metaphase spreads were pruparod using stan-
dard procedures (see ahove) from in vitro phytohemagglu-
tinin·still\ulated peripheral blood lymphocyte cultures of 
a healthy 1l\3le (46,XY). High molecular weight DNA of the 
tumor as well as control DNAs (from peJipheral blood 
cells of healthy males), were isolated using standnrd pro-
cedures 1201. CGH was performed as described before [12, 
2t-2:lJ. To exclude false positive and falso negati\'e obser-
vations, DNAs obtained from 10 healthy individuals were 
analyzed as described for t1w tumors. Regions that showed 
variations in centromeric and heterochromatic regions, 
IHlrms of acrocentric chromosomes and telomeric regions, 
wew omitted frolll Imalysis. 
Por eilch hybridization, 400 ng digoxigonin (l1-dUTP 
{Boehringer Mannheilll, GI{J) ltlbeled tUtJ\or DNA and a 
similar amount of biotinylated (l4-dATP {GIHCO-URLll 
control DNA weHl used. Eighty Ilg of COT-t DNA (Lifo 
cn~chnologiesl was added as competitor DNA to rHduce 
background signal due to repetitive sequences. After 2----4 
days of incubation und!~r a co\'erslip in;j moist chamber at 
37'C, the slides were washed according to regular fiSH 
protocols [24]. Visualization of the hybridized DNAs was 
achieved with fluorescein isothiocyanate (FITe) conju-
gated sheep-anti-digoxigenin (fllwhringorl and pelltarne-
thine cyanine dye isothiocyanate (CY3) conjugated avidin 
(Jacksons Immullol{esearch Laboratories, \Vest Grove, 
USA). The results went e\'aluated using 11 Zdss Axiophot 
epifluorescence microscope, equipped with H Photomet-
ries high-performance CH250/A cooled CCD-CallWr;j (Pho-
tometries, '1\lcson, AZ) interfaced onto a Macintosh 
Quadra 950 I:olllputer using Ilw comparative genomic hy-
bridization applications within tho Oncor-Image FISH 
software package (Oncor, Gaithershurg, MOl. Those appli-
cations alloVl' a pSHudocolor repl'Oduction of fluorescence 
ratios of CY3 (refHn~nce DNA) and fluorescein (tumor 
DNA). 
All TGeTh were a!lalyz\~d assuming no host udl con-
tamination, Le., instrulllllllt setting of 100% tumor. Bp(';Hlso 
SE are known to contain vaIiabltJ amounts of infiltr,lting 
lymphocytes [!:II, theso wore also analyzed assuming 5U% 
host cells [251. For I~ilch tumor, fiV!l nwtaphase spreads, 
with similar imh8lancns on both cllIomatids, wero inter-
preted according to I)[(wiously publislH~d critllria [22, 23, 
26]. tJigital analysis nlJo\w~(1 reprosentation of tlw results 
as fluofCscence intensity profiles for each fluofOl:hrome 
along thu chromosome. PllOlographic images wew nwdn 
using 11 Tuklronics SDxrr color dye sublimation printer. 
RESULTS 
The cytogelwtic data of the ptimary TGCrs and tho resid-
ual tumors aw sllmmarized ill Tabl!l 1 as modal wpresell-
tative karyotypes. All showed all aneuploid DNA content 
around the triploid rango with multiple numurical and 
structural aberratiolls. The modal lluJ(!lutr of short and long 
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Table 1 l\Indall'epresentativtl karyotYJles of the ti~sticular gorm Ctl\l tumors of adolescents nnd adults (TGefs), based on 
R tdploid DNA con lent (Ihn abefIati()n~ also det!~ctt~d by a comparative g?pomic hyhridization arc undlHlinedJ 
Hi.~tol()gr 
~eminoma 
N'n\~pnlinom~ 
ComioirH'cl TGCrs 
S"lllinnma 
Seminoma 
Rp,ldual Tumors 
Chro'll11hnlll~1 ConQitlllloll 
42S" 6U-7G,XX Y ,add( 1)((\1 Z), +d[, (1; \2)(p 13:q2~). :', ; ·!d"l((»)('l21'12~). t 7.+11,+0, - \:1, + 14. j 1 Ii, - lB. 
121,-22,-1 \-7111ar[cpl II ~---
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~dd(22)(pI2).+marl (cp!l) 
S!l-flZ,XXY,del( I ](p:1Ci), -2,arld(3)f pIZ), -4, - 5, tdoI(U)(p I J). -11. -1O.~dd(10)(q22), -II. -13. -\4, 
I ~,-1O, - 1 !l,dt'r(20)t(J 2;20)(p ll!I!l!l, t 21, -22. ~ marl, +mar2 (cplul 
57 -O-t.XXY, t Y.add(2]('I24).t(3: 15)(p2:1:'1241,-4,.U< (4: Il){p 16:pll ,Z), -5,add(n](q I 3), +11. --!l, -10, 
-II, - 1 1,!J,F)(p 10). +i(t~)[p IO),--=-D.. -14, - 1,",-15. -lfi. --lH,add(!9]('113.1 ).+der{2 J)l( 12:21) 
~,+ nl.lrl,+mar2. t /I1ar:l,+mHr4, to-2mJr 1':1'7If{l2-l1J.i,lplIl,+add(.tHplfij.+ll 1<;]1'11 
arms (if im'oh'ing mowlha\ 50% of iH length Hlld account~ 
ing for only the long Hrrns of acrOulutric chromosoIlws as 
dl)snibed by De Jong el al. (:J]) for each chromosnITw was 
dtl\ermincd. These data, dllpicled in Figure 1, indicate a 
similar pallelll of chromosomal O\'(~r- and undelfeprcs.m-
tatlon in SE and NS, I.e., unc\nrrepresenlatioll of (paris 00 
chnullOSOmC$ 4, 5,!J, II, 1:'1, and 10, and OI'errcpresenta-
Ij,m of (pilrts 01) ciUO[JlOS'Hnes 7, 0, 12, and X. 
Thl) aherrations ["lind by CGH are illustrated in Tabl'l 2 
and Figure 2 (only IIIP. results obtained from analysis of SE 
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Figure 1 Schematic rnph'~"lltnti"l1 of thl! H\"l!raglJ copy number 
per cilf<JlIl\)o;()t1\e fur Eix Eeminomas and SUI'nll IlOII"Jrninomatuus 
te,licubr germ r..)1 tumors uf adolr-scents and adults, 'dl<:ul,lIl!d 
Oil Ihe basis of kmyolypi<: n·,;\dts ii' f"port.)d before 13). 
with instrument settings assumillg 50% host cells are 
shown}. Those abcuations tlmt W~~Hl ,lIS!! detccted (partly) 
with kal.l'0typing are underlilwd in Tahltl 1. Within the 
group of the six prim(Jry SE, gain W<lS found 14 tinw:,; in-
volving six difflJrent l:hrolTlosomns, und loss six times involv-
ing thwll different chrolilosoml1s. For the NS (n = 7), gain 
was found to times affecting four diff{~f()nt chromosomes 
and loss fiw-\ timns affecting four diffl',rtltlt chromosomes. 
No imbalances \VerEl dotected by CGH for ChWllll)SOllWS 1, 
16,17,20,21,22, and Y (tlwse me uxcluded frolll FigHnl 
2), whnreas aberratiolls (of parts) of chromosomes 2, 5, H, 
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HI, and 19 were only found in a single pdmary tumor. The 
following regions showed aberrations in lllultiplH C(JSCS: 
loss of pnrts of chromosome 4 (in nne SE, one NS, alld ono 
SE of a C1'), II (in one NS and a SE of a CT), and 13 (in 
three SE, one NS, alld one SE of a CT), gain of parts of 
chromosome 7 (in three SE, 0110 NS, and OlHl NS of aCT), 
8 (in thref! SE, one NS, and one NS of aCT), cOlllpleto 12p 
(in three SE, six NS, and one NS of a CT), region I2p11.1-
pI2.1 (in one NS ;md both components of one CT) and X 
(ill three SE and OIlH N::». Some aberratiolTS found in SE 
\\"eIll only identified using the illstrumenl ~tltlillg.~ HSSllm-
ing ;:;0% tumor, i.e., loss of t:lq31-qter in tUlllor 4255 ,md 
13 in tumor 2fi55, [lnd gaill of Bqtllf in tumor IGG5, 7q 11 in 
tumor 57Ul, and 7, X in tumor 57:11. 
,-\1though only the SE components of thn CTs could be 
karyotyp(d (Table tj, Iwtil histological COlHjllll\el\ts were 
slut/iHt! hy CGlf (Table 2). Cain of 12pl1.1-p12.1 was dll-
teeted ill both componcnts nf tUlIl<Ir 2207 (illustrated in 
figure 3). The r,ltin value of the alJlplicon WilS approxi-
mateh' three times high or in the SE cOJnp<Ht~d to the NS 
(not shown). Other aberratiolls were found tdtlrer in tlw 51\ 
or \:S component within tllat Gr. The other CT (:12B4) 
slJIlI\"ed only gain of 12p ill tlw NS (:omponent by CGH. 
The rHsidual tUlllOrs showed four lillllJS gain, affected two 
different chrolTfosolTWS, and fi\'e tillle~ loss i1ff(~cting four 
different chrOlllOSO/ll~~. Hutl! cases showHd lms of p<lIt of 
tlw long arm of duoll\osonw (} (encompassing q15·'12J) 
and gain of the complete short arm of chromosome 12. 
Although most aberrations found by CGll were con-
firmed hy karyotyping, others weJeIIllIlXp\~ch~d, i.(~., o\'er-
representation of n~gi(Hl !lq21--q31 in 4255, Ihlll.1-'1 J 2, ,lnd 
12pl1.1-pI2.1 in :lO:15. 
mSCUSS[QN 
The series of six SE ,HId se\'cn NS presented hl-'rt~, shows a 
pattern of o\'cr- and underrnpn'S(lntation of (parts) of clHO-
Illosomcs as found in a group of more than 100 TGCTs 
Jlublislwd heforn [5]. The recelltly (IHvdoped technique of 
cOlllpara\i\'tl gtlnomic hybridization (CCH), n hicolo[ FISH-
approach that t-HlahlEs detection of lelative over- and 
IIndcrrepresentation of chrolTlosomal wgions [14), tUllwd 
out 10 bo \'ery useful in thfl dtltt~c!ion and mapping of 
D\"A-seqlloncn copy number changes in solid tumors !I2. 
14. 21-23, 27-:l.'i]. We applied this techllicpw to a series of 
karyotyped TCr.l's to screen for chronlOsolllfll THgions 
showing imLalallcfls in tlw~n tumors possibly unidentified 
by com'entional chromosomal 'lIlal),sis. 
Multiple cases showed gain of (pariS 00 chrolilosome 7, 
B. X, and the short arm of chromosome 12, an" loss of 
(parts 01) c\lronlOsomn 13 both by karyotypiug and r:CH. 
Although olher 10SSIlS or gains of some chromosomal re-
gions were expected fIOUI karyotypic analysis, these were 
not detected by CGII. This lUay 1m )lilftly d\l(~ to tho pres-
ence of chromosomal segments hidden in lI1arknr.~, tumor 
hetHrogtllwity, tho s{lnsitiyity of the CGH applied. as well 
as the presence of llO.~t cells in the samples (illustrated b)' 
the results in SE). HOWtlV~~r, somo unexpectcd copy num-
ber changes were detected hy CCH in !lllr series ofTGCTs. 
Thesn changes mostly involved ~Jllall chromosomal reo 
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Table 2 Gains and losses of chromosomal regions in testicular germ cell tumors of adolescents and 
adults detected by compllrative genomic hybridization 
Histulogy 
Nomeminuma 
C"mLined \Ulll(l!S 
.'>"l11il\"111'1 
Nonseminoma 
Rt'sidual tumors 
4255 
1665 
5718 
57:n 
7214 
2655 
239 
3n].~ 
51 til 
!lS37 
{I007 
IHH2 
l!lll 
2207 
3284 
22U7 
3284 
Loss 
'3 
4p,4q13---<Jlur 
\:1, 1/1 
1\1 
4q. l1q22--qlm 
'3 
4q.t3q 
111113-qlu[ 
S,9q2I--q:l2 
Ilqler,12p 
12p. X, 7'111 
7.1l'l,X 
4q12 
7ql1,12poX 
12p 
Gains 
71'.lJqlH--<112, 12pll.l-p12.1 
IIp 
12p 
12p 
12p 
12p. X 
12pll.l-pI2.1 
2'l:l5--qlcr, tlplO-p21.2 
7qll-qH,8q21--q23,12pll.1-p12,1 12, 
2101 (jqlS-q2! 12p 
5/l0,5 ___ 'c,_,-,qc' _12_q'-2_'_-<!c2_2C,_'_3"'--__ Bp'-,C'_'cP _________ _ 
gions nllt dtl\ecled with collventional karyotyping. In ad-
dition, CGH enabled us \0 determine tho minimal regions 
of overlap of parts of chromosomes shuwing imbalances·, 
Le., 7qll and 13q31-qtef. Thcse re~\llts ate in line with 
CGII data of U p[J[affin emilelhled SE obtained after univer-
sal DNA amplification [:Itil. Consistent ·t'>'ith karyotypic 
analysis of a large series of TGCTs (151 and this paper), 
oveaepresentation of 12p is the most frequent aberration 
found. Interestingly, CGI£ re\'ealcd in two j(12p)-negaU\'e 
tumors (one SE and both components of a CT) specific am-
plification of a wbregiull of the short arm of chromosome 
12, i.tl., 12pII.I-pI2.I. Although this same region was re-
cently found \0 he amplified in a metastasis of a tllsticular 
SE 1121. we now report that this anomaly rna)' also he en· 
countered in primary TGCTs. A \'ery similar observation 
was recently made in three additional primalY TGCTs (M. 
Koru, personal cornmunic.:ltion). 
Figure 2 Schematic representation of relative los~ (inolkJted 
on the left side of the chromosomel and gain (indjr,11ed on the 
right sid", of the chrnmosnrne) of chromosomal l"egions, detected 
by compM,ltil'e gelloulic hyblidization In six seminomas (marked 
hy IinC's), SGven nonseminomatous testicular germ cell tumOl$ of 
adolescents and adults (marb"d by dotted linp~l, hnlh compo-
nll·nls of the combined tumors (illuslrd\!ld as the PUf<J SE and NS), 
<lnd two tl\f<I.J,tatir. l"OSitiU3] tumors (also indicated bv dotted 
linesl. -
Becallse karyutyping of both the SE and NS compo-
rwnts of CTs is hard to achieve, CGH was used to (;ornpare 
their chromosomal constitutions. The results obtained il-
lustrate that the SE and NS componcnts ofhuth cases stud-
ied here were at least partially gmwtically distinct. The 
only common aberration. wa~ tlw amplification. of 12pll.l-
p12.1 in both cornpnnents of one CT. 1I0wcvcr, the ratiu 
value in tlw SE was flpproxilllfltely three times higher than 
in litH NS. As we recently suggested [371 these results indi-
cate the SE and NS components of CTs might he lHono~ 
clonal or biclonal in origin. 
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CGH of testicular germ cel/tumors 
Figure 3 E"alllpin of th" n'·;ult of, "ml';lf<ltiw, genomic hybridization on chromo>omn 12 of thn H'lIlinoma component of combined 
tumor 22U7. showing tlllUOf sp,~dfio: alilplifiration (r,)pl','~nnt"d~, rtllalivtl o\'tlrrepresentJtion of the gn,on I:OlllPM'),J to thn r,1d signal). 
nll,oll1pa'~ing fO'gioll 12pl1.I-]112,\, 'llil! blun linn WPh'''''llts thn I.lti" pr"filn. i.tl .. tIn' n,d to gr~oll /1uOfescnnrn intf'nsitie, O\'ef the 
\\'11011" IIr"Jl\o,oll1" I"nglh. 
Annthru int()resting lin ding with CGH is thH sptldfl<: 
loss of filp;I''lllnllcrs (involl'ing 'l15-q21j in both wsidual 
tlllll(lr.~. This sllgg!~sts thrtt Inss of gnnn(s) localized in this 
fngioll lllay 1m i!1volv(~d ill r,~shl;HlC'~ to Ch(~llHltlwr;t(l(~\ltic 
tff"rttllwn\, as It!cenlly S\lg!:WSh~d for g1i(lhla~tollla multi-
forl1l'~ 1:181. Obviously, molt) diltil ClW It!qllired 10 Hllilslallti-
attltiris notion. 
III t:!)[}(:lllsion, Ollf study nf eGI I on il limited nilmbcr of 
TGCTs largdy confirms nllr bry()typk findings nn i1 ~1,rir5 
of more than 100 tlllll<Jrs [:1): (l1"~rr'~Jln~StHlt;lti()n (If (p;lrts 
of) chromosomes 7.B,I:!:, Rlld X, alld llndt'![lejlfHSelllation 
of cliromosollw 13. In addition. through CGH the most 
likel~' rngiolls involw~d could bn identified. i.e" 7ql1 and 
13q:ll---jltnr. Tl\l~ most intriguing finding, how()ycr, is the 
mnplification of a rnslrich~d Tt~gi(ll\ of tlw sliint arm of chrn· 
11l0some 12, l:!:pl1.I-pI2.I, in difftlrent pritnary TGCT.~. 
Analysis of more TGCTs using this approach will bring the 
isolation of tlw rdnVilnl gends) Oll 12p in the realm of fea· 
sibility. 
\\'n th~nl G tn I\1r"lmdn ano! U. de IOllg <If tlw M"dil',ll (;Ollwtk, 
DepaJ\ll\t'nt of tIl() Uni\','rsity of Groningen for their assistance 
<Hul addeO), \\'" HI,,, \\',,"Id til!) t" H"\..noll'lo-'dgH thr.. dillicians 
in\'o!v~d in tho (Oll"rtioll of Ihn ]ldtiO'nt llHltO'I'iaL This work \\"l~ 
suppO/tnd by thn Dlltch Call(,'r Sod!'ly (Koningin WilhelminJ 
FOllol,) gr.llll I1I1HK n Hl:ln. 
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C)10genetically, testicular genn cell tumors of adoles-
cents and adults (fGCTs) are characterized by gain of 
12p-sequences, most often through isochromosome for-
mation (i(12p». Fluorescence in situ hybridization 
(FISH) has shown that i(12p»-negath'e TGCTs also 
cryptically contain extra 12p-sequeuces. The consistency 
of 12p-owr-representation in all histological subtypes of 
TGCTs, illcludlng their prelnmsiw stage, suggests tbat 
gain of one or more genes Oil 12p is crucial in the 
del"elopment of this cancer. So far, studies aimed at the 
identification of the relennt gene{s) were based on the 
'candidate-gene approach'. No conrincing e\idence in 
fa\'or of or against a particular gene has been reported. 
We combined comentional karyotyping, comparathe 
genomic bybridization, and FISH to identify TGCTs 
with ampUfications of restricted regions of 12p. Out of 
49 primary TGCTs (23 \\ithout i{12p), 13 with and 13 
unknown), eigbt tumors (six nithout i(12p) and hlO 
unknown) showed amplifications corresponding to 
12pII.I-pI2.1. Using bicolour-FISH, physical mapping, 
and semi-quantitathe polYlIjerase chain reactions, the 
size of tbe shortest region of Olwlap of amplification 
(SROA) was estimated to be between 1750-3000 kb. In 
addition, we mapped a number of genes in and around 
lhis region, While fourteen known genes cou1d be 
excluded as candidates based on their location outside 
this region, we demonstrate thai KRAS2, JA WI and 
SOX5 genes are localized within the SROA. While 
KRAS2 and JA WI map to the proximal border of the 
SROA, SOX5 maps centrally in the SROA. KRAS2 and 
JA WI are expressed in all TGCTs, whereas one 12p 
amplicon-positi\'e TGeT lacks expression of SOX5. The 
critical region of 12p m-er-represented in TGCTs is less 
than 8% of the total length of the sholl arm of 
chromosome 12. It \\ilI be helpful in the identification 
of tbe gene(s) in,-ohed in TGCT-de,·elopment. 
Keywords: testicular germ cell tumors; 12p; over-
representation; critical region; candidate gene(s) 
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Introduction 
Testicular geml cell tumors of adolescents and adults 
(TGCTs) are the most common cancer in Caucasian 
males in the age between 15 and 45 years, and an 
increasing incidence has been reported in most 
European countries as well as in the USA (Adami et 
aI" 1994; Molter et at., 1995; Feuer, 1995; Bergstrom et 
al., 1996; Bosl el al., 1997), Histologically and clinically 
they can be divided into two main groups, the 
seminomas (SE) and the nonseminomatous-TGCTs 
(NS) (Mostofi et al., (987). Both types of TGCTs 
originate from a common precursor, known as 
carcinoma ill sim (Skakkebrek et al., 1987) or 
intra tubular genn cell neoplasia (Stamp and Jacob-
sen, 1995). A large number of TGCTs, both primary 
and metastatic, of various histologies have been studied 
for their chromosomal constitution by different 
investigators, including ourselves (Rodriquez et al., 
1993a; Van Echten el ai" 1995; Sandberg et al., 1996, 
for review). Besides non-random patterns of over- and 
underrepresentation of (parts of) chromosomes, gain of 
12p is a consistent finding. In the majority of TGCTs 
tested this was due to the presence of one or more 
copies of isochromosome 12p [i(l2p)]. In addition, it 
was found using fluorescence ill situ hybridization 
(FISH) that TGCTs without i(l2p) always show over-
representation of 12p-sequences cryptically hidden in 
the genome (Suijkerbuijk et of" 1993; Rodriquez et 01., 
1993b; Smolarek e! ai" 1995). We showed that i(12p) 
may also be present in CIS (Vos et aI" 1990), 
indicating that over-representation of 12p-sequences is 
probably a relatively early evcnt in the pathogenesis of 
this cancer, not related to invasive growth. We 
confimled this by numerical analysis on tissue sections 
using ill situ hybridization (Looijenga el 01., 1993; Gillis 
eJ al., 1994), 
Although more than 14 years have passed since the 
first publication of i(l2p) as a specific chromosomal 
abnonnality for TGCTs (Atkin and Baker, 1983), ideas 
on the critical target gene(s) still remain speculative. 
This can be explained by the fact that most TGCTs 
show over-representation of the complete short ann of 
chromosome 12, encompassing approximately 40 
Megabases (1Ib) and containillg theoretically between 
850 and 1400 genes (Marynen and Kucheriapati, 1996), 
Therefore, alternative approaches are required to 
identify the genets) on 12p of which copy-gain is 
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beneficial for the development of TGCTs. One possible 
strategy was initiated by our previous identification of 
a metastatic SE sho\\ing amplification of a restricted 
region of 12p (Suijkerbuijk et al., 1994). },.fore recently, 
we and others demonstrated via comparative genomic 
hybridization (CGH), a technique developed to identify 
relative (sub-) chromosomal gains and losses (Kallio-
niemi el al., 1992), that also a certain percentage of 
primary TGCTs shows amplification of a restricted 
region of 12p, cytogenetically similar to the one 
observed before (l\fostert el aI., 1996a; Korn et al., 
1996). This finding of a restricted 12p-amplification 
allows identification of relevant genes using a direct 
approach. 
To determine the shortest region of overlap of 
amplification (SROA) of 12p in TGCTs we combined 
conventional karyotyping, CGH, (bicolour-)FISH, 
physical mapping, and semi-quantitative polymerase 
chain reaction (PCR) analyses. Identification of such a 
SROA aliows the exclusion of a number of known 
genes on 12p as candidates, and will facilitate a more 
direct approach to identify novel genes on 12p critical 
to the pathogenesis of this cancer. 
Results 
Detection of J2p-amplification 
To identify cases with a restricted amplified region of 
l2p, we used CGR to screen a series of 49 primary 
TGCTs, including 26 SE and 23 NS, of which 23 
lacked i(l2p) by conventional karyotyping (13 SE and 
10 NS). In 13 tumors i(12p) was identified and 13 
tumors could not be analysed due to lack of 
metaphases. Eight tumors (six lacking i(l2p) and two 
unknown) showed amplification of a part of 12p 
detectable by CGH, identified as region 12p11.l-
p12. L similar to the previously reported case of a 
metastatic SE (Suijkerbuijk et 01., 1994). Four tumors 
were classified as SE (T2655, T2814, T8763 and n02) 
and four as NS (TIO077, n035, T2207 and T60). 
Tumors T2207 and T60 are NS with a SE-component, 
socalled combined tumors ac<:ording to the British 
classification (pugh, 1976). The amplification was 
found in both SE components, and in only one of 
the NS components (not shown). 
Six of these tumors with amplification (T2655, 
T2814, T8763, Tl0077, T3035 and T2207) were 
karyotyped successfully. The metaphases were further 
analysed by FISH with a Yeast Artificial Chromosome 
probe, known as YAC#5 which was formerly mapped 
to region 12pll.2-pI2.1 (Suijkerbuijk et al., 1994). This 
probe was used since it allowed the detection of gain of 
12p·sequences in all TGCTs tested so far (unpublished 
observations). It was found that the amplifications 
were due to the presence ofadditional12p-sequences in 
add(12)(P 13) or der(l2)t(l2;?;hsr)(p 13;?;?) in Tl 0077, 
,dd(12)(P13) in T2655, add(12)(p12) in T2814, 
der(6;?17)(qlO;qI0)add(6)(q21) and a marker (which 
was cytogenetically identified as an i(8)(qlO» in T8763 
(not shown). In the remaining two tumors there were 
no metaphases suitable for FISH. 
All eight TGCTs with a proven restricted amplifica-
tion of 12p by CGH w..:re studied by FISH using 
YAC#5 on interphase nuclei. This probe showed 
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between 15-30 hybridization signals per nucleus in 
these tumors as reported before in other TGCTs 
(Suijkerbuijk et al., 1994; Mostert et al., 1996b; Korn 
et 01., 1996). Circumstantial evidence that YAC#5 
indeed maps \\'ithin (or at least close to) the critically 
amplified region was obtained by combining CGH on 
tumor T2207 with FISH of YAC#5: YAC#5 
hybridization co-incided exactly with the amplified 
12p-region, both in metaphase spreads and interphase 
nuclei (not shown). Of the samples T2655 and T2207 
suitable material for further FISH analysis was lacking, 
be<:ause only a small part of tumor cell nuclei 
contained the l2p-amplification. The 12p-amplicon 
negative nuclei in these particular tumors however, 
also contained extra 12p sequences identifiable v,'ith 
FISH, although in a lower total copy number. In 
which form these sequences· were present could not be 
detennined due to lack of meta phases. Using FISH 
with YAC#5 in combination with a probe specific for 
the centromeric region of chromosome 12 (Looijenga 
et al., 1990) we checked the remaining 41 TGCTs for 
12p-amplification. This approach showed no indica-
tions that amplification of a restricted region (contain-
ing YAC#5) was missed by the procedure followed. 
Constructioll of a YAC-contig of 12pll.2-p/2.1 regiol/ 
and mapping of YAC#5 
YAC#5, previously mapped to 12pl1.2-pI2.1 (Suij-
kerbuijk et al., 1994), was used as a starting point to 
generate a contig suitable to detennine the SROA. The 
most relevant part of the contig is shown in Figure la. 
The length of the different YACs was estimated by 
pulsed-field gel electrophoresis. The presence or 
absence of STS markers was checked by PCR using 
STS specific primer sets on the relevant YACs. Both 
proximal and distal directions were analysed until a 
Y AC was proven to be negative for the next STS. The 
assumed order of STS markers was in agreement with 
the data from the Whitehead Institute database. The 
seeming <:ontradiction in length of YACs 803B2, 
845DII and 957B7, which all are positive for the 
same markers (see Figure la), is most probably due to 
chimerism of the YACs 803B2 and 845DII, as these 
YACs also score positive with markers of other 
chromosomes than chromosome 12. YAC#5 was 
placed on the contig by inter-Alu fingerprinting and 
by Southern blot hybridization of a YAC#5 interAlu 
probe (not shown). As indicated, YAC#5 was found to 
overlap \\ith YACs 922D9, 928G2 and 753F12. In 
addition, YAC#5 was positive for STS DI2SI057 by 
PCR, which secured YAC#5 to a fixed position on the 
map. Furthennore, a number of cosmids specific for 
different STSs within the contig were isolated (Figure 
la). 
Shortest region of over/ap of amplification (SROA) 
To define the borders of the SROA, the six remaining 
12p amplification-positive tumors were studied using 
bicolour-FISH, as reported before (11ostert et 01., 
J996b). Therefore, different YACs and cosmids within 
the contig were hybridized simultaneous!y \\ith YAC#5 
on interphase nuclei isolated from the tumors. YAC#5 
was visualized in green and the other probes in red. 
The number of signals per interphase nucleus, and 
Chapter 6 
_Tel Cen I> 
STS, 
. ,-" .. ", 
YACs 
.~ 
'-+--
,,: . .,....,""~, 
~~, 
R:"~, on:;;:, Cosmld; 
b 
shones! region of 
overlap of amplification 
= 
---.----------
.----------
-0 ________ _ 
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,imullaneollS])' with other probes from the region The regions which are amplified in the tumors at a similar level as YAC;'I5 are 
indicated by bold lines, while the regions that are nol indudeJ in the amplKOns are illustrated by dotted line,. Note th.lt the shortest 
region of overlap of amplification maps bet,~een the marker; OI2S!6SS at the distal side and OllS]3l) at the pro:l:imal side The 
lengtb of tbe YAes and cosmids are not drawn to scale 
metaphase spread if available, was scored. The results 
are summarized in Figure lb. None of the YACs tested 
showed higher numbers of signals than YAC#5, 
indicating that the region showing the highest level of 
amplification includes sequences recognized by 
YAC#5. For all tumors similar signal numbers were 
found for YAC#5 and YACs 927011, 922D9 and 
753F12. In contrast, at the telomeric side, YAC 80382 
showed significantly fewer signals than YAC#5 in 
TI0077, whereas on the centromeric side YAC 744011 
showed significantly less signals in T60 and TS763. Due 
to the sizes of the different YACs used (indicated in 
Figure la), the exact borders of the amplicon could not 
be determined accurately. Therefore, a number of 
cosmids (specific for STSs localized in the putative 
border regions of the amplicon) were used in a similar 
bicolour-FISH approach as described above with 
YAC#5. The results are also indicated in Figure lb 
and a representative example is shown in Figure 2. In 
the distal region, cosmid 235Cl. containing STS 
012S1945, showed fewer signals than YAC#5 in 
TIO077, TS763 and T202. About 25% of the nuclei 
of the latter tumor showed this difference, while the 
majority of nuclei had similar copy numbers. FISH 
\vith cosmid 34F8. containing 012S1688. showed the 
same pattern as with 235Cl in TJO077 while cosmid 
95C2, specific for AFM267yc9, demonstrated an equal 
number of signals as with YAC#5. The data indicate 
that the distal border of the SROA maps between the 
STSs 012S1688 and AFi\U67yc9. 
At the proximal side fewer signals than with YAC#5 
were found in four of the tumors with cosmid 164F2 
(containing STS DI2S1325), in three tumors with 
124A3 (containing STS 012SI411), in two tumors 
\\'ith both 177011 (containing STS 012S1034) and 
52CIO (containing STS DI2S1313). Cosmid 31C2 
(containing STS 012SI350E) showed similar signal 
numbers as with YAC#5. The data indicate that the 
proximal border of the SROA lies between 012S1350£ 
and DI2S13I3. 
It can be concluded that based on this set of tumors, 
the SROA lies between Dl2S1688 al the distal end and 
D12S1313 at the proximal end. More tumors contain-
ing smaller l2p-amplifications have to be identified and 
studied to further narrow the SROA. 
CalJdidalc gcnes alld semi-quGl/tiwtil'e (RT -peR) 
A number of genes have been mapped to the region 
12pll-p13. as summarized in Table 1. These can be 
considered as candidates to e.\plain gain of 12p-
sequences in TGCTs. We were able to map the genes 
(from distal to proximal). RECQL, lAPP. LGS, 
LDHB. SO.\'5, JA WI. KRAS2, KRAG. ITPR2. 
PTHLH and LGP within the cootig (Figure Ja). LGS 
(Nuttall el aI., 1994). ITPR2 (Hcighway el af .• 1996), 
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Figure 2 hampk of bicolour nUorelcence in s;w h,bridizalion on isolated nuclei fwm tumor T8763, shov.ing {al similar signa! 
numbers using YAC#~ (detected in green) and co,mid 31G (containing STS DI2SI3S0E) (dew:ted in red) as probe,; and (b) a 
lower signal number (or cosrnid ]24AJ, specific for STS DI251411 (detected in red) as compared to YAC#5 (dete.::ted in green) 
Signals for the cQsmids (in red) are larger than the signal, for the YACs (in green) because of a biotin}\·lyr"mide amplification step 
used to \isualize the cosmids 
PTHLH (Raeymaekers et al., 1995) and LGP (New-
gard e( aI" 1986) have been localized as part of a long 
term project to map all kno\\ll human genes and 
ESTs (Krauter el 01., 1995, and http://www 
genome.wLmit.edu). YAC ICI36ECI was the smallest 
YAC found to be positive for KRAG by PCR, placing 
this gene between STS 012S1596 and DI2S1316. The 
human ONA helicase QI (RECQL) (Seki el al., 1994; 
Puranam, 1995), the islet· amyloid polypeptide (lAPP) 
(Hoovers el al., 1993) and lactate dehydrogenase 
isoenzyme B (LDHD) genes (Li el al., 1988) were 
previously mapped to band 12p12. We were able to 
localize these genes to the distal part of our YAC 
contig (Figure la) and their order was determined by 
PCR on the different YACs. 
Three genes, SOX5, JA WI and KRAS2 were found 
to map within the SRQA. KRAS2 was previously 
mapped between markers DI2S1435 and 012S1596 
(Krauter e! al., 1995). peR with KRAS2 specific 
primers showed that proper amplification products 
were generated rrom YACs 753FI2 and 761BS, while 
no signals were obtained using YACs 928G2 and 
744011. This obser\'ation places KRAS2 between the 
markers 012S1350E and 012S1313. This localization 
was confirmed by Southern blot analysis using a 
KRAS2 specific probe (not shown). Our data demon-
strate that KRAS2 is localized just at the proximal 
border of the SROA (see Figure I). Bicolour-FISH 
using YAC#5 and a cosmid containing KRAS2 showed 
that this region was indeed amplified at the same level 
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as YAC#5 in all tumors. SOX5 was previously mapped 
to 12p12.1 by FISH (Wunderle el al., 1996). Southern 
blot analysis with an inter-Alu specific rragment of 
YAC y90001253, which contains the SOX5 gene 
(Wundec!e et al., 1996), showed only hybridization 
with YAC 92209 (not shown). PCR with SOX5 
specific primers confirmed localization of this gene on 
both YAC 92209 and y900G1253. In addition, YAC 
y900GI253 scored positive for STSs D12S1942 and 
012S1950. Thererore, we conclude that SOX5 maps 
between the markers AFMB351ZH5 and Dl2S1591 
(illustrated in Figure la). A sequence homology search 
with markers from our contig showed 100% identity of 
STS DI2S1350E with the JAWI gene. 
As an additional approach to define the SROA, 
semi-quantitative PeR-analyses were perrormed on five 
TOCTs with a 12p·amplicon (TlOOn, T3035, T2814, 
T60 and T8763) to study differences in copy number:; 
or genes mapping to the region of interest: i.e., LGS, 
KRAS2, KRAG and ITPR2 (Figure 3). Two non-12p 
genes were included as references (ProgR and 
17pTEL). which revealed similar results. No clear 
differences in copy numbers of the tested genes on 
12p were found in TGCTs without 12p-amplicons that 
were used as controls (not shown). Also, no unbalances 
were found between the 12p-genes themselves in T2814, 
which is in agreement with the results of the bicolour-
FISH experiments. While all 12p genes tested showed 
over-representation at least to some degree relative to 
ProgR and 17pTEL in noon, n035 and T2814, no 
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gain of KRAG and ITPR2 was found in T60 and 
T8763, again concordant \vith the results obtained by 
bicolour-FISH. This indicates that this region of 12p is 
not included in the amplicons in these particular 
Table 1 Summar)' of the different genes mapped \0 chromosomal region I2pll-pl3; their \o_aliution I\ilhin the YAC--<:ontig and the shortest 
region of overlap (If amplification (SROAl is indkated 
Gene Description YAC 
Maps /0 
STS Region SROA' ~~:flf'o~f Refa~lla(J) 
CCND2 eyelin D2 12p\3 Sc,Db (Rae}makus et al., 1995) 
CM9 Early T -(ell activation WI-9214 12pJ3 Db (Lopez-Cabrera ({ aI., 1993; 
antigen Schnittger el al., \993) 
CD9.f Type 2 membrane glycv- 12p13 Py (Chang el oL, \995) 
protein 
GDFJ Grol-lth differentiation 12p13 Ph (Caricasole et a/., in press.) 
factor 3 
GRI,\'lB Glutamate re~eptor 12pl2 S, (Mandich (I (Jt., 1994) 
lAPP Islet amyloid pol)'peptide 803B2j934H5 12p12 
" 
(Hoovers et al., 1993; 
Raeymaekers (I a/" 1995) 
lTPR2 Type 2 inositol 1,4,5-tri- ICI36EClj798DI D12S2033 12pl2 Py,Ob (Heighway el aI" 1996) 
pho,phate receptor 744G11/753FI2 
JAWI L}'mphoid marker 753FI2J92SG2J76- 012S130E + Dd,Py (Behrens el (J/., 1994; 
1B8 Behrens el ai" 1996) 
KRAG Kirsten Tas associated gene ICI36ECI,I798DI 12p12.J Py {Heighwa}' el (Jt., 1996) 
744G11/753F12 
KRASl Signaltransdu~tion protein 761BSj753F12 12pI2.! Sg,Py 
(P21) 
LDHB Lactate dehydrogenase 803B21957B7 J2pI2.1 Py (Raeymakers el aI., 1995) 
isoenz:,me B 934H5/845011 
LGP liver GJU(ogen Phosphol1" 754CI 012S2025 Db 
,,~ 
LGS liver Glycogen S)l1thase 803 B2/957B7 012S1945 P)"Db (NultalJ el at., 1994) 
934H5/845DII 
PTHLH Parath}roid like hormone 754C1 WI-9193 Db (Rae)makers el al., 1995) 
RECQL DNA helicase Ql 934H5 Py (Seki el al .. 1994; 
Larramendy el al .. 1997) 
SOX5 Sex determining region 922D9h9QOGI253 J2p12 + Py (Wunderle et al., 1996) 
y box 5 
TXFRI Tumor necrosis factor a 12p13 (Krauter el (J/., 1995) 
receptor 
mapped outside the SROA, -.- mapped within the SROA. bDb-data obtained from the Whitehead Institute and/or the Human 
Genome Database, Ph = PCR of a gene spedfic primer pair to the chromosome l2p h}'brid panel. Py= PCR of a gene specific primer pair on the 
YAC·contig $=Southem blot analysis using a eONA probe (Sc) or genomic probe (Sg) 
l7pTEL -
KRAS2-
ITPR2-
ProgR-
KRAG-
KRAS2-
• 
4 5 6 
KRAG 
ProgR 
b 
d 
2 3 4 
Figure 3 Re;ult, ofsemi~quantitati\'e pol)merase chain reactions on tumor TS763 and fOUl control samples. Gels (a) and (b) sho\'. 
amplification in the tumor of KRAS2 ",''sus conlrolloci. (c and d) show equivalent lel'els of ITPR2 and KRAG I'ffSUS controllod 
lele!s, whilst (e) confirms tumor amplification of KRAS2 It'rSlJ5 KRAG. {f) shows amplification of LGS I'USUS ProgR but the degree 
of amplification seems to be reduced compared to KRAS2 lewls. Tracks: J, 2, 4. 5 = DNA derired from nonnallung tissue; 3 = 
TS763; 6 = negatil'e control (no target DNA); 7 = 0X!?4IHat'l1i marker 87 
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tumors (see Figure lb). The results suggest that in both 
cases a region encoding KRAS2 but excluding KRAG! 
ITPR2 is preferentially amplified. The fact that LGS 
has a similar level in peR·amplification in tumor T60 
as in tumor T8763 is most likely explained by the 
relatiyely low percentage of tumor cells containing the 
smallest amplified region on 12p in the latter sample as 
demonstrated by FISH with cosmid 235Cl. 
In addition, the levels of amplification of PTHLH 
and ITPR2 relative to KRAS2 were determined. No 
differences were found between ITPR2 and KRASl in 
the tumors TI0077, n035 and T2814, again in 
agreement with the bicolour-FISH results (Figure Ib). 
ITPR2 was not found to be amplified in tumors T60 
and T8763. When comparing KRAS2 \vith PTHLH, 
four of the tumors (T3035, T2814, T60 and T8763) 
showed a higher amplification of KRAS2, also 
concordant v..:ith the data obtained by bicolour-FISH. 
Although the bicolour-FISH with YAC#5 and cosmid 
34F8 showed differences in signal numbers in tumor 
T10077 (Figure Ib), no differences in levels of PCR-
amplification as compared to KRAS2 were found with 
specific primers for STS D12S1688, for which 34F8 is 
positive. The differences between double-FISH and 
PCR could be due to the heterogeneity in length and 
num ber of the amplicons and the difference in 
sensitivity of both methods to dete<:t them. No 
difference in level of PCR-amplification compared to 
KRAS2 was found for the STSs DI2S1606 and 
DI2S1596 in tumors TIO077, T60 and T8763. As the 
localization of SOX5 and JAWI was identified at a 
later stage during our investigation, these were not 
included in the semi-quantitative analysis. 
In order to study the expression of the SOX5 and 
KRAS2 genes mapped within the SROA, a semi-
quantitative reverse transcription (RT - peR) was 
performed. As illustrated in Figure 4, most tumors 
with amplification of a restricted region of 12p showed 
a similar level of expression of KRAS2. In one tumor a 
lower level was found. In contrast, a more hetero-
geneous pattern of expression was found for SOX5. In 
four tumors it was expressed at a lower level than 
KRAS2, and in two at a higher level. In addition, no 
expression of SOX5 could be detected in T8763. To 
.--691bp 
KRAS2 .l9~bp 
-50!.4g9bp 
::::::i~ci~~ 
...--M2bp 
SOX5 H7bp -So!.4S9~p 
---4CHp 
---no bp 
...--692bp 
HPRr 5S7bp -SOl.4R9bp 
::::::;~~~ 
flgllre oj Examples of semi-quanti!atiw reverse transcription 
pol>merase chain reaction anal,'5es of KRAS2 and SOX5 as 
{ompared to IlPRT in testicular germ ceU tumor; of adole;cents 
and adults \\ith amplification of restricted regions on 12p. Note 
the comparable lel'els of KRAS2 expression in all tumors, the 
variable levels of expression of SOX5 in the different samples, and 
the absence of expression of this gene in tumor T8763 
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exclude loss of this particular genomic fragment in the 
amplicon, we performed FISH with a YAC containing 
SOX5 (y900G 1253) simultaneously with YAC#5. 
Similar numbers of signals of both probes were 
detected in the tumors with 12p-amplification. All 
control samples of normal testis parenchyma and 
parenchyma samples \",ith different amounts of 
carcinoma ill situ cells tested showed expression of 
both KRAS2 and SOX5 (not shown). For JA WI 
relatively high expression was found in the tumors 
containing a l2p-amplification, but also in TGCTs 
without such an amplicon (not shown). In addition, 
expression of this gene was also detected in nonnal 
testis and placenta. 
Discussion 
One of the most important problems in the study of 
the pathogenesis of TGCTs is the identification of the 
tumor biologically relevant gene or genes in t~ over-
represented region of 12p. It has been known for more 
than a decade that the majority of TGCTs contains 
one or more isochromosomes of the short ann of 
chromosome 12 (Mukherjee et ar, 1991; Rodriquez el 
al., 1993a; Van Echten et al., 1995; Mostert el al., 
I 996b). Moreover, it has been demonstrated, that 
TGCTs without j(l2p) also show over-representation 
of l2p-sequences (Suijkerbuijk el al., 1993; Rodriquez 
et al., 1993b; Smolarek et al., 1995). Since in those 
studies a paint for the whole short arm of chromosome 
12 was used, or a probe which was not mapped in 
detail, it was not possible to localize the region 
involved. The finding of amplification of a restricted 
region of 12p in a case of metastatic SE (Suijkerbuijk 
et al., 1994) was a key observation. More recently, we 
and others reported the presence of similar amplifica-
tions in several primary TGCTs (Moster! el al., 1996a; 
Korn el al., 1996). Apparently gain of 12p-sequences 
by means of amplification of a smaller region of 12p 
(instead of i(l2p)-fonnation) is not restricted to 
metastatic lesions_ 
We found amplification of a limited region of 12p in 
eight out of 49 primary TGCTs. In this relatively small 
and selected sample it occurred in SE as well as NS, 
suggesting that this type of amplification is not 
correlated with the histology of the TGCT. Amplifica-
tion of a restricted region of 12p was preferentially 
found in TGCTs without i(12p) (six out of 23 cases 
(26%) and none out of 13 TGCTs with i(l2p)). We 
demonstrate that the borders of the 12p-amplicon vary 
in different TGCTs, thereby defining the SROA as the 
region of interest. By assuming that the STSs are 
equally divided over the YACs 753F12, 922D9 and 
957B7, we estimate that the SROA could be as small as 
1750 kb. However, when the average distance between 
markers on chromosome 12 is 248 kb as suggested by 
Krauter et ai. (1995) the SROA could be as large as 
3000 kb. Although this is still a relatively large 
fragment, it drastically reduces the crucial region on 
the short arm of chromosome 12 involved in the 
pathogenesis of TGCTs. 
Identification of this SROA pennits the selection of 
the most likely genes involved in the pathogenesiS of 
TGCTs. For example, cyelin D2 (CCND2), mapped to 
12pl3 (Inaba et ai., 1992), was recently reported as the 
gene of interest (Sicinski el al., 1996; Houldsworth et 
al., 1997). We demonstrated by Southern blot analysis 
using a eDNA probe on all YACs within that region 
that eyelin D2 maps outside the SROA (not shown). 
Obviously, eyelin D2 is not likely to be the gene 
explaining the gain of 12p-sequences in TGCTs. The 
published findings support this view, because this gene 
is preferentially expressed in yolk sac tumors and not 
for example in embryonal carcinoma celllines (Sicinski 
el al., 1996), being representative for the stem cells of 
NS (Andrews el al., 1990), The fact that the presence 
of the eyelio D2 in NS depends on the histology 
(Houldsworth el 01., 1997) is neutral with respect to the 
hypothesis that eyelin D2 is the gene of interest. Over-
representation of the eyclin D2 gene in most of the 
TaCTs and derived cen lines (Sicinski el a/., 1996) 
probably merely reflects the over-representation of the 
complete short ann of chromosome 12 found in 
virtually all TGCTs (Mukherjee e( aI" 1991; Rodri-
quez el al., 1993a,b; Van Echten el al., 1995; Mostert el 
01., 1996b). A number of other genes previously 
proposed as candidates we also considered Jess likely 
because they map outside the SROA (Table 1). Some 
of these candidates were plausible, like LGS, encoding 
the rate limiting enzyme in the synthesis of glycogen 
(Nuttall el 01., 1994) and LDHB, encoding lactate 
dehydrogenase type B (Li el af., 1988). Glycogen is 
found abundantly in carcinoma in Silu and the majority 
of the different invasive components {rI<fostofi et al., 
1987). LDHB is used as a serum marker for TGCTs, in 
which its level seems to correlate with the copy 
numbers of the short arm. of chromosome 12 (Taylor 
el af., 1986; Von Eyben et ai., 1988, 1992). TNFRI, 
also located on 12pl3 (Fuchs et 01., 1992; Krauter et 
01., 1995) might be a candidate because mouse 
primordial germ cells, the mouse equivalent of the 
normal human counterpart of carcinoma in Silu and 
SE, show proliferation after TNF exposure (Kawase et 
a/., 1994). Howe\'er, LGS, LDHB and TNFRI map 
outside the SROA. 
We reduced the size of the crucial region on 12p to a 
minimal length of about 1750 kb. Theoretically, 
between 25-50 genes could be present within such a 
stletch of DNA. However, SOX5, JA WI and KRAS2 
are the only genes which were so far mapped within 
this SROA (popescu el af., 1985; Wunderle et af., 1996 
and this manuscript). The human SOX5 gene was only 
very recenlly described. Studies in the adult mouse 
showed expression of this gene in haploid round 
spermatids, where the protein may function as a 
transcription factor. Human SOX5 transcripts have 
been found in adult testis, heart, liver, lung, kidney, 
spleen and fetal brain. Because we found one TaCT 
without expression of this gene, SOX5 does not seem 
to be the gene of interest. Involvement of KRAS2 in 
the pathogenesis of TGCTs has been suggested and 
questioned by different investigators and its role is 
largely unclear so far (Dmitrovsky el al., 1990; Moul el 
af., 1992; Olie el al., 1995). Moreover, it has been 
reported that activation of KRAS2 is not sufficient for 
malignant transformation (Kumar et af., 1990; 
Rodenhuis, 1992; McCormick, 1994). 
Jawl is expressed in a developmental stage-specific 
fashion in both mouse B- and T-lymphocyte lineages, 
with the highest expression levels found in pre-B cells, 
mature B cells and pre-T cells (Behrens el af., 1994, 
Chapler 6 
1996). No detectable expression was found in non-
hematopoietic cell Jines. The encoded protein is 
localized on the cytoplasmic face of the endoplasmatic 
reticulum (Behrens et af., 1994, 1996). The exact 
function of this protein is not yet knO\\11 and the role 
it might have in cancer pathogenesis is not clear. The 
JAH'I expression as we found in TaCTs might be 
related to lymphocytic infiltrations, which are most 
profoundly present in SE (MostojL~e't al., 1987), 
although expression of this gene was also found in 
NS, which are known to contain significantly less 
lymphocytic infiltrates (M05tofi el af., 1987). 
Gain of 12p-sequences as an initiating event in the 
pathogenesis of TGCTs seems unlikely, because we 
reported that polyploidization, resulting in consistent 
aneuploidy of TGCTs (Oosterhuis et of., 1989; 
I,.ooijenga et at., 1991), precedes j(l2p) formation 
(Geurts van Kessel el 01., 1989) and, therefore, 
probably also amplification of 12p·sequences. This 
finding and the fact that amplifications of 12p 
sequences within one TGCT can be heterogeneous 
suggests that the increasing copy number is a 
progression-related phenomenon. This indicates that 
the pathogenesis of TGCTs is not a single step process. 
To this day it remains to be elucidated why a number 
of tumors preferentially amplify a specific region of 12p 
in contrast to gain of the complete short ann as found 
in the majority of TGCTs. Proving that SOX5, JA WI, 
KRAS2, or any other gene mapping within the SROA 
is the biologically relevant gene for the development of 
TGCTs, requires more extensive expression analyses at 
different developmental stages during the pathogenesis 
of TGCTs, and the development of proper ill vitro and 
in vim model systems to test these genes. 
In conclusion, we report on the reduction of the 
region on the short arm of chromosome 12 crucial in the 
pathogenesis of TGCTs to 1750-3000 kb. This will 
facilitate the development of assays for the early 
identification of this chromosomal anomaly and more-
over, the amplicon on 12p is a starting point for cloning 
and characterizing novel genes, which by their mere 
presence in this region are potential candidate genes. 
Materials and methods 
Samples 
The TGCTs included in tbis study were collected at the 
operating theatre in collaboration with Urology- and 
Pathology-departments in the South-Western part of tbe 
Netherlands. After incision of the orchidectomr·specimen, 
representative samples of the tumor and adjacent parench-
yma (when available) were snap frozen in liquid nitrogen, 
and formaline·fixed and SUbsequently paraffin embedded 
for histological examination. The tumors were classified 
according to the World Health Organization classification 
for testicular tumors (Mostofi and Price, 1973). 
Slide preparation for com'entional chromosome banding. FISH 
and CGH 
After SUrgical removal, representative parts of SE were 
directl>· handled to isolate metaphase spreads as described 
before (Castedo et al., 1989). Briefly, the mitotic cells were, 
after mecbanical dissociation of the tumor, directly 
harvested in the presence of co!cemid (Life Technologies). 
The cells were subsequently swollen in hypotonic KCll 
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EGTA/Hepes solution and fixed with methanol-acetic acid 
(3: 1). Representative parts of NS were enzymatically 
digested (collagenase. Sigma), and short term cultured in 
T75 flasks (Costar) under standard conditions, i.e., 37"C, 
5% CO, in air humidified atmosphere in DMEM/HF12 
with 10% heat-inactivated FCS (BRL-GIBCO). Mitotic 
cells were harvested after 2-4 h of colcemid treatment, 
again swollen in hypotonic solution and fixed in 
methanol:acetic acid. For conventional karyotyping, air-
dried preparations were banded with pancreatin (Sigma) as 
reported previously (Moster! el al., 1996b). The chromo-
some constitution was described according to the Interna-
tional System for Human Cytogenetic Nomenclature 1995 
(Mitelman, 1995). 
Slides for single- and bicolour-FISH were either prepared 
from methanol-acetic acid fixed material as reported 
previously (Mostert et af., 1996b), or from nuclei isolated 
from frozen material. For the latter method ten frozen tissue 
sections of 50 JIffi thickness, of a histologically checked 
sample, were resuspended in I ml PBS by pipetting. The 
nuclei were dire.;:t1y fixed by adding 70% ethanol (-20°C). 
After centrifugation for 10 min at 1200 r.p.m., the super-
natant was replaced by 5 ml 70% fresh ethanol (- 20'C). 
Finally, lixed suspensions were dropped on slides, air dried 
and baked for 30 min at 65~C. 
For CGH, metaphase spreads were prepared using 
standard pro~dures from in vitro phytohemagglutinin-
stimulated peripheral blood I}IDphocyte cultures of a healthy 
male (46,X'Y), as reported before (1\fostert e/ af., 1996a). 
Campara/il'e genomiC hybridizatioll 
High molecular weight DNAs were isolated from 
histologically checked samples using standard procedUres 
(proteinase K_sodium dodecyl sulphate treatment followed 
by phenol-chloroform extraction and ethanol precipitation 
(Maniatis el af., 1982». CGH was perfonned as described 
(Mostert el at., 1996a) with a few modifications. For each 
hybridization, 200 ng lissamine-Iabeled (I1-dUTP, Dupont) 
control male DNA and 200 ng digoxigenin-Iabeled (11-
dUTP, Boehringer Mannheim) tumor DNA and 10 jjg 
COT I DNA dissolved in 10 jj! standard hybridization 
mixture were hybridized to normal ,meta phases and 
incubated at 37~C for 4 days. The hybridized slides were 
washed three times with 2 x SSC at 37"C followed by 0.1 x 
SSC at 60'C (three washes). Fluorescence detection of the 
tumor DNA was accomplished using one layer of anti-
digoxigenin-FlTC (Boehringer Mannheim). The slides were 
mounted in antifade (Vectashield) containing 4,6-diamidi-
no.2·phenylindole (DAPf, Sigma) for counterstaining of 
the chromosomes. 
The results were e¥aiuatoo using an epifluorescence 
microscope (Leica DM) equipped \\ith a cooled CeD 
camera (Photometries, Tucson, AZ), a triple band pass 
beam splitter and emission filters (p·I filter set, Chroma 
Technology). Images were saved using a routine built up in 
SCIL-Image implemented on a Power Macintosh 8100. 
Image analyses were perfonned with the use of QUIPS XL 
software (Vysis Inc. Downers Grove, IL). The green and red 
fiuorescent intensities were measured with the Xwoolz 
software for a Sun work station. In the first experiment the 
nonnalization was carried out as described before (Mostert el 
af., 1996J), by using the average of the green to red 
fluorescent intensities for the entire metaphase. Regions that 
showed \,uiations in centromeric and heterochromatic 
regions (chromosome I, 9, 16 and Y) and the immediate 
(elomeric regions were omitted from analysis. 
Yeas/ artificial chromosomes: origin al/d characteriza/ioll 
YAC#5 was kindly provided by Dr B Gemmill (Denver, 
USA). The SQX5 containing YAC ICRFy900G1253 was 
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obtained through the Resource Center in Berlin. YAC 
ICI36ECI was obtained by Dr J Heighway. All other 
YACs used are from the CEPH mega-YAC library (contig 
WC 12.1) and were obtained through the Leiden YAC 
Screening Centre. YAC clones were grown and DNA was 
isolated according to standard protocols (Moster! et al., 
1996b). Proper localization of the YACs was tested by 
FISH on normal human lymphocytes. The length of the 
YACs was determined by pulsed field gel electrophoresis. 
Inter-Alu peR on YAC#5 and other YACs from the 
contig was perfonned using primers ALUI and ALUIV 
(Cotter el al., 1991). 
STS and cosmids 
Cosmids mapping within the contig were isolated from a 
chromosome 12 specific library by hybridization of spotted 
filters .... ith amplified fragments generated by PCR using 
STS-specific primer products isolated from norlJlal human 
placenta, The STS-specific primer sequences were obtained 
from the Whitehead Institute for Biomedical Research 
database, and additional information (localization, poly-
morphism, PCR conditions, etc.) was obtained from the 
Genome Database. The reactions were performed on 250-
500 ng DNA, in 50 jjl reaction volume (containing 10 mM 
Tris-HCI, 50 mM KCI, 1.5 m~j MgCb, 0.25 mM of each 
dNTP and 0,2 units of Taq pol}merase), as well as the 
different STS-specific primers. After initial heating to 94°C 
for 5 min, foilowed by 30-35 cycles of DNA denaturation 
(1 min at 94"C), annealing (1 min at 55°C, 58'C or 60°C 
depending on the primer set used) and extension (I min at 
noq, final extension was performed at n'c for 10 min. 
Five ill of the volume was analysed by electrophoresis on a 
3% agarose gel (50% regular and 50% NuSieve GTG 
agarose) and ethidium bromide staining. The different PCR 
products were isolated from gel using the Quiaquick Gel 
Extraction Kit (Quiagen). Subsequently, 100 ng was 
radioactively labeled using random primed labeling and 
hybridized to the chromosome l2-specific cosmid·library. 
Sonicated placental DNA was used to reduce background 
staining. In addition, CA repeat containing STS fragments 
were prchybridized with other CA repeat·containing 
probes for I h in 5 x SSC. For STS fragments smaller 
than 200 bp, end-labeled oligo's were used as probe. 
Positive cosmid clones were checked for their specificity 
for the relevant STS by PCR using 50 ng cosmid DNA. In 
addition, the cosmids were tested for their suitability for 
FISH on normal lymphocyte. preparations. 
FISH: labeling of the probes GIld hybridizatioll 
The single and bicolour-FISH experiments were performed 
as described earlier (Moster! et aI., 1996b) using YAC#5 
and either one of the other YACs or cosmids as probe. 
YAC#5 was purified by pulsed field gel ele.;:trophoresis, 
amplified and labeled .",ith digoxigenin-ll-dUTP 
(GIBCO-BRL) as reported before. The other probes 
were labeled using a standard nick-translation kit 
(GlBCO-BRL) with biotin-ll·dUTP. One hundred ng of 
both labeled probes and 0,5 jjg COT I DNA (GIBCO-
BRL) were dissolved in 10 JIl standard hybridization 
mixture containing 50% formamide/2 x SSCllO% dextran-
sulphate. The slides were prepared from methanol,acetic 
acid fixed sediment from cases T2814, T8763 and T202 and 
from ethanol liwd suspensions containing nuclei from 
frozen tissue of cases Tl0077, TJ035, T2207, T2655 and 
T60, Before hybridization, the slides were pretreated as 
follows: the methanol/acelic acid fixed slides were rinsed in 
water and incubated in 50% HAc/HIO and 50% HAc/ 
MeOH for 4 min respectively and airdried. The slides were 
dehydrated in 70% ethanol (O°C) and subsequently in 80%, 
90% and 100% al room temperature for 3 min, respec-
livldy. After air-drying, the slides were treated with RNase 
(0.1 mg/ml) (SIGMA) in 2 x sse for 30 min at room 
temperature and rinsed in 2 x sse. The ethanol fixed slides 
were incubated in 0.1 mg.ltnl pepsine in 0.01% HCL 
(SIGMA) for 20 min at 37'C. After rinsing in water and 
PBS, five times each, the nuclei were post-fixed with 1% 
formaldehyde in PBS for 10 min at 4'C. After another five 
rinses ""ith PBS the nuclei were dehydrated in 70%, 80%, 
90% and 100% ethanol, respectively. After in silll 
hybridization for 48 h at 37~C, the biotin labeled probes 
were visualized by a new detection method with biotin}'l-
tyramide (Raap el al., 1995) with a few modifications. 
Briefly, the slides were incubated with ABC (DAKO) 
sireptuvidin-peroxide for 30 min at room temperature. 
Following washes with PBS{O.J% Tween, the biotinyl-
tyramide solution (NEP-116 kit of Dupont) I: 200-1 : 400, 
0.01% HIOI in PBS was incubated for 10 min at room 
temperature. After enzymatic reaction, probe YAC#5 was 
visualized \~ith fluorescein isothiocyanate (FITC) conju. 
gated sheep<.(.digoxigenin (Boehringer) and the biotin 
labeled probe with avidin-CY3 (Jacksons Immunoresearch 
Laboratories). 
For every tumor, 30 nuclei v.ith amplification of YAC#5 
were analysed by three different investigators. In each 
nucleus, the number of hybridization signals of YAC#5 
(green) was compared to the number of signals of the other 
probe (detected in red). 
Mapping 0/ cGndidale genes alld expressioll analysis 
LGS-specifie primers were generated \\ithin the 3'UTR 
(positions 2349-2368 and 2610-2631, GENBank acces-
sion number S70004), with the following sequences: LGSI: 
5'-AGTTAGGCATGAGGAGGAGC-3', and LGS2: 5'-
AATCATGGTTCTGATGCATGTG-3'. The primers used 
for SOX5 were SOX5f2 (5'-CACTGCTGGTGTTGTG-
TAC-3') and 2E2reva (Wunderk el 01., 1996), and for 
KRAS2 KR! (5'-TGATAGTGTATTAACCTTATG-3') 
and KR2 (5'-TTTATCTGTATCAAAGAATG.3') (both in 
exon I). The primers for JAWI (5'·CAGCAGGACATCC-
TAATATATGG-3' and 5'-CCCATTGTATTTTAGTTG-
GGG-3') were the STS primers for DI2S1350E. The PCR 
e~periments were performed as described in the Results 
section. 
RT -PCR was performed on total RNA isolated from 
approximately five tissue sections of 50 /1m thickness of the 
snap·frozen samples, using RNA STAT-60 (TEL-TEST). Of 
every sample, two 5 }Im sections (the first and the last in the 
series) were stained ""ith hematoxylin and eosin for 
microscopic analysis of the histological composition. After 
treatment of the RNA with RNase-free DNase (Boehringer), 
phenol/chlorofonn extraction and precipitation, 5 /.ig of total 
RNA was reverse transcribed at 37'C for 2 h in a total 
volume of 40 /.il containing I mM each dNTP (Pharmacia), 
I mM dithiothreitol, 1.2/1g random heumer primers 
(pd(l\']6) (Pharmacia), I.2l'g oligo d(T) primer d[TJI2-18 
(Pharmacia), 4.5 U of RNasin (Pharmacia), 50 m:>'1 Tris-He! 
(pH 8,3), 75 m:>.! KCI, 3 mM MgCh and I 1'1 of Superscript 
RNAse H- RT (BRL; 200 U//1I). Absence of contaminating 
DNA was checked by PCR \\ithout prior reverse transcrip-
tion. Integrity of the cDNA was tested \~a amplification of 
Hypoxanthine Phospho-Ribosyl-Transferase (HPR7) tran-
scripts (28 cycles), \\ith primm 244 and 246 as published 
before (Gibbs el 01., 1989) (5'-AATTATGGACAGGACT-
GAACGTC-3' and 5'·GGCGATGTCAATAGGACTCCA-
GATG-3', respectively), generating a fragment of 587 bp. 
Amplification \\as performed using 1.51'1 of the same reverse 
transcription reaction mix in a total volume of 50/11 
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containing 1 x Taq DNA polymerase buffer with 1.5 m~l 
MgCI" 25 pmol of each primer, 0.2 mM each dNTP and I U 
of Taq DNA pol)merase (promega). After an initial 
denaturation of 4 min at 94<C, ever)' amplification cycle 
consisted (in total 32) of I min at 95°C, I min at 64T and 
1.5 min at 72'C. PCR products were visualized on 3% (50% 
.egular and 50% NuSieve GTG (FMC» agarose gels stained 
\\lth ethidium bromide. This was also used as reference for 
the level of expression of SOX5 and KRAS2. The primers 
med for SOX5 (spanning an intron) were SOX5fore and 
2E2reva (Wundede tJl 01., 1996), generating a fragment of 
477 bp. Primers (spanning two introns) used for KRAS were 
KRll in exonJ (5'-GAGTGCCTTGACGATACAGCT·Y) 
and KR12 in exon 3 (5'-CTTTGCTGATGTITCAATAA-
AAGG-3'), generating a fragment of 394 bp. Amplification of 
SOX5 and KRAS2 transcripts was done using an initial 
denaturation of 5 min at 94°C, and subsequently 35 cycles 
consisted of 45 s 94'C, 30 s 60'C and 30 s nT, and finally 
10 min at 72'C for SOX5 and after initial denaturation 35 
cycles consisted of I min 94°C, 1 min 58'C and I min 72'C, 
and finally 10 min at 72'C, for KRAS2. 
Scmi-quantitalire peR 
The semi-quantitatiw PCR was performed as described 
before (Heighway CI 01., 1996). Besides the seven TGCTs 
~vith the amplification of 12p sequences, seven TGCTs 
\.vithout such amplificatiom were included as controls. The 
cases were studied under code not knowing the origin of 
the samples. The progesterone receptor (ProgR), whieh 
maps to 11q23 and the /7pTEL SIS, were included in 
every experiment as references (Bettincher et at., 1996; 
White cl al., 1996). The following target genes were 
studied: LGS, KRAS2, KRAG (primers 021/022) and 
ITPR2. Briefiy, for each PCR 0.5/.ig tumor DNA was 
amplified in a 1001'1 reaction with 0,5 JIg of each primer 
(two primer pairs) in standard reaction mb:; over 30 cycles 
of I min at 55-60'C, I min at HOC, I min at 94'C and 
final steps of! min at 55-60'C and 10 min 74<C. After gel 
electrophoresis (2%' agarose), relative band intensities of 
PCR products (test I"CTSUS control) were compared yisually, 
with reference to band intemities derived from normal 
genomic DNA controls. 
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Abstract 
Human testicular germ cell tumors of adolescents and young adults (TGCT), histologically 
seminomas and llonseminomas, are characterized by 12p-Dverrepresentation, mostly due to 
isochromosomes of 12p, of which the biological and clinical significance is still unclear. A limited 
number of TOCr has been identified with an additional high level amplification of a restricted 
region of 12p, including the K-RAS proto-oncogene. Here we show that the incidence of these 
restricted 12p-amplifications in primary TGCT is about 8%, affecting both seminomas and 
nonscminomas. FOllnation of i(12p) and restticted 12p-amplification is mutually exclusive in a 
single cell. The shortest region of overlap of amplification was not reduced compared to previous 
rep0l1s. It appears that the borders of the amplicons cluster in short regions. \Vhile most 
seminomas showed the amplification in all tumor cells (homogeneous pattem), only a minority of 
the tumor cells fi-om nonsemillomas contained the amplicon (heterogeneous pattem). The 
amplicon was never found in the adjacent carcinoma in situ cells. Seminomas with the restricted 
12p-amplification virtually lacked apoptosis, and the tumor cells showed prolonged in vitro 
survival, like seminoma cells with a mutated RAS gene. No differences in proliferation index were 
found between these different groups of seminomas. Seminoma patients with a homogeneous 
restricted 12p-amplification presented at a significantly younger age than those lacking it. The 
presence of a restricted 12p-amplificationlRAS mutation did not predict the stage of the disease at 
clinical presentation and the treatment response of primary seminomas. In 55 primary and 
metastatic tUlllors from 44 different patients who £1iled cisplatinum-based chemotherapy the 
restricted 12p-amplification and RAS-mutations had the same incidence as in the consecutive 
series of responding patients. 
These data suppOli the model that gain of 121' is progression-related in the development of 
TGCT: it allows tumor cells, in pat1icular those showing characteristics of early genu celis, i.e. the 
seminoma cells, to survive outside their specific micro-enviromuent. Probably overexpression of 
certain genes on 121' inhibit apoptosis in these tumor cells. However, the copy numbers of the 
restricted amplification of 12p and K-RAS mutations do not predict response to therapy and 
survival of the patients. 
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Introduction 
Malignant transfonnation is a complex, multistep process, in which inactivation of tumor 
suppressor genes and activation of proto-oncogenes play an important role (Vogelstein & Kinzler, 
1993). Although involvement of several genes has been suggested in the development of testicular 
geml cell tumors of adolescents and young adults (TGCT), histologically seminoma and 
nonseminomas (Mostofi et al., 1987), evidence is lacking. 
All TGCT originate from carcinoma ill Sitll (CIS) (Skakkebrek, 1972), composed oftumor 
cells that phenotypically resemble primordial genn cells (Jorgensen el al., 1995). CIS is frequently 
found in the parenchyma adjacent to an invasive TGCT. These cells are located on the hiller side 
ofthe basal membrane of the seminiferous tubules, in close association with Sertoli cells (Gondos, 
1993). Initially they expand in the seminiferous tubules, eventually, via the micro-invasive stage, 
the tumor cells form oveli invasive tumors. The mechanisms involved in this progression are still 
unclear. Obviously tumor cells are selected capable to survive and grow outside the specific 
micro-environment of the seminiferous tubule. 
The only consistent chromosomal anomaly in TGCT is gain of the short ann of 
chromosome 12, mostly due to isocru'omosomes of 12p (Atkin & Baker, 1983; Sandberg et al. 
1996, for review). K-RAS has been proposed as the relevant gene (Dmitrovsky el al., 1990; 
Houldsworth el al., 1997; Murty & Chaganti, 1998). The copy number of 12p reportedly predicts 
prognosis (Bosl & Chaganti, 1994; Bosl el al., 1989; Malek el al., 1997). The RAS protein (P21) is 
involved in signal transduction by switching between an inactive (GDP-bound) and active (GTP-
bound) state. Mutations leading to constitutive activation have been found in many types of 
cancers. For example, Imitated RAS correlates wi th poor prognosis in childhood acute lymphocytic 
leukemia (LUbber! el al., 1990), and non-small cell lung cancer (Slebos el al., 1990; Mitsudomi el 
al .. 1991). Recently, activation of RAS has been shown to be involved in tumor~maintenance 
(Chin el al., 1999; Hahn et al., 1999), and in inducing anchorage independent growth, due to 
inhibition of apoptosis (Arends ef al., 1993; Frisch & Francis, 1994). Indeed, a correlation 
between activated RAS and metastatic capacity has been repolied (Ananthaswamy el al., 1989; 
Takiguchi el al., 1992). Besides activation by means of mutations, RAS can also be involved in 
malignant transfonnation due to increased copy numbers of the wild type gene, resulting in 
overexpression of wild type mRNA, and accumulation of the wild type protein (Coleman et al., 
1994; Fluita el al., 1987; McKay el al., 1986; Pn1ciani el al., 1985; Radinsky el al., 1987; Zhang 
el al., 1997). 
Seminomas are highly sensitive to in'adiation and cisplatinum-based chemotherapy. The 
vast majOlity of patients with metastatic nonseminomas is cured by cisplatinUln~based 
combination chemotherapy (Bokemeyer & Schmoll, 1993, for review). In spite of the application 
of clinical and histological prognostic factors to predict treatment response ofTGCT, the clinical 
course of these tumors can still not be predicted for individual patients. Additional prognostic 
markers are therefore needed. Interestingly, activated RAS genes increase the intrinsic resistance to 
radiation and cisplatinum therapy (Holford et al., 1998; Isonishi et al., 1991; Kinashi el al., 1998; 
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Sklar, 1988a; Sklar, 1988b). It is unclear whether amplification of wild type RAS has the same 
effect. 
A small percentage ofTGCT has RAS mutations (Ganguly et ai., 1990; Moul et ai., 1992; 
Olie el a/., 1995a). The clinical relevance of the mutations was not studied. We showed that 
seminomas with a mutated RAS gene have survival advantage il1 vitro, and have reduced apoptosis 
in the primary tumor (Olie et al., 1996; Otic et a/., 1995b). Note\VOlihy, i1l vitro survival of tumor 
cells correlates with poor prognosis in patients with adult acute myeloid leukemia (Lowenberg el 
ai., 1993), and in metastatic TGCT (Otto et ai., 1997). Recently, a number of invasive TGCT with 
amplification ofa restricted region of 12p have been identified (Korn et (Ii., 1996; Mostert et ai., 
1998; Mosteli et (Ii., 1996; Suijkerbuijk et (Ii., 1994). We showed that the shotiest region of 
overlap of amplification (SROA) is about 1.7 Mbases, containing three known genes, Le., SOX5, 
JA WI, and K-RAS (Mostert et ai., 1998). It is unknown so far whether amplification of wild type 
K-RAS in these tumors has the same effects as RAS mutations. Finally, the clinical relevance of a 
restricted 12p-amplification has not been conclusively investigated in TGCT. 
The goal of this study is to further investigate the biological and cliuieal siguificanee of 
gain of 12p-sequences in TGCT. The incidence of restricted 12p-amplification \vas studied in a 
consecutive series of 76 untreated primalY TGCT. The newly identified six tumors, as well as 
previously found nine cases were studied for the distribution of the restricted 12p-amplification 
\vithin the tumor (homogeneous or heterogeneous pattem), the borders of the SROA, the presence 
of i(12p), the proliferative activity, the presence of apoptosis and capacity of the tumor cells to 
survive ill vitro. In addition, cOlTesponding CIS and micro-invasive seminoma were tested for the 
presence of the restricted 12p-amplification. The clinical importance of the restricted 12p-
amplification and RAS mutation was fmiher studied in 44 patients who failed cisplatinum-based 
chemotherapy. 
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Material and methods 
Samples 
The freshly obtained tumor samples included in this Shldy were collected in close 
collaboration with urologists and pathologists in the South-Westem part of the Netherlands. All 
tumors were obtained prior to chemotherapy and/or irradiation. Directly after surgical removal, 
representative paris of the tumor and adjacent 110nnal tissue (when available) were snap frozen 
mld other pieces were fixed ovemight in 10% buffered fOllnalin and embedded in paraffin. The 
size of the testis and the tumor was measured in three dimensions. The hlmors were diagnosed 
according to the World Health Organisation (WHO) classification for testicular tUlllors (Mostofi 
& Sesterherll1, 1998). Nonseminomas containing both a seminoma mld a nonseminoma were 
classified as combined tumors, according to the British classification (pugh, 1976), instead of as 
nonseminomas according to the WHO classification system. Identification of CIS, seminoma and 
embryonal carcinoma was aided by a direct enzyme-histochemical detection of alkaline 
phosphatase activity on representative frozen tissue sections, as repOlied before (1vIosselman el al., 
1996). The consecutive series tested for the presence of a restricted 12p-amplification (see below) 
consisted of 46 seminomas, 23 nonseminomas (14 embryonal carcinomas/yolk sac 
tumor/teratoma; 3 teratomas; 2 embryonal carcinoma/yolk sac tumor; 2 yolk sac tumors, I 
teratoma/yolk sac tumor; I embryonal carcinoma) and seven combined tumors (3 embryonal 
carcinoma/seminoma; 3 embryonal carcinoma/yolk sac/seminoma; 1 teratoma/yolk sac 
tumor/seminoma). The newly identified cases with a reshicted 12p-amplification and the 
previously found cases (1vIostert et al., 1998 mId unpublished observations) were shldied for the 
borders of the amplicon (see below), the distribution within the tumor (see below), presence of 
i(12p) by karyotyping (when available), proliferation index (see below), apoptosis and ill vitro 
survival, as described before (see below, and Olie el al., 1996; OIie el al., 1995b). In addition, the 
fomlCrly identified seminomas with a mutated RAS gene (Olie et al., 1995a), were included in this 
analysis. 
The analysis of the possible clinical impact of the restricted 12p-amplificationlK-RAS 
mutation was studied on a series of patients who failed cisplatinum based chemotherapy. These 
cases were collected in collaboration with the Departments of Hematology and Oncology, 
University of Tiibingen (Germany), and Internal Medicine, Netherlands Cancer Institute, 
Amsterdam (The Netherlands). In total, 44 patients were included, of whom 22 primary TGCT 
and 33 metastases were shldied (of 11 patients both the prima1Y and metastases was available). 
Immunohistochemical delection of Ki-67 
Sections were cut from one representative paraffin block per tumor, which was mounted 
ou APES (3-aminopropyl-triethoxysilane)-coated slides and dried at 50°C ovemight. 
Subsequently, the sections were heated to 120°C in sodiumcitrate solution (0.01 M pH 8.0) 
using an autoclave (Shin et al., 1991). Endogenous peroxidase reactivity was blocked with 
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H,o,/methanol. The Ki-67 antigen was demonstrated usiug the polyclonal antibody A 0047 
(Dako), diluted I: I 00, Incubation was done for I hour at room temperature following blocking 
of non-specific binding sites with 5% BSA. After extensive washing, biotinylated swine-anti-
rabbit (l :200) (Dako) was used as second step, which was detected using the horseradish-
labeled streptavidin-biotin complex (Dako), diluted 1:100, Peroxidase was visualized with 
diaminobenzidinc, after which the sections were counterstained lightly with Mayer's hemalum, 
Of each tumor three times 50 tumor cells were independently counted by two observers in one 
tissue section. The results were statistically analyzed using the Student's t test. Positive and 
negative (excluding the first antibody) controls' were included in each experiment. 
Metaphase preparations 
After surgical removal, representative palis of nonseminomas were enzymatically digested 
(collagenase, Sigma), and cultured in T75 flasks (Costar) for several days under standard 
conditions, i.e. 37°C in a humidified atmosphere with 5% CO2 in air in DMEMfHF12 culture 
medium with 10% heat-inactivated FCS (BRL-GIBCO) as described before (Castedo ef ai" 
1989a). Mitotic cells were harvested after 2-4 hours of colcemid treatment, swollen in hypotonic 
solution, and fixed in methanol/acetic acid (3:1). Representative parts of seminoma were directly 
processed to isolate metaphase spreads as descJibed before (Castedo ef ai" 1989b), BIiefly, the 
mitotic cells were, after meclumical dissociation of the tumor, directly harvested in the presence of 
colcemid. The cells were subsequently swollen in hypotonic KCIIEGT AlHepes solution and fixed 
with methanol:acetic acid (3:1). For conventional G~band kalyotyping, ail'~dried preparations were 
digested with pancreatin. The chromosome constitution was described according to the 
Intemational System for Human Cytogenetic Nomenclature 1995 (Mitehnan, 1995), 
Restricted 12p-amplijicatioll 
The fluorescence ill situ hybridisation (FISH) experiments on the methanol/acetic acid 
fixed nuclei suspensions on the consecutive series ,vere perfonned as described earlier (Mostert et 
ai" 1998) using Y AC#5 (mapped to 12p 11.2-12, I, kindly provided by Dr, B, Genunill, Denver, 
USA), YAC#5 is known to map to the SROA as detel1nined in our earlier study (Mostel1 ef ai" 
1998), To make tills probe suitable for the FISH approach, it was purified by pulsed field gel 
electrophoresis, amplified and labeled with digoxigellln-ll-dUTP (GIBCO-BRL), It was 
visualised with fluorescein isothiocyanate (FITC) conjugated sheep-a-digoxigenin (Boeluinger) 
as reported before, The presence ofa 12p-amplification was defined as reported before (Mostert ef 
ai" 1998), being around 15-30 signals per interphase nncleus, 
TaCT identified with a restricted 12p-amplification were studied in more detaiL Of these 
cases, frozen tissue sections of 16 ~m thickness containing hunor, micro-invasive seminoma, and 
CIS (when available), were Clit and air-dried ovemight at 37°C on microscope slides treated with 
tissue adhesive. In addition, one parallel section (4 ~lm thickness) was stained with hematoxylin 
and eosin, and the other for alkaline phosphatase reactivity, (see above) for histological 
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examination. The slides for the FISH were submerged in 70% ethanol (-20'C) for one hour and 
dehydrated in an increasing ethanol series (80%, 90%, 100%, 2 minutes each) and air-dried. 
Subsequently, the tissue sections undenvent protein digestion (0,0005% pepsin (Sigma, st. Louis, 
USA) in 0,01 M HClIPBS, I minute at 37'C) followed by a wash step (PBS, 5 minutes) and 
dehydration. Hybridisation was perfonned as described for the methanoVacidic acid fixed nuclei 
(Mostert ef at., 1998). YAC#5 was used as a control probe in combination with another probe (test 
probe) (see Figure 1). In particular, probes positive for STSs D l2S 1945, D12S 1688, AFM267yc9 
(on the distal side) and D12S1350E, KRAS2, D12Sl3l3, and D12Sl4ll (on the proximal border) 
were used. YAC#5 was labeled as described above with digoxigenin-ll-dUTP (GIBCO-BRL) 
and visualised with fluorescein isothiocyanate (FIre) conjugated sheep-a-digoxigenin 
(Boehringer). The test probes were labeled using a nick-translation kit (GIBCO BRL) with biotin-
II-dUTP and visualised using avidine-CY3 (Jacksons immunoresearch Laboratories). A restricted 
12p-amplification was defined as the presence of nuclei with at least 15 hybridisation signals. The 
pattem was identified as heterogeneous when such nuclei (possibly in groups) are scattered 
throughout the tissue section: both regions with and without restricted 12p-amplification are 
present. In contrast, the pattern is defined as homogeneous when all regions showed nuclei with 
restricted 12p-amplification. Because oftissLie cutting artifacts, this does not exclude the presence 
of single nuclei without such an amplification. The criteria used to determine the borders of the 
breakpoints were similar as used in our former study (Mostert et al., 1998). Briefly, the probe was 
scored at pmt of the amplicon when paired hybridisation signals with the control probe (YAC#5) 
was observed, and scored as outside the amplicon when less hybridisation signals were found 
compared to the control probe. Higher copy numbers of the test probes (see above) compared to 
the control probes have not been found so far. 
The paraffin-embedded tissue sections of the treatment-resistant TGCT (4 ~lm thickness) 
were preincubated ovemight at 50°C, and subsequently baked for 10 min. at 80°C. The sections 
were deparaffined using xylene, washed in 100% methanol four times at room temperature and 
air-dried. Sodium-thiocyanate (I M) pretreatment was done for 10 minutes at 80°C, after which 
the slides were thoroughly rinsed in water. Digestion was done using 0.1 % pronase E (Sigma) in 
PBS at 37°C for 30-40 minutes, depending on the tissue under investigation. After rinsing in PBS 
at 4°C, dehydration was done using a series of increasing ethanol concentrations (70, 80, 90, 
100%), The hybridisation, washing and detection procedures were perfonned as described for the 
methanoVacetic acid fixed nuclei (see above). A restricted 12p-amplification was defined as the 
presence of at least 10 hybridisation signals. Because of the thickness of the tissue sections used, 
the hlmors were not scored for the presence of a homogeneous or heterogeneous pattem. 
Visualization was done with a Zeiss Axioskop epifluorescence microscope (Carl Zeiss 
Jena, Genllany) with a Pinkel filter in combination with a triple band-pass filter, which enabled 
the observation ofFITC, CY3 and DAPI in one view. 
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Comparative Gellomie Hybriciisatioll (CGH) 
For CGH, metaphase spreads were prepared llsing standard procedures from ill vitro 
phytohemagglutinin-stimulated petipheral blood lymphocyte cultures of a healthy male as 
reported previously (Rosenberg el al., 1998a). High molecular weight DNA was isolated from the 
snap frozen tissue samples (test DNA) and from peripheral blood of a nOl1ual male (reference 
DNA) using standard procedures (Maniatis el al., 1982). The CGH procedure and analysis was 
perfonned as described before (Rosenberg el al., 1998b). Both the control male DNA and the 
tumor DNA were directly labeled by nicktranslation with lissamine and FITC respectively. The 
data were analysed using Quips XL software from Vysis (Downers Grove, IL). Nomlalization was 
canied out using the average of the green to red fluorescent intensities for the entire metaphase. At 
least ten metaphases were studied for each case. Losses of DNA sequences were defined as 
chromosomal regions where the average greelHo~red ratio and its 95% confidence intervals are 
below 0.9 whilc gains are above l.l (Rosenberg el al., 1999). The heterochromatic blocks of 
chromosome 1,9, 16 and Y, and the inU11Cdiate telomeric regions were excluded from the analysis 
because these regions present variable results in experiments with HornIaI control DNAs. 
Speclral km),olypillg (SKY) 
SKY was perfollned on a single seminoma with a restricted l2p-amplification, 
demonstrated both by CGH and FISH, using a SKY -kit and analysis system (Applicd Spectral 
Imaging) with a slightly modified procedure as described by the supplier. In particular, proteinase 
K digestion was perfonned in 1 M Tris-HCL, pH 7.5, and after denaturation of the probe, the mix 
was kept on ice. Washing during the detection procedure was perfonned in 55% formamide and 
39'C in stead of 45'C. In addition, 0.05% instead of 0. I % tween was used in 4 times SSC, and the 
last washing step was perfonned at room temperature. 
RAS gene UIlltation detection 
Mutations in codon 12 or 13 of the N- and K-RAS genes were analyzed by direct 
sequencing (Amplicycle, Amersham), using primer NA (5'-GACTGAGTACAAACTGGTGG-
3')/NB (5'-CTCTATGGTGGGATCATATT-3') and KA (5'-GACTGAATATAAACTTGTGG-
3')/KB (5'-CTATTGTTGGATCATATTCC-3'), respectively, on DNA isolated from snap fimen 
seminomas tested for in vitro survival and presence of apoptosis. DNA was isolated as decribed 
above. Only histological areas containing more than 70% tumor cells were used. In addition, the 
presence of K-RAS codon 12 Illutations was investigated in the series of paraffin-embedded 
tumors of the nOlH'esponding patients as follows: two 15 ~tln thickness sections from each 
sample were first deparaffinized with xylene and then dehydrated with absolute ethanol. A 
parallel section (4 ~tm thickness) was stained with hematoxylin and eosin to confinn the presence 
of tumor, and check for histology. Only sections with a major tumor component were used for 
DNA isolation. DNA was eluted in 30 ul of water by heating the air-dried tissues at 95°C for 5 
minutes. Typically 50-100 ng of DNA was used for each PCR reaction. Each sample was first 
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tested with HLA-dQ primers (Benhattar el ai" 1993) to assess the quality of the eluted DNA, 
Only samples showing proper amplification were subsequently used, The PCR reactions to 
detect lllutations in codon 12 of K-RAS were perfollned essentially as described before (Kahn el 
ai" 1991) with the following modifications, The K-RAS 5' primer used in the two rounds of 
amplifications carried a biotin label at the 5' end, After the first Mva I digestion, the PCR 
products were affinity purificd on streptavidin coated paramagnetic beads (Dynal) and the 
bound PCR products were re-digested on the beads in 50 ul of MvaI buffer containing IOU of 
enzyme for 3 hours at 37'C, Subsequently the beads were affinity purified and washed on the 
magnet to remove the buffer and the unbound fraction, Finally, single stranded DNA was eluted 
from the bound fraction by boiling the beads with 10 ul of water. One half of each fraction was 
used in the second amplification step, Samples positive for mutations in codon 12 were further 
characterized by cycle sequencing the single stranded DNA obtained by affinity purification of 
the PCR products retained on the beads after the final MvaI digestion, The procedure was 
controlled at evel}' stage with DNA samples obtained from archival paraffin embedded primal}' 
TGCT with and without codon 12 mutations (Olie el ai" 1995a), 
Deleclion of DNA laddering 
High molecular weight DNA was isolated from snap frozen histologically checked 
samples (see above) using standard procedures (see above), DNA laddering was visualised using 
ethidiulll bromide staining after electrophoresis of I ug as descIibed previously (Olie el ai" 1996), 
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Results 
Restricted 12p-amplicatioll and i(12p) in primm)' invasive TGCT 
The incidence of a restricted 12p-ampHfication in primary untreated TOCT was 
detennined by analysis of methanoVacetic fixed nuclei suspensions of 76 surgically removed, 
consecutively collected TOCT, including 46 seminomas, 23 nonseminomas and 7 combined 
tumors (see Table I and Materials and Methods for histology). Double fluorescent FISH showed 
that all tumor nuclei had more than four copies of 12p, and at least three chromosome 12-
centromeres (not shown). Six tumors (7,9%), i.e., four seminomas (8,7%), one nonscminoma 
(4.3%) and one combined tumor (14.2%) showed the restticted 12p-amplification (see Table I). 
So far, in total 15 primmy TGCT with such a restricted 12p-amplification are available (the six 
identified in this consecutive study, and nine previously found by us, of which six have been 
included in our previous study (Mostert et al., 1998): nine seminomas, four nonseminomas and 
two combined tumors. Karyotyping (see Table I) revealed the presence ofi(12p) in two out of the 
six successfully analyzed seminomas with a restricted 12p-amplification. However, the presence 
of an i(l2p) could not be confinned by FISH on matched metaphase spreads, although the 
amplification was found (not shown). Three of the four karyotyped restricted 12p-amplification 
positive nonseminomas lacked i(l2p), as well as the only karyotyped combined tumor. 
Table I. 
Results of detection of (he restricted J 2p-amplijicatioll using methanol/acetic acid fixed 1/uclei 
suspensions of a consecutive series of prim my seminomas (SE), l1ol1seminomas (NS) and 
combined tumors (eT) as detected by double fluorescent in situ hybridisatioll (FISH). 
SE 
NS 
CT 
TIle total number of cases with a restricted 12p-amplijicatioll identified so far are 
indicated between brackets. The results of kmyotyping and il1 situ hybridisatioll 
01/ matched frozen tisslle sections are also showll (NA = lIot available; 
+ J 2p ampl. = with restricted 12p amplification) 
Consecutive series i(12p) + Heterogeneity 
tested + 12pampl. karyotyping ISH 
46 4 (9) 2/6 0/6 3/9 
23 1 (4) 0/3 NA 4/4 
7 1 (2) 0/1 NA 2/2 
Tolal: 76 6 (15) 
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The other nonseminomas with a restricted 12p-amplification had i(l2p) in some of the 
studied metaphases. Because of inappropriate quality of this material, no FISH could be 
performed on these cases. In the infonnative cases, it was found that the additional 12p~sequences 
visualized by FISH were predominantly (five out the nine cases) present as tandemly organized 
units as add(l 2)(P I I), add(12)(P12), or add(l2)(p13), although also other sites were found to 
contain 12p~specific sequences, including parts of chromosomes 6, 8, and II (not shown). 
Breakpoints involverl in the restricted 12p~amplification 
In addition to our earlier report consisting of six cases (Moster! el al., 1998) (indicated by 
an asterisk in Figure I), FISH was applied on the newly identified TGCT (n~9) with a restricted 
l2p-amplification. 
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Fig.1: Schematic representation of tlre physical map of the 12pll.2-p12.1 regiol/. Genes, STSs 
ami the position the YAC#5 probe are indicated. The results of the double fluorescent in situ 
hybrirlisatioll e.'periments pe/formed on ji'ozen tissue sections to determine the shortest region of 
overlap of amplification are shoWII. The continuolls bold lilies indicate the regions included in the 
restricted 12p~amplificatioll, and the dotted lines indicate the regions outside the amplification. 
Probes specific for STSs D12S1945, D12S1688, AFM267yc9, K-RAS. D12S1313, alld D12S1411 
are llsed for these alla~l'ses. The results are shmvlI per histological subgroup (seminomas (SE), 
lIollsemillomas (l\'S), alld combined tUl1lors(CT)). The tumors studied in 0111' previous analysis 
(J\lostert et al., 1998), are indicated by an asterisk. Note that three breakpoints map between 
AFM267yc9 alld D12S1688, alld sevell betweell AFM267yc9 alld DI2S1945 al the distal side, alld 
six between K-RAS and D12S1313 at the proximal side. The shortest region of amplification 
encompasses the genomic fi'agment between AF}vf267yc9 and K-RAs' 
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Because this analysis was done on frozen tissue sections instead of methanol/acetic acid fixed 
nuclei suspension, as performed in our earlier study, all cases could be analyzed, including the two 
previously identified nOIl-infoITllative cases (1vfostert et al., 1998). Again YAC#5 was used in 
combination with probes specific for the more proximal and distal regions of the contig (see 
Figure 1). In accordance ''lith our previous findings, the amplified region always includes the 
genomic fragment between STS AFM267yc9 at the distal end, and K-RAS at the proximal end. 
Therefore, K-RAS, JAWI, and SOX5 are consistently amplified in all TGCT with a restricted 12p-
amplification, inespective of histology. In addition to this finding, the borders of the amplicon 
appeared to cluster in narrow regions: 40% between K-RAS and STS D 12S 1313 at the distal side 
(44.4% for seminoma and 25% for nonseminoma), and 20% between AFM267ye9 and D12S1688 
at the proximal side (11% for seminoma and 50% for nonseminoma). In addition, 47% of the 
breakpoints map between AFM267yc9 and D12S1945 (44% for seminoma and 75% for 
nonseminoma) (see Figure 1). 
intratllmo}' 12p-amplijication and tumor heterogeneity 
FISH results on the sLispensions of nuclei already indicated that 12p-amplification can be 
heterogeneously distributed in one tumor (not shown). This was verified by FISH on frozen tissue 
sections. Six out of the nine seminomas showed the amplification homogeneously throughout the 
tumor (see Table 1). The other three cases showed regions with and without amplification, of 
which two contained i{l2p) by karyotyping. All nOl1seminomas and combined tumors showed a 
heterogeneous pattem. In two cases the amplification was present in a subpopulation of cells of 
the yolk sac tumor component, and in one in a subpopulation of both the embryonal carcinoma 
and yolk sac tumor component. One of the combined tumors with the restticted 12p-amplification 
was a mixture of seminoma and embryonal carcinoma. The amplification was found in a 
subpopulation of both components. No i(12p) was identified in this case. The other combined 
tumor showed ampli fication in a minority of the seminoma cells only, and katyotyping failed. One 
of the nonseminomas, initially diagnosed as mixed nonseminoma showed no i{12p) by 
karyotyping. This tumor was xenografted orthotopic ally into a nude rat, and after about 10 
months, a tumor completely composed of yolk sac tumor was formed. Karyotyping after direct 
harvesting revealed i(12p) in seven out of 14 metaphase spreads, confinned by FISH (not 
shown). These metaphase spreads did not contain the 12p-amplification. However, a limited 
number of interphase nuclei isolated from the original tumor and the xenograft showed the 
presence of 12p-amplification by FISH (not shown). FISH on frozen tissue sections of these 
tumors demonstrated that less than 5% of the tumor cells from the primary tumor showed the 
12p-amplification, preferentially in the embryonal carcinoma and yolk sac tumor component. 
This percentage was constant during subsequent xenograft-passages. 
CGH was perfonned on three seminomas with homogeneous 12p-amplification, three of 
the heterogeneolls nonseminomas and on both combined tumors. No other high level 
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amplifications, besides the one on 12p, were found in these cases, and a similar pattem of gains 
and losses was identified as reported before (Mostel1 e/ al., 1996; Rosenberg e/ al., 1999, not 
shown). EvelY tumor with 12p-amplification also showed gain of the complete ShOli ann of 
chromosome 12, of which representative examples are illustrated in Figure 2A. 
n = 12 n", 11 
Fig.2 A: Representative examples of comparative genomic hybridisatioll for chromosome 12 on a 
seminoma without a restricted 12p-amplijication (left) and one 'with a homogeneous 12p-
amplijication (right). Note that the seminoma wilh the restricted 12p-amplijication also shows gain 
of the complete short arm of this chromosome. The number of metaphase spreads analyzed is 
indicated. 
Spectral kmyotyping was done on one seminoma, of which a sufficient number of metaphase 
spreads including the restricted 12p-amplification was available. The results confirm the presence 
of chromosome 12 material in the aberrant chromosome 12 derivatives, and in the most telomeric 
region a pal1 of chromosome 20 (see Figure 2B). 
Fig.2 B: Represeflfative example of handing 
(Iejl pallel) alld spectral km),otJ'l'illg (real 
color at the right alld false color in the 
middle) of a chromosome 12 derivative known 
to contain restricted 12p-amplijicafioll (as 
determined by ill situ hybridisatioll and 
CGH). Note that the chromosome is 
composed of chromosome 12 material 
(indicated il1 purple), except the most distal 
region of fhe p-arm, showing chromosome 
20-specific material (indicated ill blue). 
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Restricted 12p-ampl(ficatio}l ami tumor progression 
Matched CIS cells and micro"invasive seminoma of the TGCT with 12p"amplification 
were studied by FISH on tissue sections. The cells of interest were visualized by enzyme-
histochemistry for alkaline phosphatase reactivity. Out of the eight seminomas studied, three 
showed the presence of both CIS and micro-invasive seminoma, and one only of CIS. The 
amplification was found in all micro-invasive components, but never in CIS, of which examples 
are shown in Figure 3. Also no restricted 12p-amplification was found in the matched CIS of one 
nonseminoma and one combined tumor. The micro-invasive seminoma cells adjacent to the 
combined tumor showed also a heterogeneous pattem of restricted 12p-amplification, as detected 
in the matched invasive hunor (not shown), 
A B 
Fig.3: Representative examples of double fluorescent ill situ hybridisatioll all frozen tissue 
sectiolls of 4 Jim lIsing a probe specific for the centromeric region of chromosome 12 (red) and 
YAC#5 (green), mapped within the shortest region of overlap of amplification (see Figure 1), 
Shmvn are A) carcinoma ill situ; B) micro-invasive seminoma; C) invasive seminoma, The tumor 
cells are identified by the direct enzymatic alkaline phosphatase detection met/wd (stained ill red) 
all a parallel tissue sectioll, 
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12p-amplijicationlRAS mutatioll, proliferation, apoptosis and ill vitro sUl1
'
ival 
Immunohistochemistry for ki-67 on histological sections was performed to investigate the 
proliferation index in seminomas containing 12p~amplification (n=8)/RAS mutation (n=4, of two 
no approprioate material was available anymore), or neither of these (n=13). As indicated in 
Table 2, no differences behveen these groups were observed. However, all nine seminomas with 
12p-amplification, as well as five out of the six with a mutated RAS gene, demonstrated low level 
of apoptosis in the primaty tUlllor, indicated by the lack of profound DNA laddering after 
electrophoresis. In contrast, nine of the 13 tested seminomas without any of these features 
showed apoptosis (see Table 2 and Figure 4). 
Table 2. 
Summmy of the results 011 proliferation index (prolifindeJ), apoptosis, and in vitro sun1ival 
and volume of the tUII/or (cmJ) in seminomas with and 'without a restricted 12p-
amplijicatiolllRAS mutation. (N = not available; +=present; -=absellt) 
(standard deviations are indicated between brackets) 
Wild-type RAS 
proliL in vitro tumor 
index apoptosis survival size 
+ + 
12p-ampl. 34.5 (10.5) 9 4 1 11 256 (173) 
+ 29.7(15.3) 
° 
9 4 
° 
246 (294) 
Mutant RAS 
proliL in vitro tumor 
index apoptosis survival size 
+ + 
12p-ampl. 30.8 (3.1) 1 5 6 
° 
121 (88) 
+ N N N N N N 
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The capacity of the tumor cells to slln1ive in vitro after disruption of their micro-
environment to generate single cell sllspensions was studied, of which the results are also 
summarized in Table 2. We excluded that one of the newly identified seminomas in this study 
contained a mutation of either the N- or K-RAS gene in codons 12 and 13 (not shown), All six 
seminomas with a RAS mutation and all four tested seminomas with a restricted 12p-amplification 
showed prolonged in vitro survival (at least up to 10 days). Eleven seminomas without a restricted 
l2p-amplification or RAS mutation out of the 12 tested could not be maintained ill vitro. Nine of 
these showed profound apoptosis. The seminoma that showed ill vitro survival for several days 
did not show obviolls apoptosis. 
+ 
Fig.4: Representative examples of the presence of DNA laddering after electrophoresis (indicative 
for apoptosis) of J fig high molecular weight DNA isolated fl'01ll primm)! seminomas with and 
without a restricted J 2p-amplijication/RAS mutation. Note the correlation behveen absence of 
apoptosis and presence ~r amplification or RAS mutation. III addition, the results of ill vitro 
culture of the tumor cells are shown (see also Table 2). 
The nonseminomas, with or without restricted 12p-amplification all lacked significant 
apoptosis, as was found for both combined tumors. All nonseminomas and one combined tumor 
were successfully kalyotyped afler ShOli tenll in vitro culturing, indicating that these tumors 
allowed short term cultUling in vitro (see :Materials and l\'1ethods). 
J 2p-amplijicalioJl, RAS mutation, and clinical behaviour 
The age at clinical diagnosis of patients with a seminoma ,,,ith and without a restricted 12p-
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amplificationlRAS mutation is indicated in Figure 5, No age differences exist between seminoma 
and nonseminoma patients with and without a RAS mutation (Figure 5 and not shown), In spite of 
the small number of cases, seminoma patients with a restticted 12p-amplification showed a trend 
toward a younger age at clinical presentation than those without (p~0.055, Student's t test). When 
only the seminomas with a homogeneous pattem of 12p-amplification were included (11=6) (see 
above), the age difference was significant: 36,7 years without a restricted 12p-amplification, and 
26.78 years with a restricted l2p'amplification (p~ 0.023, Student's t test). 
80 
70 a 
60 
'i! 50 f- ! ro ~ .00. '" 40 ~ '" 0 ro 30 0 
20 
10 
0 
RAS+ 
00 
o 
RAS·/12p· 
groups 
o 
o 
o 
w 
o 
, 
12p+ 12p+ homo 
Fig.S: Schematical representation of the ages of patients at clinical presentation with a 
seminoma with and without a restricted 12p-amplijicatioJ/ and RAS mutation (mean, average 
and standard deviations are indicated). In additioll, the ages of the subgroup of patients 'with a 
homogeneous J 2p-amplijicatioll are shO'rl'n. No differences were found bel1veen the ages of 
patients lvitll a seminoma without either of these aberrations and those with a RAS mutatioll. 
However, those with a J 2p-amplijicatioll positive seminoma showed a borderline signijicant 
difference compared to the control group, while a signijicant difference was fowul ill case only 
patients with a homogeneolls 12p-ampliJicatioll were included (p= 0.023). (Ahbreviations used: 
RAS+ = RAS mutatioll; l?AS-112p- = no RAS mutation or restricted 12p-amplijication; 12p+ = 
restricted 12p-amplijication both heterogeneously and homogeneollsly present; 12p+ homo = 
homogeneous restricted 12p-ampliJication). 
No differences were found between these different groups regarding stage of the disease (they all 
presented as stage I or II), size of the tllmor (see Table 2) and clinical response (all had a complete 
response). In addition, no corrclation was found between outcome and age, stage, proliferation 
index, or apoplosis. Also no correlation was detected between the presencc of 12p-
amplification/RAS mutation and proliferation index. 
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To extend the analysis of the clinical significance of K-RAS mutations/12p-
amplifications, we retrospectively investigated a series of 22 primary tumors and 33 surgical 
specimens from metastasis from a total of 44 different patients who failed cisplatinum~based 
chemotherapy. No K-RAS mutations were identified. The sensitive detection method (see 
Materials and Methods), makes it highly unlikely that mutated genes were obscured by a 
predominance of wild type alleles. A restricted l2p-amplification was detected once in a 
metastatic tumor (primary not available). 
113 
Role of restricted 12p-amplificatioll alld RAS mutation 
Discussion 
Although gain of the shOlt ann of chromosome 12 has already been recognized since more 
than 25 years as a charactedstic chromosomal anomaly in TGCT (Atkin & Baker, 1983; Sandberg 
et al., 1996, for review), the biological significance still remains unknown, and the clinical 
impOliance is a matter of debate. Because ovelTepresentation of 12p is found in all TGCT, mostly 
due to the presence of one or more isochromosomes of 12p (up to 80%) (Sandberg e/ al., 1996; 
Van Echten-Arends et al., 1995, for revicw), it is most probably a cl11cial step in the development 
of this cancer. Amplification of a restricted region of I2p on top of gain of the complete short ann 
of chromosome 12 was for the first time found in a metastatic seminoma (Suijkerbuijk e( al., 
1994). Subsequently, we and others showed that this anomaly can also be present in primary 
TGCT (Mostert e/ al., 1996; Kom e/ al., 1996; Mostert e/ al., 1998, and this study). Here we show 
that the achml incidence of a restricted 12p-amplification is around 8% for primary TOCT. Our 
earlier observation that the three known genes JAW}, SOX5, and K-RAS map in this region 
(Mostert et al., 1998), is confinned in the study presented here. We hypothesized, that if important 
genes for the development of this cancer reside in tlus region of I2p, a comparative study of 
TGCT with and without tlus type of amplification, could be meaningful. In addition, because K-
RAS maps within the SROA, thesc tumors were compared with previously published seminomas 
with a RAS mutation (Olie e/ al., I 995a). 
Although we investigated nine additional TGCT with a restdcted 12p amplification 
compared to our previous study (Mostert et al., 1998). we were unable to further reduce the 
SROA. However, it was found that the breakpoints of the amplicon cluster in rather BatTOW 
regions: 40% between D12S1313 and K-RAS at the distal end, and 53% between AFM267yc9 and 
DI2S1945 at the proximal cnd. The total length afthe short ann of chromosome 12 is expected to 
be around 40Mb. Assuming that the STSs are spread over the genome with intervals of about 250 
kb, 160 fragments are to be expected. The chance that one breakpoint maps within the region 
between AFM267yc9 and DI2S1945 is estimated to be 6.3E-3. The change that six additional 
breakpoints map to that paliicular region is around 5. 7E~ 11. In addition, the chance that six 
breakpoints map between K-RAS and D 12S 1313 is aronnd 1.3E-Il (binomial distribution). This 
indicates a strong positive selection towards these particular regions. This could be due to the 
presence of fragile sites, although they have not been identified at these regions. The closest 
fragile site on chromosome 12 has been reported on 12p 11 (Ford. 1981), which might be related to 
the development of the isochromosome 12p. The borders may altematively be determined by the 
presence of genes which confer selective advantage to the tumors. If this is tme, the amplicoll 
contains at least two genes of interest, a hypothesis which is currently under investigation. 
All TGCT with i2p-amplification identified so far also show gain of the compietc short 
ann of chromosome 12. Interestingly, seminomas with a homogeneous 12p-amplification, j.e., 
present in all cells, lack i( 12p), while those showing a heterogeneous pattem could contain an 
isochromosome. The restricted 12p-amplification and i(l2p) were never found in the same cell. A 
similar pattem was found for the nonseminomas and combined tumors. Interestingly, the 
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scminomatolls components of the combined tumors showed a similar pattem of restricted 12p~ 
amplification as the pure seminomas. Clearly. 12p~amplification is found predominantly in TGCT 
without i(12p), These results suggest that there are at least two mechanisms leading to extra copies 
of the 8hOl1 ann of chromosome 12 in TGCT: i(l2p) fonnation, and an altemative way, also 
leading to extra copies of the complete 5hOl1 ann of chromosome 12, which can be followed by 
amplification of a restricted region of 12p. 
The homogeneous presence of 1 2p-amplification in most orlhe identified seminomas (and 
not in nOll seminomas) implies that increased copy numbers of genes present in the amplified 
region result in a selective advantage for these tumor cells containing tills specific anomaly. We 
demonstrated that tIlis is related to a reduced apoptosis, and not due to enhanced proliferation. A 
similar lack of apoptosis was observed previously by us in seminomas containing a mutated RAS 
gene (Olie el al., 1995b; Oosterhuis et al., 1997), wlllch also showed an enhanced ill vitro survival 
and reduced apoptosis. These results are in accordance with the idea that activation of RAS by 
mutation or amplification can cause inllibition of apoptosis. 
In spite of data on the role of activated RAS in resistance to irradiation and chemotherapy, 
and induction of mel astatic potential (Ananthaswamy el al., 1989; Holford el al., 1998; ISOllishi et 
al., 1991; Kinashi el al., 1998; Sklar, 1988a; Sklar, 1988b; Takiguchi el al., 1992), and our results 
on ill vitro survival and apoptosis (Olie et al., 1996; Olie et al., 1995b), no differences were found 
regarding stage of the primaty seminoma at clinical presentation and treatment response based on 
the presence of a RAS mutation or restricted 12p~amplification. Tllis is supported by an 
observation in two patients (Rao el al., 1998): the restricted 12p-amplification (detected by CGH) 
was present in both a responding and a nonresponding tumor. In addition, we observed no 
predictive value of K-RAS mutations and restricted 12p-amplification in chemo-resistance of 
patients with extensively pretreated TGCT. Patients having a seminoma with a homogeneous 
restricted 12p-amplification were, however, younger at clinical presentation than those lacking it. 
This is most likely explained by an early development of the restricted 12p~amplification in these 
tumors, leading to reduced apoptosis. This combined with an unchanged proliferation index 
results in faster growth of the tumor and an earlier clinical presentation. Such an age difference 
was not observed in the case of a RAS mutation, which is likely because mutation of RAS is a 
relatively late event in the pathogenesis ofTGCT. This is suppOl1ed by our observation that TGCT 
with a mutated RAS gene also show gain of the complete short ann of chromosome 12, although 
no infonnation about the presence ofi(12p) is available (not shown). 
Our data suggest that RAS mutation and restricted 12p-amplification are related to 
progression of TGCT. It allows tumor cells to sun·ive outside the spccific micro-environment of 
the CIS cells by inhibition of induction ofapoptosisJ known as "anoikis" (Frisch & Francis, 1994). 
The reason that homogeneous 12p-amplification is predominantly found in seminomas can be 
related to the diminished requirements of nonseminomatous hUllor cells for survival. Tills idea is 
supported by the relative ease of ShOlt tenn culture for karyotyping (Van Echten-Arends el al., 
1995), and the success rate of establishing nonseminoma cell lines (Andrews el al., 1996). It 
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remains to be established whether involvement of RAS causes down-regulation of FAS, as 
suggested recently (Fenton ef al., 1998; Peli ef al., 1999), and whether activation of the 
serine/threonine kinase AKT is involved (Aoki ef al., 1998; Bmnet ef al., 1999). In addition, it is 
unknown thus far, which genes in the SROA are in fact involved. The absence or at least lower 
incidence of gain of 12p sequences in CIS as rep0l1ed before (Looijenga et al., 1999; 
Vorechovsky & Mazanec, 1989; Vos ef al., 1990 and unpublished observations) support this 
model. 
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Until recently. metaphase spreads were required for the analysis of the chromosomal 
constitution of neoplasms. This requirement was partly circumvented by the introduction of 
FISH (Pinkel et al. 1986). Ever since the method has been improved and modified. CGH 
introduced by Kallioniemi in 1992, is an entirely novel application of FISH (Kallioniemi et al. 
1992; Dn Manoir et al. 1993). This technique visualises chromosomal gains and losses 
compared to the average ploidy by hybrid ising nonnal and tumor DNA with normal metaphase 
spreads. FISH and CGR have created new opportunities for identification of chromosomal 
anomalies in tumors, because they can be applied on frozen and paraffin-embedded archival 
tissue. 
Mainly due to low incidence, little is known about the chromosomal constitution of the 
varous types of genn cell tumors. A more thorough knowledge of the chromosomes in the 
different types of genu cell hImors could shed Jight on their relationship and the genes involved 
in their pathogenesis. With this aim, we did katyotyping, FISH and CGH on a series of human 
testicular gem) cell tumors of neonates and infants (GCTI), adolescents and young adults 
(TGCT) and elderly men (SS). In the following paragraphs the contribution of the findings to 
the understanding of the pathogenesis of these tumors will be discussed, including the role of 
gain of 12p. 
Neonates and infanls 
In this pm1icular group of germ cell tumors one of the striking findings is that 
histologically they are either teratomas or yolk sac tumors, and rarely a mixture of both 
(Moston and Sesterhenn 1985; Hanns and Janig 1986). CIS has not been found in these tumors 
with some questionable exceptions (Jorgensen et al. 1995; Jendell1Y et al. 1995; Chapter 2). So 
far, most of the teratomas have been investigated with flow cytomehy and/or karyotyping. 
Using these methods, no aberrations have been observed (Kaplan et al. 1979; Silver et al. 1994; 
Stock et al. 1995), whieh theoretically may be related to loss oftumor cells dllling processing of 
the samples. To exclude this problem, we did CGH on microdissected teratomatous elements, 
and confinned the absence of gross chromosomal anomalies. In additiol1, FISH showed that 
these tumors are diploid. 
In contrast, aneuploidy has been reported for the yolk sac tumor (Kommoss et a1. 1990; 
Silver et al. 1994). Karyotyping and FISH demonstrated loss of 11'36, 6q and aberrations of3p 
(Oosterhuis et al. 1988; Oosterhuis et al. 1993; Perlman et al. 1994; Jendemy et al. 1995; Stock 
et al. 1995; Periman et al. 1996; Bussey et al. 1999). Although we could not confinl1 loss of 
I p36 by CGH, FISH showed that this particular region is indeed unden"epreseuted in all yolk 
sac tumors studied. In total, we perfonncd CGH 011 four yolk sac tumors of the infantile testis. 
In spite of this limited number of cases, a rather consistent pattem of chromosomal imbalances 
was found. The following imbalances (involved bands are between brackets) were detected: loss 
123 
General discussion 
of parts of 4q (23-33) and 6q (16-22), and gain of palis of 20q was found in all cases, and loss 
of parts of I p (21-31), 8q (23) and gain of palis of 3p (22-24), 9q (34), 12p (12-13), 17q (22-
25), 19q (13) and 22 (13) in at least three cases (see also Table I): 
Table 1; 
Chromosomal aberrations ill testiclllar germ celllllmors fOlllld by CGH in at least 50% oflhe 
cases of yolk sac tllmors (YS) of illfimls and spennatocytic seminomas (8S) (Mostert et ai, 
submitted,' Rosenberg et al. 1998) respectively. and in at least two of the jive studies 
all seminomas (SE) alld nonsemillomas (NS) (Kom e( al. 1996,' Mostert et al. 1996,. 
Ottesen et al. 1997,. Sllmmersgill et al. 1998; Rosenberg et al. 1999) as depicted 
in Figure 1. Aberrations present ill all cases of a specific group are presellted 
in bold and those unique for a particular entity are ullderlined. (Only the 
p or q arm is illdicated, 1101 the :.pecific regiolls illvolved). 
Group histology Loss Gain 
Neonates & 
infants 
adolescents & 
young adults 
elderly 
YS 
SE 
NS 
SS 
• only 12p 12-p13 is involved 
I p, 4q, 6q, fuj, Xp 
lp, 4, 5, 9p, 11, 13, 
lful, lln, 18 
4,5, 6q, 10, llq, 
13,18 
13,12, 22 
3p,9q, 12p*, 17,1.2, 20q, Y 
Iq,2,3p,QQ, 7,8, 10, 12p, 
12q, 14, 15,20,21,22, X 
1,2, Qg, 7, 8, 12p, 12q, 14 
15,16,17q,20q,21,X 
Iq,2,ll\,20 
Besides the four yolk sac tumors, we also studied a reCUlTent yolk sac tumor of a sacral 
teratoma, A highly similar pattem of chromosomal abelTations, both gains and losses, was 
found compared to those of the infantile testis. This is in agreement with earlier kat)'otypic 
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findings (Perlman et al. 1994; Bussey et al. 1999), and indicates that histology rather than 
anatomical site determines the genetic constitution of these tumors. 
One of the yolk sac tumors of the infantile testis showed a high level amplification of 
the 12q12-q14 region, known to contain the MDAl2 gene. MDM2 is described to fonn a 
complex with P53, resulting in degradation thereby inhibiting the function of P53 (Haupt et al. 
1997; Lane and Hall 1997; Midgley and Lane 1997). This led us to investigate the presence of 
P53 and MDM2 in these tumors using immunohistochemistry. While all teratomas and yolk sac 
tumors showed the presence of MDM2, no P53 was observed. Accordingly, 110 mutations 
within exons 5-8 of P53 were found. These data indicate that P53 is not genetically inactivated 
in these tumors but might be non-functional (prives 1998), 
Because of the absence of chromosomal abnonnalities in teratoma, our data do not give 
new insights about the possible relationship between teratoma and yolk sac tumors. It remains 
to be proven whether teratoma can progress into yolk sac tumor, as has been suggested for 
teratoma of the sacral region (Oonzalez-Crussi 1982) and supported by findings in a mouse 
model (Van Berlo et al. 1990). 
Adolescents and adults 
rOCT comprising SE and NS, have been studied extensively with flow cytometry, 
karyotyping and/or FISH. So far the data show that SE and NS are consistently aneuploid, with 
a specific pattem of reiative gains and losses, (Van Echten-Arends et a!. 1995; Sandberg et a!. 
1996, for review). In fact, SE, like CIS, are hypertriploid, and NS hypotriploid. Because of the 
need of ill vitro culturing of cells ofNS for kalyotyping, selection might occur. In addition, this 
can also be the case for SE which are analysed after direct harvesting of metaphase spreads 
from the tumor. Therefore, TGCT have also been investigated by CGH recently (Kol11 et al. 
1996; Mostert et a!. 1996; Ottesen et al. 1997; Summersgill et a!. 1998; Rosenberg et al. 1999). 
In Figure I, the results of the different published CGH studies arc summarised and in Table I 
the most occun"ing chromosomal aben"ations found arc indicated. Overall, the findings support 
the infonnation obtained with karyotyping, i.e. gains of chromosomes 7, 8, 12 and X and losses 
of chromosomes 4, 5, II, 13, 18 and Y (Van Echten-Arends et a!. 1995). FurthemlOre, all CGH 
studies confinl1 the presence of extra copies of the complete short aml of chromosome 12. Our 
initial study (Mostert et al. 1996) showed the lowest number of anomalies, which can be 
explained by the limitations ofihe software used. 
Because SE have all intenncdiate DNA content between 3 and 411 and NS between 2 and 
311, the used average ploidy in CGH to detect imbalances does not cOITespond to any of the 
ploidy fraction of the tumor genome. This problem has been solved recently using multiple 
nonnalisations besides the average as l10nnally applied (Rosenberg et al. 1997; Rosenberg et a!. 
1999). The modified analysis showed additional numerical aberrations which are usually not 
detected by conventional CGH: gain of chromosome I. 2, 6, 14, 15 and 21 and loss of 
chromosome 9" Again, this approach showed that gain of 12p is consistent, even higher than the 
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Fig. 1 :OveNiew of the Chromosomal gains and losses of primary testicular germ ceff tumors of adolescents and adults as determined by five independent 
comparative genomic hybridization·studies (1: Summersgilf et al., 199B; 2: Ottesen et af., 1997; 3: Kom eta!., 1996; 4: Mostertet al. 1996; 5: Rosenberg 
et al., 1999). Gains and losses are indicated at the right and left side of the chromosomes, respectively. Seminomas are shown in black and nonseminomas 
in gray. The anomalies Shown are those which are present in at least 25% of the tumors in that particular study. In total 43 seminomas and 31 nonseminomas 
have been investigated. 
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upper-ploidy level in the majority of cases. 
Besides a highly similar pattcm of chromosomal gains and losses in SE and NS, several 
differences have been observed both using CGH and karyotyping (Van Echten-Arends et aJ. 
1995; Summersgill et aJ. 1998; Rosenberg et aJ. 1999). For example, loss of chromosome 10 
was only found in NS, while loss of (parts at) chromosome 16 and 17 \vas mainly seen in SE. In 
addition, chromosomes 15 and 22 are present in higher numbers in SE than in NS (De Jong et 
a!. 1990, see Figure I). These differences might explain the hypel1riploid versus hypotriploid 
DNA content for SE and NS, respectively (Oosterhuis et aJ. 1989). 
Elderly 
The first infonnation about the ciu·omosomai constitution of SS became available in 
1973, showing a modal chromosome number of two cases, containing 52 and 82 chromosomes, 
respectively (Atkin 1973). Subsequently, several investigators studied the ploidy of these 
tumors either by flO\v cytomctry or image analysis, resulting in conflicting data (Talennan et al. 
1984; Dekker et al. 1992; Takahashi 1993; Looijenga et al. 1994). We reported the first 
karyotype of a SS, showing an aneuploid chromosome number and a limited amount of 
stmctural aberrations (Rosenberg et at 1998). In addition, this sample and three others, 
including bilateral tumors, were studied with CGH, indicating that gain of chromosome 9 was 
the only consistent anomaly (Rosenberg et al. 1998, see Table 1). The finding that most 
imbalances involved whole chromosomes, might be associated with their relatively benign 
behaviour. In situ hybridisation with probes specific for the X and Y chromosomes revealed a 
heterogeneous population of tumor cells. This might be related to the presence of small, 
intermediate and large cells in the histology (Burke and Mostofi 1993; Cummings et al. 1994; 
Eble 1994; Looijenga et al. 1994). The relationship between these particular cell types remains 
to be established. Microdissection in combination with CGH is going to be a useful tool to 
answer this question (Looijenga et al. 1999). 
SS are supposed to originate from type B spennatogonia (Masson 1946; Rosai et at. 
1969; Romanenko and Persidskii 1983). The finding of common chromosomal abnolTIlalities in 
the bilateral SS might challenge this idea. Possible explanations for these similarities are a germ 
line mutation (de novo or familial) or the presence of a metastases. Both ideas seem unlikely 
because no familial SS have been reported and metastases have never been found in pure SS. 
Recently, however, another hypothesis was put forward. Based on the finding of c~KIT in SS it 
has been suggested that at least a percentage of SS originate from early (primordial) germ cells 
(Kraggemd et aI.1999). This might implicate that l11utation(s) take place before migration to the 
gonadal anlages. A relationship between SE and SS has also been suggested based on the 
positivity of these tumors for the nuclear antigen Ki-A 1 0 (Rudolph et al. 1999). Analysis of SE 
and SS for expression of stage specific and meiosis related genes might be informative. 
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Pathogenetic l'e!atiollship(s) 
It is generally agreed upon that SS does not originate from CIS, although an early 
(primordial) origin seems to be possible (see above). The discussion regarding separate or 
common pathogenetic relationships of GCT! and TGCT is partly due to the finding of CIS-like 
cells in the adjacent parenchyma of the first. In fact, two case reports showed these cells based 
on PLAP-positivity and morphology (Jacobsen 1992; Stamp et aL 1993), although these 
findings were criticized by others (Parkinson and Ramani 1993; Hawkins and Hicks 1998). Of 
notice is that immunohistochemistry cmmot be used to identify CIS cells in testicular 
parenchyma in the first year of life since nonnal parenchyma may contain PLAP positive genu 
cells (Jorgensen et aL 1993). In addition, a common pathogenetic pathway of GCT! and TGCT 
seems unlikely, because of their difference in ploidy (see above and Figure 2). 
Interesting however is the finding that yolk sac tumor of the infantile testis may contain 
extra copies of the complete 121' region (Stock et aL 1995; Jendemy et aL 1996), sometimes 
even an i(12p) detected by FISH (Stock et aL 1995), although karyotyping could not confilm 
this (Perlman et aL 1994). This finding of extra copies of the complete 12p region was not 
found in our limited series of cases. We found gain of a restricted part of 12p in three of the five 
yolk sac tumors (Figure 2 and Chapter 2), but this region is different from the region amplified 
in TGCT (Chapter 5). Most likely one is dealing with a TGCT from a patient with early puberty 
in case an i( 12p) is present. 
Additional support for an independent pathogenesis of GCT! and TGCT comes from 
both epidemiological and immunohistochemical data. In contrast to TGCT, no rising incidetlce 
is observed for GCT!. While P53 is reported to be present in TGCT (Schenkman et aL 1995; 
Guillou et aL 1996), this protein was not found in GCT! (Chapter 2). 
Moreover, putative animal models for GCTr and SS have been identified. Mouse 
teratocarcinomas most probably are models for GCT! (Wait et aL 1993), showing a similar 
capacity of progression to yolk sac tumor as their human counterparts (Van Berlo et a1. 1990). 
Canine seminomas most likely are the counterpart of human SS (Looijenga et a1. 1994). The 
absence of animal models for TGCT underscores their uniqueness of these tumors for men. 
In conclusion, these data and the CGH studies reported here are strongly in favour of 
separate genetic pathways for the GCT!, TGCT and SS (see Figure 2). 
12p-alllplijicalioll ill rGCr 
All TOCT show gain of the complete short ann of chromosome 12, illustrated by 
karyotyping, FISH and CGH (see above). In the majority of cases this is due to the presence of 
i(12p). FISH using a probe specific for the centromere, has been reported as a tool to detect 
i(12p) in interphase nuclei (Mukheljee et al. 1991; Rodriquez et al. 1992). We demonstrated 
that this method is not reliable, although it can be improved using double FISH, i.e., 
combination of two probes, specific for the centromere and for the sholi an11 of chromosome 12 
(Chapter 4). In addition, a combination of paint probes specific for the short and long arm of 
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Fig.2: Schematic representation of the development a/normal male germ cells (left panel) and 
testicular germ cell tumors (right panel). The e.ristence a/three separate pathogenetic pathways 
for germ cell tumors of neonates and ill/ants, adolescents and young adults, and elderly are 
supported by their chromosomal constitution. (Abbreviations used; TE= teratoma; YS= yolk 
sac tumor; CIS= carcinoma ill situ; NS= lIonseminoma; SE= seminoma; SS= spermatocytic 
sell/iI/on/a). 
* affecting Ihe 121'12-p13 region; # predominanlly affecling Ihe cOlllplele 12p region. 
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chromosome 12 was also successfully applied for this pUl]Jose (Blough et al. 1997; Blough et 
al. 1998). 
Although the fonnation of an isochromosome 12 is not the initial step in the 
pathogenesis of TGCT (Gem1s van Kessel et al. 1989), its consistent presence in invasive 
tumors indicates that extra copies of genes on the short ann of chromosome 12 are crucial in the 
development of this cancer. Identification of the involved genes is however difficult, because 
the short ann of chromosome 12 is 40 Mb containing as many as 850-1400 genes 
(http://www.ncbLnlm.nih.gov/genemap). Interestingly, we and others identified a number of 
TGCT with an amplification of a restricted region of 12p (Suijkerbuijk et al. 1994; Kom et al. 
1996; Mosteli et al. 1996). We hypothesized that if important genes reside within the amplified 
region, a comparative investigation ofTGCT with and without such an amplification can give a 
clue regarding the biological role of gain of 12p in the development of TGCT. Therefore, we 
studied the incidence of the restricted 12p amplification in a non-selected series of primary 
consecutive TGCT. The 12p amplification was found in around 8% of the cases, both affecting 
SE and NS (Chapter 7). This amplification was predominantly found in cases without i(l2p), 
suggesting it to be an alternative mechanism to gain 12p-sequences. 
FISH showed that the presence of the restricted 12p amplification is related to invasive 
growth. It was found in the invasive tumor and micro-invasive SE cells, but not in CIS. 
Interestingly, it'was homogeneously present in most SE, suggesting that it results in a selective 
advantage for either growth or inhibition of apoptosis in these particular cells. This latter 
possibility was supported by analysis of DNA laddering (Olie et al. 1996) (Chapter 7) and ill 
vitro survival (Chapter 7). Furthennore, SE with a homogeneous restricted 12p-amplification 
presented at a significantly earlier age than those without, although it was not cOlTelated with 
the stage of the disease at clinical presentation or treatment response. Similarly, restricted 121'-
amplification has no prognostic or predictive value in NS. 
In spite of identification of a relative large series of TGCT with a 12p amplification 
(Chapter 7), the shortest region of overlap of amplification (SROA) was not found to be smaller 
than initially detenllined (Chapter 6). Noteworthy, the breakpoints of the amplicons seem to 
cluster in particular regions which might suggest involvement of multiple genes in this 
particular region. This model is cunently under investigation. Thus far three genes have been 
mapped within the SROA: SOX5, JA Wi and K-RAS. Although we do not exclude other genes to 
be involved, we currently favour K-RAS as at lcast one of the candidate genes because of similar 
ill vitro behaviour of SE with a RAS mutation (Olie et al. 1995). Mutations of K-RAS: like 12p 
amplification, has no clinical value. 
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Future perspectives 
The studies described in this thesis have contributed to the understanding of the 
(molecular) cytogenetics of human testicular genn cell tumors. Obviously, many questions 
remain to be answered, in particular related to the factors (genes) involved in the early 
development of these cancers. Investigation of families with a predisposition for a specific type 
of cancer appears to be very fruitful in the elucidation of its molecular mechanisms. For TGCT 
is has been proposed that about 30% of all the patients have a genetic predisposition (Nicholson 
and Harland 1995) and the search for predisposing genes in these tumors resulted in suggestive 
evidence for parts of chromosomes 1,3,4,5,12,14,18 and X (Leahy et aL 1995; Rapley et aL 
1998; Rapley et aL 2000). To obtain more evidence for the presence of predisposing genes, 
more families need to he studied or altemative approaches must be exploited. If these tum out 
to be tumor suppressor genes, these results have to be compared with loss of heterozygosity 
studies. 
The biological role of gain of genes 011 12p in the development ofTOCT remains to be 
resolvcd. In this context analysis of (low) copy numbers of 12p iu CIS, and the possible 
increase during the early phase of invasive growth is of great interest. Final proof about the 
involvement of candidate genes awaits the development of appropriate assays in t'itro or in 
animal models. 
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Summary 
Geml cell tumors are a heterogeneous group of tumors with an incidence between 0. I ~ 
8/100.000. They occur mainly in the gonads, but also in extragonadal sites. In the male, the 
most occurring site of origin is the testis. Three groups of testicular germ cell tumors can be 
distinguished: 
geml cell tumors of neonates and infants (GCTI): teratomas and yolk sac tumors 
testicular germ cell tUlllorS of adolescents and young adults (TGCT): seminomas and 
nonseminomas 
testicular genn cell hllllorS of the elderly man (SS): spermatocytic seminomas 
This thesis describes the study of chromosomal aberrations in these three groups of 
testicular genn cell tumors by karyotyping, fluorescence ill situ hybridisation (FISH) and 
comparative genomic hybridisation (CGH). Because of their rarity (0.1-21100.000), the genetic 
infol1nation of especially the GCTI and SS is limited. Chapter 2 describes the chromosomal 
analyses of GCT!. The results confiml previous indications for the gross absence of 
chromosomal abenations in teratomas (TE). In contrast, the yolk sac tumors (YST) show a 
consistent pattem of chromosomal abnol1nalities; loss of (parts of) Ip, 4q, 6q and gain of parts 
of 3p, 9q, 12p, 17, 19q, 20q and 22. Immunohistochemistry shows presence of MDM2 and 
absence of P53 in all studied GCT!. In chapter 3 the chromosomal constitution of four SS, 
including one bilateral, is investigated. These tumors show mainly numerical aberrations, with 
gain of chromsome 9 as only consistent aberration. FISH illustrate that SS are heterogeneous, 
supporting histological findings. 
The TaCT always show overrepresentation of the short ann of chromosome 12; in 50-
80% as an isochromosome. Chapter 4 describes the detection of this aberration in cell-lines of 
TGCT usiug a bi-colour FISH approach. A series of plimary TGCT was analysed with CGH 
and described in chapter 5. Besides the confonnation of earlier karyotypic data, this study 
identifies the presence of a small amplicon on the short ann of chromosome 12, previously 
described only in a metastasis of TGCT. Chaple!" 6 describes the detection and mapping of the 
shortest region of overlap of amplification (SROA) on 12p. In the SROA, estimated between 
1.7-3.2 Mb in size, three known genes are mapped; K-RAS, SOX5 en JAW]. In an attempt to 
diminish the SROA, a series of TGCT (n~76) was investigated for the presence of 12p-
amplicons (chapte!" 7). Despite the fact that 12p amplicons are found in about 8% of these 
hUllors, affecting both seminoma and nonseminoma, the SROA is not reduced. The breakpoints 
of the ampticons are found to cluster in particular regions which might suggest the involvement 
of multiple genes in the amplified region. 
FISH indicates that 12p~amplification arise rather early during tumor development, 
associated with invasive growth. Seminomas with a restricted 12p amplification show, like 
tumors with a RAS mutation, a better ill vitro survival. This finding together with the absence of 
DNA~laddering, suggest a blockade of apoptosis in these tumors. The in vitro similarities of 
tumors with 12p amplicon and those with a mutation in RAS are in favour for K~RAS as one of 
the candidate genes on 12p. Despite the fact that seminomas with 12p amplification in all 
tUll10rcells are manifested clinically at a significantly younger age, no other clinical value was 
found. ChapIN· 8 describes the pathogenetic relationship between the different groups of 
testicular genn cell tumors. The differences in ploidy, chromosome pattern, presence or absence 
of CIS and immunohistochemistry, support a separate pathogenesis for each group of testicular 
genu celJ tumors. 
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Samenvatting 
Oit proefschrift beschrijft het onderzoek naar afwijkingen in het DNA van 
kiemceitumoren van de testis. Om dit onderzoek te kUIUlen begrijpen voIgt eerst enige bas ale 
infollnatie over DNA en kanker. 
De elfelijke /nformatie vall iedere cel bevindt zich in het DNA, gelegen in de celkern, Bij 
delende cellen is he! DNA sterk gecomprimeerd ell zichtbaar in de vorm vaJl speciale 
structuren: de chromosomen, Aile mel1selijke cellen, mel uilzondering vall de geslachtscellen, 
bevatten 23 paar chromosomen. S011lS komen afwijkillgell in deze chromosomen Vaal', zoals bij 
kankercellen, Deze afivijkingell kWlflen spontaan ontstaan of door verschillende exteme 
facloren zoals bijvoorbeeld virussell of bepaalde slo/fen ill voeding ell omgeving, en kWl1Iell 
ollder speciale cond/ties wordell overgei!lfd. Afivijkillgell il1 chromosomen of DNA kUllllell 
aanletding geven tot het ontstaan van kallker, eel/ proces dat zicll llleestal ultstreld over een 
periode van tielltallenjaren. 
Het aantonen van deze afivijkillgen kall van nut Zijll bij hef identificerell ell hel 
voorspellen vall hef gedrag vall een kanker. Rovend/en kwmen bepaalde afivijk/ngell een 
indica tie geven over welke gellell * betrokken zijll bij de ontwikkelillg ervan. Kankel' word! 
veelal gekenmerkt door oll!regelillg vall een of mea genen. Dit kunnell genen zijn die Ilormaal 
gesproken de groei remmell (suppressorgenell), genen die grod slil1lllleren (ollcogenen) of 
genen die schade in het DNA herstellell (DNA l'epair-genen), 
Genet/selle ajwijkingen kwmell op chromosomaal nivealt zichtbaar zijn, Dit kall 
aangetoond l1!ordell door de chr011l0somell, verkl'egell lilt delende cellen, Ie behandelell met 
speciale kleurillgsteelmiekeJl. Meer recent olltwikkelde teclllliekell als FISH (jIuorescellce in 
situ hybridisattoll) ell CGH (comparative genomic hybridisation) kllllJleJl zelJs bij afivezigheid 
vall deleJ/de cellen, clll'OmOsomale afivijkillgen ill kaal't brellgell. Dil is vooral van belang bi) 
soUde tumOl'eJl Wam1!Qn deleJtde cellen vaak moeilijk te verkri)gen zijn. In dil proefsellrift 
werden deze !eclmieken !oegepast VOOI' de analyse van ellromosomale afivijkingen vall de 
(solide) kiemceltumoren wm de testis. 
Kiemceltumoren zijn relatief zeldzaam met een incidentie van 0.1 ~8 per 100.000. Zij 
ontstaan uit kiemcellen, welke de vooriopers zijn van de zaadcellen bij de man en de eicellen 
bij de vrouw. De tllmoren die uit deze cellen ontstaan kUllnen op verschillende plaatsen 
voorkomen, Bij de man is de testis de meest voorkomcnde locatie. Bitmen de groep van 
testiclilaire kiemceltumoren worden drie groepen onderscheiden: 
- die van hel jonge kind (GCT!): leralomen (TE) en dooierzak lumoren (YS) 
~ die van adolescenten en jonge volwassenen (TGCT): semillomen en 
nonsemillomen 
- die van de ouderc man (SS): spermatocytair seminomcn 
Door de chromosomale samellstelling van deze drie groepen te onderzoeken kan kennis worden 
verkregen over welke (genetische) afwijkingen betrokken zijn bij hun ontwikkeling. Het 
vergelijken van deze groepen onderling, geeft infonnatie over de mogelijke pathogenctische 
relatie(s) tussen de verschillende tumortypen, 
De GCT! en SS zijn het meest zeldzaam (0,1-0,2 per 100,000,), Over de chromosomale 
samenstelling van deze tumoren is dan ook nog maar wcinig bekcnd. Met bchulp van de 
tcclmicken FISH en CGH wcrd voor beidc grocpcn een karaktcristiek chromosoompatroon 
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gevonden. De GCTr vertonen een aantal consistente chromosoom afwijkingen: verlies van 
de1en van ehromosoom C 4 en 6 en winst van delen van ehromosoom 3, 9, 12, 17, 19,20 en 22. 
Bovendien kon aannemelijk worden gemaakt dat het (proto) oncogen MDA12 een rol zou 
kunnen spelen in de ontwikkeling van deze tUl11oren. Bij de SS werden voomamelijk 
afwijkingen van complete chromosomen gevonden met winst van chromosoom 9 als enige 
consistente af\vijking. 
Doordat de incidentie van de TOCT een stuk hoger is dan die van de andere twee 
groepen nl. 6-8 per 100.000, zijn deze tumoren veelvuldiger bestudeerd, inclusief hun 
chromosomale patroon. TGCT bezitten altijd extra kopieen van het bovenste deel (de korte 
affil) van chromosoom 12, meestal in de voml van een zogenaamd isochromosoom. Dit wijst 
erop dat genen op de karte arm van chromosoam 12 van belang zijn voor de ontwikkeling van 
TGCT. Identificatie van deze genen is echter moeilijk ollldat theoretisch 2000-4500 genen in dit 
gebied kUllllen liggen. Met behulp van de CGH techniek was het mogelijk in ongeveer 8 % van 
de primaire TGCT een amplificatie** van een klein gebied van de korte aml van chromosoom 
12 (121') te detecteren. Hierdoor waren we in staat het gebied van studie 01' 121' te verkleinen en 
een aantal genen te selecteren die van belang zijn voor de biologie van TGCT. Tot nu toe lijkt 
het oncogen K-RAS de meest voor de hand liggende kandidaat. Deze conclusie wordt 
ondersteund door het feit dat in weefselkweek, tumoren met een 12p-amplificatie hetzelfde 
gedrag vertonen als tumoren met een mutatie van K-RAS. Om meer infonnatie over de 
biologische 1'01 van de 12p-amplificatie te verktijgen, werden tumoren met en zonder 
amplifieatie met elkaar vergeleken. Seminomen met een 12p-amplificatie manifesteren zieh op 
significant jongere leeftijd (ca. 27 jaar) dan selllinomen zonder 12p-alllplificatie (ca. 35 jaar). 
Desondanks kon geen klinische betekenis van de 12p-amplifieatie worden vastgesteld. 
De gevonden versehillen in ehromosoompatroon bij de drie groepen testieulaire kiemcel 
tumoren ondersteunen de gedachte dat de tUll10ren van deze drie groepen verschillende, 
onafhankelijke ontstaanswijzen hebben en dat hierbij verschillende genen een rol spelen. 
* 
** 
stukken DNA die de erfelijke informatie bevatten voor de eigensehappen van een eel. 
een groat aantal kopieen. 
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AMCA 
bp 
CARD 
CGH 
CIS 
COBRA 
CT 
DOP 
DMs 
DNA 
FISH 
FITC 
GCTI 
HSRs 
i( 12p) 
Kb 
Mb 
NS 
PCR 
PLAP 
PRINS 
SE 
SKY 
SS 
TE 
TGCT 
YS(T) 
Abbreviations 
amino~methyl-coumarinyJacetic acid 
base-pairs 
catalysed reporter deposition 
comparative genomic hybridisation 
carcinoma ill situ 
combined binary ratio labeling 
combined tumor' 
degenerated oligoprimed PCR 
double minutes 
deoxyribonucleic acid 
fluorescence ill silu hybridisation 
fluorescein isothiocyanaat 
genu cell tumors of neonates and infants 
hOl11ogenously staining regions 
isochromosome 12p 
kilobase 
megabase 
nonseminoma 
polymerase chain reaction 
placental alkaline phosphatase 
primed in situ peR 
seminoma 
spectral karyotyping 
spennatocytic seminoma 
teratoma 
testicular genu cell tumors of adolescents and young adults 
yolk sac tumors 
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Dallkwoord 
"Vaal' het kellllen van de weg, moe/en we gelvooll op weg. Je dingen doen, liefs! met plezier, 
heel simpel op de Poell manier" 
Mijn weg begon in 1964 in CapeJ1e aid JJssel aan de Reigeriaan, als eerste uit het nest 
van Henk en Riet Mostert. Na het velgen van verschillende opleidingen kwam ik aIs groentjc 
(roodje) terecht in het wetenschappelijk onderzoek bij TNO in Rijswijk. Daar werd mij al snel 
duidelijk dat wetenschap een echte hobby is. Dit "lord vooral geYllustreerd door twee gedreven 
onderzoekers; Barb Trask en Ger v/d Engh. Hun interesse en enthousiasme voor zowel 
wetcllschap als nahmf hebben een belangrijke stempel gezet op het verdere vcrloop van mijll 
wegen, zowel wetcllschappelijk als prive. Zij stimuleerden mij in het valgon van avondstudies 
en introduceerden mij in de meerdaagse "hikes". Ook was ik zeer blij met de mogelijkheid, 
jaren later in Seattle, een half jaar onderzoek bij hun te kunnen doen, en de gelegenheid die zij 
mij tijdens deze periode gaven om tevens wat werk voor LEPO te kunnen verrichten. 
Een nieuw avontuur startte met Lambert Dorssers, die mij vroeg am als ana list een lab fe 
helpen opzetten op de Daniel den Hoed kliniek. Als "moleculair verpleegkundige" met de 
meest besproken benen van de Daniel, liet hij mij kClUlis maken met de echte moleculail'e 
biologie en stelde mij bovendien in de gelegenheid am deeltijd biologie te gaan studeren in 
Utrecht. Ondanks onze goede band, bekoelde mijn interesse in het gesleutel aan het humane 
lL3-gen wat rcsulteerde in full-time studeren. De keuze om biologie te gaan studeren was een 
goede, al was het aIleen al voor de ontmoeting met Reina. Reina, onze wegen komen voor een 
groot deel overeen (gelukkig voor Leendert niet helemaal) wat leidt tot vele gesprekken (tijdens 
hoogte en diepte-punten), wilde planncn en regelmatige uitstapjes (gaan we nu eindeIijk 
kanoen?). kortom ik ben erg blij datjij een van mijn paranimfen bent. 
Droog brood op de plank dwong mij tot een bijbaantje in de diagnostiek bij LEPO. Na 
een half jaar werd er cen nieuw project gestm1 en wisten Prof. Oosterhuis en Leendert 
Looijenga mij te motiveren voor hun onderzoek naar chromosomale afwijkingen in 
kiemceItumoren. Aangesteld op een analistenplaals gaven zij mij de mogelijkheid zelfstandig 
onderzoek te doen en ook gelegenheid om de resultaten op papier te zetten. Dat heeft 
uiteindelijk geleid tot dit proefschrift. Uiteraard is al dit werk niet aIleen gedaan. Veel mensen 
hebben hieraan bijgedragen. Ondanks dat het waarschijnlijk leidt tot het onterecht vergeten van 
personen, \Vii ik toch een aantal mensen met name Iloemen, In eerste instantie Mirjam, ofte\vel 
"polIeke", Nu ex-lid van het LEPO-team. Ben groot dee I van dit werk is ook jOllW verdienste, 
ontelbare hi situ's heb je gedaan en mede door jOllw chromosomen-kennis konden we samen de 
CGH resultaten in Nijmegen analyseren. Samen met AtUlemieke Verkerk heb je ook sterk 
bijgedragen aan de mapping van het 12p-amplicon en binnenkort zal eindelijk blijken dat die 
buik niet aileen door het snoepen bij LEPO komt. Annemieke, jij hebt het 12p werk een Oinke 
duw (in de goede richting) gegeven. Ondanks dat wij het duidelijk niet altijd met elkaar eens 
waren, decldcn wij in elk geval de HHelieboms" interesse. Ook de overige (ex) LEPO-Illensen 
(Jacqueline, Robert, Marjolein, Ruud, Ad, HmUlie, Ton, Helene, Marja, Kirsten en Fons) 
hebben op de een of andere manier bijgedragen en ook wat verdragen. Met bctrekking tot het 
laatste wil ik hierbij mijn oprechte excuses aanbieden voor mijn dagelijks terugkerende 
gezoem. Hans Stoop, een van de nieuwe LEPO aanwinsten, is met name zeer ondersteunend 
ge\Veest bij de meer recentc artikelen. Plczier in wetenschap wordt zeker door jou gerllustreerd 
en jij bent vast de voIgende. 
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Het hier beschrevcn onderzoek is enkel mogelijk door het bestaan van de verzameling 
tumoren die het "LEPO~team" in de loop van de jaren llCeft opgebouwd. Dit is gelukt door de 
bereidwilligheid van verschillende pathologen en urologen, dank hiervoor. 
Prof. Oosterhuis; opperhoofd van de afdcling LEPO en tevens mijn promotor, u ben ik 
dankbaar om tenminste twee verschillende redenen. Ten eerste zorgde u, samen met Leendeli, 
voor het bestaan van een project dat op mijn Jijf was geschreven, maar vooral, voor het uit 
Groningen meenemen en binnen gezichtsveld brengen van "mijn" Leendeli. 
Het groDtste dee 1 van de CGH-anal)'ses konden gelukkig dichter bij Imis worden 
uitgevoerd, op de afdeling cytochemie cn cytometrie (Leiden), met de hulp van Carla 
Rosenberg. This resulted in several publications but also a nice friendship, Since morc than a 
year the common interest is expanded in baby~stuff. Carla, I really enjoyed the time in Leiden, 
thanks for all your suppOli." ... " , .. , .. Iet's go to Bleiswijk. 
Het afgclopen jaar is vooral gewijd aan het schrijven van dit boekje, Dit had als gevolg 
dat de socia Ie contacten op een laag pitje kwamell te staan. Dank aan iedereen voor het geduld 
en begtip, zullen we nu dan eindelijk die skate~, 1lUis gaan bekijken-, thais eten- of zomaar 
afspraak maken??? 'Vat het schrijven ook zcer ten goede kwam was de bereidwilligheid van 
Gerard van den Aardweg om gedurende deze periode zijn kamer te delen met mij, Gerard, 
bedankt voor je zorgzaamheid en gastvrijheid, 
IvIijn aanwezigheid op LEPO werd ook gekenmerkt door tweemaal een periode van 
afwezigheid. Dit werd veroorzaakt door in eerste instantie de geboorte van Maarten, en 2,5 jaar 
later van Anna. Ik kon blijven werken omdat :NIaarten en AlUla in goed handen warenizijn. 
Halma bedankt voor je liefdevolle zorgen, jouw flexibiliteit en betrokkenheid is een onmisbare 
schakel in dit gehee!. 
De andere teIgen uit het al genoemde Mostert nest zijn vervolgens; Mark, Saskia en 
Jeroell. Elk hebben ze een aandeel gehad. Mark, al zeg je weinig, leuk dat je regelmatig 
langskomt, iets wat speciaal door Anna wordt gewaardeerd, Het maakt niet uit dat jij soms voor 
vier eet, zodat we niks meer hebben om in te vriezen, en inderdaad; er zit al een glas om een 
flesje bier, Jeroen, niet enkel als bewijs dat erfelijkheid complex, maar het uiterlijke resultaat 
ten dele herhaalbaar is, ben ik blij met jOll, \Vij zijn het levende bewijs dat er vele wegen naar 
Rome leiden. Sas, we verschillen sterk op allerlei fronten, toch kUt111en we heerlijk bomen en 
als wcdcrzijdse praatpaal fungercn, Fijn dat je 111 'n ZLiS en paranimfbent. 
Als een van de laatsten maar zeker niet in de minste: pap en mam, Ook al staan jullie 
niet altijd te juichen bij mijn (welovcrwogen) beslissingen, jullie altijd oprechte 
gei'nteresseerdheid, medeleven, steun en bereidwilligheid 0111 bij te springen als oma Riet en 
opa Hcnk, zijn van onschatbare waarde. 
Lievc Leendert, dit boekje is eigenlijk het meest voor jOll. Voor jou zal het ook een hele 
opluchting zijn als het allemaal achter de rug is. Geen werkbesprekingcn meer in de auto en 
thuis ... " .. we zullen het nog rnissen. Dank voor dc ontelbare malen dat je de stukkcn hebt 
doorge1ezen en gecorrigeerd, je hulp bij de figuren maken en vooral je (bijna) altijd positieve 
benadering en vertrouwen in mijn kUtUlen." ... ", 
Ik ga \'erder op weg, mijn dingen doen, Iie!>t met plezier, heel simpel op de A1arijke manier, 
Marijke 
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Curriculum vitae 
Marijke Mosteli werd op 14 september 1964 geboren te Capelle aid IJsse!. In 1980 
behaalde zij haar diploma aan de christelijke MA VO in De Lier. Hiema vlerd begonncn met de 
analistenopieiding aan het Van Leeuwenhoek Instituut te Delft waaf de volgende specialismen 
met succes werden afgesloten: HBO-A botanie (1983), HBO-A zoologie (1984), HBO-B 
biochemie (1987) en HLO biochemie (1988). Tijdens deze studies werden onderzoekstages 
uitgcvoerd bij het Instituut voar Plantenziektekundig Onderzoek in \Vageningen, het 
Radiobiologisch instituut TNO in Rijswijk en Lawrence LivelIDore laboratorium te Livennore 
in Califomie (USA), In 1989 werd begoIU1en aan de studie biologic aan de universiteit in 
Utrecht welke in 1993 succesvol werd afgerond. Tijdens deze studie vanden twee 
onderzoeksstages plaats: I) op de afdeling haematologie bij TNO in Rijswijk waal' detectie van 
5q deleties bij het myelodysplastisch syndroom werd geoptimaliseerd en 2) bij het Integraal 
Kanker Centrum in Rotterdam waar cell voorlichtingsfolder voor beenmerg-donoren werd 
ontwikkeld. 
Gedurende een deel van de studies heeft zij gewerkt als research analist op verschillende 
instituten: de afdeling flowcytometrie van het Radiobiologisch instituut TNO (1984-1987), de 
afdeling Moleculaire Biologie van de Dr. Daniel den Hoed kliniek (DDHK)(I987-1991) en het 
Laboratorium voor Experimentele Patho-Oncologie (LEPOIDDHK) (1993). Teyens was zij in 
1993 freelance wel'kzaam als medewerkster voorlichting bij de DDHK. Vanafjanuari 1994 tim 
juni 1994 verrichte zij onderzoek op de afdeling Moleculaire Biotechnologie aan de 
Washington University in Seattle (USA). In angustus 1994 werd zij aaugesteld als research 
analist op de afdeling LEPO (DDHK). Het verrichte onderzoek werd gefinancierd door de 
Nederlandse Kanker bestrijding (Koningin Wilhelmina Fonds, K\VF) en staat beschreven in dit 
proefschrift. Marijke is getrouwd met Leendert Looijenga waatmee zij twee kinderen heeft; 
Maarten Wieger (1995) en Anna Marije (1998). 
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Chapter 2. Fig. 1: Representative example of a frozen tissue section of a teratoma of the 
infantile testis, before (left panel) and after (right panel) microdissection. 
Chapter 2. Fig. 3: Representative 
e).·ample of the double fluorescent in 
situ hybridisatioll with a probe specific 
for the centromeric region of 
chromosome 1 (red signa/), and one for 
the Jp36 region (green signal) on a 
forma/infixed, paraffin-embechled yolk 
sac tumor of the inflmlile testis (case 
no. 4). Note the reduced number of 
signals of the lp36 region (green) 
compared to the centromere (red). 
Chapter 7. Fig.2 B: Representative 
example of banding (left panel) and 
spectral kwyotyping (real color al the 
right andfalse color ill the middle) ofa 
chromosome j 2 derivative, known to 
contain restricted j 2p-amplijiclltion (as 
determined by in sitll hyhridisatioll alld 
CGH). Note that the chromosome is 
composed of chromosome j 2 material 
(indicated in plOple), except the most 
distal region of the p -arnl, showing 
chromosome 20-specijic material 
(indicated in blue). 
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Lefipage: 
Chapter 2. Fig. 4: Representative examples a/the immunohistochemical detection of the P53 
protein (middle panel) and MDM2 protein (lower panel) on a tissue section of a forma/in-
fixed, paraffin-embedded teratoma (left panel) and yolk sac tumor (right panel) of the 
infantile testis. No P53 could be detected, while all tumor cells showed the presence of 
MDM2. The corresponding hematoxylin and eosin (H&E) stained slide is represented in the 
upper panel of the illustration. (magnification 100 X). 
Rightpage: 
(uppe/) 
Chapter 3. Fig. 1: Results of comparative genomic hybridisation of spermatocytic seminoma 
2 (SS2) showing a representative example of a digital image of a normal metaphase spread 
(46,XY) hybridised with DNA isolated from the tumor (detected in green) and reference DNA 
(46,XY) (detected in red). 
(lower) 
Chapter 5. Fig. 3: Example of the result of comparative genomic hybridisation on 
chromosome 12 of the seminoma component of combined tumor 2207, showing tumor 
specific amplification (represented as relative overrepresentation of the green compared to 
the red signal), encompassing region 12p11.1-p12.1 The blue line represents the ratio profile, 
i.e. the red to greenjluorescence intensities over the whole chromosome length. 
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Leftpage: 
Chapter 4. Fig.2: (A) Double fluorescence in situ hybridisation (FISH) of a metaphase 
~pread of S2 with the centromere-specific probe for pa12H8 (tetramethyl-rodamine 
isothiocyanate TRITC; red signal) and I2p paint (FITC, yellow signal) and DAPI as 
counterstaining of the chromosomes: No 12p- or centromere-derived sequences are present 
on the cytogenetically identified iO 2p) (arrow), whereas 12p and centromere sequences are 
hidden in the cytogenetically identified der(4)(4;I2)(pI3;qII) (lower right). (B) Double FISH 
with paI2H8 (TRITC) and yeast artificial chromosome (YAC#5) (FITC) on a metaphase 
spread of S2; there was no hybridisation of YAC#5 with the cytogenetically identified 
der(4)t(4;l2)(pJ3;qll) (arrow). (C) FISH with pal2H8 (TRITC) and YAC#5 (FITC) on a 
metaphase spread of H12.I showing centromeric region in the add(J8)(pll.I) (arrow). (D) 
Original photograph of a single FISH on a metaphase spread of NT2 with paI2H8 (FITC) 
and propidium iodide as counters/aining of the chromosomes showing enlarged centromeric 
hybridisation regions a/the i(12p)s (arrows) as compared with their normal counterparts. (E) 
Original photograph of a double FISH with paI2H8 (TRITC) and YAC#5 on an interphase 
nucleus olNT2 showing three normal chromosomes 12 (one centromeric and one YAC signal) 
and two i(l2p)s (one centromeric and two YAC signals), without size differences of the 
TRiTe-signals. (F) Overrepresentation of the short arm of chromosome 12 in NT2, as 
detected by comparative genomic hybridisation. 
Right page: 
(upper) 
Chapter 6. Fig. 2: Example of bicolour fluorescence in situ hybridisation on isolated nuclei 
from tumor T8763, showing (a) similar signal numbers using YAC#5 (detected in green) alld 
c08mid 3IC2 (containing STS DI2S1350E) (detected in red) as probes; and (b) a lower signal 
number for cosmid 124A3, specific for STS D12S1411 (detected in red) as compared to 
YAC#5 (detected in green). Signals for the cosmids (in red) are larger than the signals for the 
YACs (in green) because of a biotinyl-tyramide amplification step used to visualise the 
cosmids. 
(lower) 
Chapter 7. fig. 3: Representative examples of double fluorescent in situ hybridisation all 
frozen tissue sections of 4 flm using a probe specific for the centromeric region of 
chromosome 12 (red) and YAC#5 (green), mapped within the shortest region of overlap of 
amplification (see Figure 1). Shown are A) carcinoma in situ,· B) micro-invasive seminoma; 
C) invasive seminoma. The tumor cells are identified by the direct enzymatic alkaline 
phosphatase detection method (stained in red) all a parallel tissue section. 
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